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SUMMARY
Epidemiological studies suggest differences in the prevalence and 
natural history of microvascular complications between subjects w ith  
insulin dependent (IDDM) and non-insulin dependent (NIDDM) diabetes. 
The haemodynamic hypothesis proposes that early functional changes 
in the m icrocirculation result in the eventual development of diabetic 
microangiopathy. There is now a large body of experimental evidence 
in support of th is hypothesis in patients w ith  IDDM, w ith  abnormalities 
in blood flo w , capillary pressure and permeability having been 
demonstrated. In contrast, there have been few  studies investigating 
microvascular function in NIDDM; however, preliminary w ork has 
identified a profound lim itation in microvascular vasodilation at an early 
stage, while capillary pressure does not appear to  be elevated. The 
aim o f this thesis was to  further investigate functional changes in the 
skin m icrocirculation in patients w ith  NIDDM and impaired glucose 
tolerance (IGT).
1. Using a sensitive plethysmographic system, no difference was found 
in microvascular flu id permeability between patients w ith  NIDDM and 
control subjects (5.3 (3.2-9.1) x 10"^ ml.min'^ .1 OOg tissue"^.mmHg"^ 
vs 5.4 (3.5-8.0) X 10"^ m l.m in '\ lO O g  tissue"^ .m m H g'^, median and 
range; p = 0 .98 , Mann-Whitney).
2. In confirmation of previous studies, reduced m icrovascular 
hyperaemia in response to local heating of the skin was found (using 
laser Doppler fluxim etry) in NIDDM patients w ith  large vessel disease 
excluded (0.82 (0.42-1.41 ) V vs 1.40 (0 .89-2.13) V control
XU
subjects; p < 0 .005). Limited vasodilation correlated w ith  fasting 
plasma insulin {Rg = -0 .6 3 , p < 0 .0 4 ) but not glycaemic control. 
M icrovascular hyperaemia increased after one year of improved 
glycaemic control in recently diagnosed patients (1 .20 (0 .51-3 .93) V 
vs 0 .97 (0 .22-2.17) V at baseline; p < 0 .0 5 ). In hypertensive 
NIDDM patients, there was no further reduction in m icrovascular 
vasodilation (1.05 (0 .70-1.42) V vs 1.04 (0 .79-1.63) V
normotensive NIDDM, p = 0.82), although there was an increase in 
calculated resistance to blood flo w  (127.2 (87 .5 -181 .3 ) mmHg.V"'* 
vs 84.7  (61 .9-123.0) mmHg.V"^ normotensive patients, p <  0.02).
3. Reduced microvascular hyperaemia was found in subjects w ith  IGT 
(1.01 (0 .71-1.57) V vs 1.41 (1.32-2.13) V control subjects,
p <  0 .001), and also insulin resistant patients w ith  acromegaly 
(0 .96 (0 .56-1.70) V vs 1.46 (1.24-2.13) V control subjects,
p <  0.05). In subjects w ith  IGT, limited vasodilation was found to  
correlate w ith  fasting plasma insulin (Rg = -0.7; p <  0 .001) and 
insulin sensitiv ity (Rg = 0 .52 ; p <  0.02), but not w ith  B-cell 
function, plasma glucose or serum lipid concentrations.
4. Using iontophoresis and laser Doppler fluxim etry, defective
endothelium-dependent vasodilation was found in subjects w ith  IGT 
(518 (410-905) AU .m in-l vs 1236 (875-1588) A U .m in i control
subjects, median and range; p < 0.003). In contrast there was no 
significant difference in myogenic (683 (301-1175) A U .m in i vs 898 
(303-998) A U .m in i control subjects; p = 0.5) or neurogenic 
vasodilation ( 61 (31-109) AU vs 46 (37-146) control subjects; p = 
0 .8).
Xlll
5. No differences in skin capillary density were found between patients 
w ith  NIDDM, subjects w ith  IGT and control subjects under basal 
conditions (112 (71-144) caps.m m '^ vs 107 (76-140) caps.mm-2 vs 
112 (76-138) caps.mm'2 respectively; p =  0.9, Kruskal Wallis), or 
after venous occlusion (122 (87-157) caps.mm"2 vs 121 (90-143) 
caps.mm'2 IGT vs 123 (81-147) caps.m nr^; p =  0.9).
In light o f the above results, a unifying hypothesis has been proposed 
to  explain the differences in epidemiology and pathophysiology of 
m icrovascular disease between IDDM and NIDDM.
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CHAPTER 1
INTRODUCTION
Damage to the m icrocirculation plays a central role in the 
development of the long term  complications of diabetes, leading to  a 
specific m icroangiopathy characterised by basement membrane 
thickening in capillaries, arterioles and venulesT A lthough classically 
affecting the retina and kidney, the histological features of 
m icroangiopathy are apparent in a w ide variety of other m icrovascular 
beds including skin^, adipose tissue^, skeletal^ and cardiac muscle^. 
In addition, it is increasingly recognised that m icrovascular 
abnormalities are involved in the development of neuropathy® and 
diabetic foo t ulceration^. M icrovascular disease is responsible fo r a 
substantial amount o f morbidity, w ith  diabetic retinopathy and 
nephropathy being the commonest causes of blindness and renal failure 
respectively, in the non-elderly population in Western countries®'^.
Non-insulin-dependent diabetes mellitus (NIDDM) is a disease 
characterised by a high prevalence of large vessel disease and 
hypertension, leading to a greatly increased m orta lity from  
cardiovascular causes''®. A lthough patients w ith  NIDDM are subject to  
the same spectrum of m icrovascular complications as patients w ith  
insulin-dependent diabetes mellitus (IDDM), the prevalence and natural 
history of some of these differs markedly in the tw o  types of diabetes, 
as detailed in Chapter 1.3 (page 8). This suggests tha t there may be 
differences in the underlying pathophysiology of m icrovascular disease 
in IDDM and NIDDM. Diabetic m icroangiopathy may result from  earlier 
functional changes in the m icrocirculation, and a large number of 
studies have characterised abnormal microvascular function in patients
1
w ith  IDDM, in contrast to the situation in NIDDM where there have 
been relatively few  studies to date.
The studies in th is thesis attem pt to  determine the nature and 
extent o f abnormalities in skin microvascular function in subjects w ith , 
or at risk of developing, NIDDM; however, before considering the 
effects o f the diabetic state on the m icrocirculation, it is necessary to  
define normal m icrovascular structure and function.
1.1 The normal skin microcirculation.
Microvascular structure:
The m icrocirculation consists of arterioles, capillaries and venules. 
In the skin, small branch arteries divide into a subpapillary arteriolar 
plexus from  which capillary loops supplying the skin surface arise''"' {Fig 
1.1). These nutritional capillaries are arranged in functional units w ith  
one to three capillary loops per dermal papilla''"'. The venous ends o f 
the capillaries merge to form  postcapillary venules which unite to  form  
collecting venules in a subpapillary venous plexus'*''. In the skin there 
are also specialised arterio-venous shunt v e s s e l s ’^ 2 , 1 3  arranged in 
parallel w ith  the nutritive capillaries, which are involved in 
thermoregulation. These are coiled channels of average diameter 35//m  
w hich are most numerous in the nailbeds and pulps of the digits, and 
almost absent on the dorsum of the hands or feet"'2. High blood flo w  
through arterio-venous shunts allows the dissipation of heat, although
Fig 1.1 Diagrammatic representation o f the skin microcircuiation
Epidermis
Capillary loops
Dennis
Arteriole
Arteriovenous anastamosisVenule
even under resting conditions the bulk of skin blood flo w  passes 
through shunt vessels^^
Capillaries consist of a single layer of endothelial cells surrounding 
the lumen and an outer layer of basement membrane which encloses 
occasional pehcytesl^. Arterioles and larger venules have an additional 
outer layer o f smooth muscle cells surrounding the basement 
m e m b r a n e ' ^  5  Endothelial cells are joined together by intercellular 
junctions which are areas of direct contact between specialised regions 
of the plasma membrane of adjacent cells”’ ®. The luminal surface of 
endothelial cells is covered in a layer of glycoprotein material 
(glycocalyx) which also fills  the intercellular junctions'!®. The basement 
membrane is also composed of a lattice of glycoproteins consisting 
mainly of Type 4 collagen, laminin and negatively charged heparan 
sulphate proteoglycan'’ ^. Capillary endothelium in skin, muscle, fa t 
and retina is o f the continuous varie ty ’’ ®, whereas in the glomerulus it 
is fenestrated (perforated by small holes), although the basement 
membrane remains in ta c t”’ ®.
M icrovascular function:
The main functions of the m icrocirculation are the delivery and 
transfer of oxygen and nutrients from  blood to the tissues and removal 
of waste products of metabolism. Exchange of substances across the 
m icrocirculation occurs by a variety of mechanisms depending on their 
exact nature. Fluid and small hydrophilic molecules move through 
intercellular junctions in capillaries and post capillary venules'!, whereas 
small lipophilic molecules (e.g. oxygen) diffuse directly through cell 
membranes'!®. Larger hydrophilic molecules (e.g. proteins) move largely
w ith  fluid by the process of solvent dragi®, ease of passage being 
dependent on molecular size and charge, w ith  the glycocalyx and 
basement membrane acting as a molecular sieve^o, and the strong 
negative charge of heparan sulphate proteoglycan being an im portant 
lim iting fa c to r^ !. The passage of fluid is dependent on the 
transcapillary pressure gradient, which in turn depends on the 
balance of Starling's forces'!® (the hydraulic pressure of blood inside the 
capillary, the oncotic pressure of plasma proteins, and interstitia l 
hydraulic and oncotic pressures). As capillary (hydraulic) pressure is 
arguably the most variable o f these, regulation of microvascular 
pressure and blood flo w  have a major bearing on the exchange process. 
Intrinsic rhythm ical variations in pre-capillary vascular resistance 
(vasomotion)22 allows periods o f filtra tion and reabsorption in individual 
capillaries. Arteriolar diameter is regulated by both neural and humoral 
mechanisms, w ith  the predominant mechanism being dependent on the 
metabolic needs of a particular tissue, and its capacity to  w ithstand 
circulatory deprivation. In the skin, neural mechanisms supervene to 
mediate thermoregulation and arteriolar tone is largely maintained by 
sym pathetic vasoconstrictor nerves, which also maintain low  arterio­
venous shunt flo w  under normal circumstances'!4. This major 
neurogenic control mechanism is modulated by local myogenic and 
humoral mechanisms, such as vasodilation due to  the build up of 
metabolites or release of vasoactive substances by the endothelium '!4. 
In addition, vascular smooth muscle cells can respond directly to 
stretch or tension by contracting (myogenic tone)^®, the sensor fo r 
w hich may reside in the endothelial cel|24.
The endothelium has numerous synthetic functions, including 
involvement in the regulation o f vascular tone through the secretion of 
vasodilator (e.g. endothelium-derived relaxant facto r (EDRF)^®,
prostacyclin^®) and vasoconstrictor substances {e.g. endotheiin^^); and 
in the control of coagulation (e.g. prostacyclin^®, plasminogen 
activator inhibitor-1 ( P A I - 1 ) 2 9 ) .  Receptors exist on endothelial and 
vascular smooth muscle cells fo r a w ide variety o f peptide and non­
peptide neurohumoral mediators, and the particular d istribution of 
these may partly determine the reactiv ity of a given vascular bed®®. 
The function of pericytes, which are more numerous in the retina, is 
poorly understood, but they may be involved in the regulation of 
angiogenesis®"!, and may have a contractile function w ith  the potential 
to  alter blood flow®^. W ith regard to  the latter, it is no tew orthy tha t 
endothelin receptors have been identified on cultured retinal 
pericytes®®. Basement membrane, in addition to  its role in 
m icrovascular permeability, provides structural s tab ility  fo r the 
microvessels, preventing over distension and acting as a scaffold for 
endothelial regeneration and repair fo llow ing i n j u r y " ! F i n a l l y ,  there is 
a netw ork o f lymphatic microvessels which return excess filtered flu id 
and macromolecules to the circulation to maintain homeostasis. The 
structure and function of these in health is poorly defined, w ith  even 
less being known about them in diabetes.
1 .2  [Mon-insulin-dependent diabetes and vascular disease.
As already mentioned, NIDDM is characterised by a high prevalence 
o f large vessel disease and hypertension!®'®4. These problems can 
already be present at diagnosis, w ith  35%  of newly diagnosed patients 
having hypertension and 18% electrocardiographic evidence of
ischaemic heart disease®®^®®. It is known tha t NIDDM may be 
preceded by a period of several years during which a variable 
combination of increasing fï-cell dysfunction and decreasing insulin 
sensitivity®^'®® lead to  hyperinsulinaemia and progressive abnormalities 
of glucose and lipid metabolism, which eventually become manifest as 
impaired glucose tolerance (IGT). Such subjects are at high risk of 
developing NIDDM in the future®®. Hypertension and large vessel 
disease are even present in people w ith  |GT4®,41 who, despite the fact 
they exhibit only a modest degree of hyperglycaemia, already have an 
increased cardiovascular m o r t a l i t y 4 ® , 4 l  _ Atherosclerosis in patients 
w ith  NIDDM differs quantitative ly from  tha t in non-diabetic subjects in 
th a t it a ffects an increased proportion of females, is more extensive 
and diffuse, and tends to  a ffect more distal vessels42.
As discussed in Chapter 1.6 (page 21), mechanisms other than 
hyperglycaemia are liable to  be im portant in the pathophysiology of 
vascular disease in NIDDM, and other metabolic factors such as 
hyperinsulinaemia have been shown to  have a direct e ffect on large and 
small blood vessels^®. There is currently much interest in the role of 
impaired vascular development in the pathogenesis of adult 
cardiovascular disease, and low  birth weight has been associated w ith  
later development of hypertension^^ and premature death from  
ischaemic heart disease^®. Low birth weight has also been associated 
w ith  the development of diabetes and impaired glucose tolerance in 
adult Iife4®, possibly due to  maldevelopment o f the pancreatic R-cells 
or islet vasculature. This observation is of potential interest in the 
context of th is thesis as maldevelopment of the m icrocirculation could 
underlie abnormal m icrovascular function.
1.3  Differences in the epidemiology of microvascular disease between  
non-insulin-dependent and insulin-dependent diabetes.
It has already been stated tha t differences exist in the prevalence 
and natural h istory of m icrovascular complications between NIDDM and 
IDDM. Firstly, m icroangiopathy tends to  be related to  disease duration 
in IDDM, w ith  the clinical manifestations firs t becoming apparent after 
several years of diabetes; for example background retinopathy is rare 
in the firs t few  years of IDDM^^ and before puberty, but increases in 
prevalence w ith  increasing duration of diabetes so tha t it is present in 
over 90%  of patients after 25 years of diabetes^^. The prevalence 
rates for proliferative retinopathy^^ and nephropathy fo llow  a similar 
pattern"^^. In contrast, and similar to  the situation fo r large vessel 
disease and hypertension, patients w ith  NIDDM may already have 
clinical evidence of m icroangiopathy at the tim e of diagnosis, w ith  
21%  o f new ly diagnosed NIDDM patients having been shown to  have 
background retinopathy In one study^^. This phenomenon applies 
equally to other complications such as maculopathy, neuropathy and 
nephropathy^^ and may relate to a long period of undiagnosed diabetes 
or to  the metabolic abnormalities of the pre-diabetic phase. Following 
diagnosis, the subsequent prevalence of m icroangiopathy tends to  be 
less closely linked to  disease duration in NIDDM, so tha t the overall 
prevalence of background retinopathy in patients w ith  a long duration 
of diabetes is lower in NIDDM than in IDDM^^
M aculopathy is a particular problem in NIDDM, being present in 
over 15% o f patients^^; however, sight threatening macular 
involvem ent is rare in patients w ith  IDDM. On the other hand, 
proliferative retinopathy affects around 50%  of IDDM patients after 25
years of diabetes^^, whereas th is Is a less common problem in NIDDM 
patients, being present in only 20%34.
There is no universally accepted definition of diabetic neuropathy 
and it is therefore d ifficu lt to compare epidemiological data from  
d iffe rent studies, w ith  prevalence rates for neuropathy varying from  
10%  in studies based on clinical findings, to  greater than 90%  in 
studies based on electrophysiology. It has previously been suggested 
th a t the prevalence of peripheral sensori-motor neuropathy and 
autonomic neuropathy was similar in the tw o  types o f diabetes^^, 
although recent evidence from  neurophysiological and anatomical 
studies suggest differences between IDDM and NIDDM. A higher 
degree of both small and large nerve fibre dysfunction being found in 
NIDDM patients w ith  both subclinical and sym ptom atic neuropathy in 
one study^O^ whereas a similar pattern of abnormalities has been 
reported in NIDDM and IDDM patients w ith  subclinical neuropathy in 
a n o th e r^ i. Differences have been found in the histopathology of 
peripheral nerve lesions, w ith  axo-glial dysjunction predominating in 
IDDM, and focal fibre loss and Wailerian degeneration in NIDDM^^. It 
appears tha t some patients w ith  NIDDM already have disturbed nerve 
function at diagnosis^G, w ith  only slight deterioration over the next 5 
years, except for some patients w ith  poor c o n t r o l ^ T  There appears to  
be a s ignificantly higher prevalence of subclinical autonomic neuropathy 
(as assessed by cardiovascular reflexes) in NIDDM^^, despite the fac t 
th a t sym ptom atic autonomic neuropathy is uncommon.
Diabetic nephropathy affects 30-40%  of patients after 1 5 years of 
IDDM^^. In contrast, only 3-8%  of elderly Caucasian NIDDM patients 
reach end-stage renal f a i l u r e ^ G , 5 7 .  however, the m ajority o f diabetic 
patients requiring renal replacement therapy in some series have NIDDM 
as th is is the more prevalent form  of diabetes^. There is evidence tha t
the rate of decline in renal function may be slower in NIDDM than in 
IDDM^8,59 Microalbuminuria is the firs t indicator o f susceptib ility to  
develop diabetic nephropathy in patients w ith  IDOM^O; however it is a 
less powerful predictor of nephropathy in NIDDM^^^ where an elevated 
urinary albumin excretion rate (AER) is more associated w ith  
macrovascular disease and high cardiovascular m o r t a l i t y G l  ^62
Despite the fac t tha t m icrovascular disease is often detectable at the 
tim e of diagnosis in patients w ith  NIDDM, evidence o f significant 
m icroangiopathy is rarely detectable in subjects w ith  IGT®^. In one 
study the frequency of retinopathy in subjects w ith  IGT was no higher 
than tha t in a control population, despite the fa c t tha t visual 
impairment occurred more frequently®^. There is, however, some 
evidence tha t microalbuminuria may be present in the pre-diabetic 
phase, as 15% of Pima Indians w ith  IGT have an elevated urinary 
albumin excretion®®. This occurred especially in those w ith  
hypertension®®, suggesting tha t microalbuminuria in this context may 
relate to other features o f the insulin resistance syndrome. There is 
also some evidence suggesting the presence of subclinical autonomic 
neuropathy, as characterised by an abnormal pupillary light reflex in 
subjects w ith  IGT®®.
1 .4  Microvascular function in insulin-dependent diabetes.
To attem pt to  explain the above differences in the pattern and 
natural h istory of m icroangiopathy in NIDDM and IDDM, it is necessary 
to  outline w ha t is known about the pathophysiology of m icrovascular
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disease in the tw o  forms of diabetes. M icrovascular function has been 
extensively studied in IDDM, whereas there have been few er studies to  
date concentrating on patients w ith  NIDDM.
The haemodynamic hypothesis:
It has been proposed tha t diabetic m icroangiopathy may be the end 
result of long-standing functional changes in the microcirculation®^, 
such as increased pressure, blood flo w  and permeability, which could 
eventually lead to  m icrovascular sclerosis, perhaps via an injury 
response to repetitive endothelial damage (Fig 1.2). In turn, such 
structural changes could lead to further impairment o f m icrovascular 
function  by lim iting flo w  reserve and the capacity to autoregulate, tha t 
is, the ability to  maintain a constant flo w  in the face of varying 
perfusion pressure. There is now a large amount of experimental 
evidence in favour of th is haemodynamic hypothesis®^"®®. An 
im portant feature o f such a chain of events is tha t the early functional 
changes are potentially reversible, in contrast to  established 
m icroangiopathy which is largely irreversible.
M icrovascular function in skin, subcutaneous tissue and muscle:
Haemodynamic changes have been extensively characterised in 
these tissues, especially the skin which is easily accessible to 
investigation using non-invasive techniques. Abnorm alities o f skin 
m icrocirculatory function may have direct clinical relevance in the 
pathogenesis of diabetic foo t ulcers, as regardless of whether
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Fig 1.2 The haemodynamic hypothesis for the pathogenesis o f diabetic 
micmangiopa th y
Early increased microvascular pressure and flo w
Microvascular sclerosis 
(injury response)
Lim ited vasodilation and impaired autoregulation
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predominantly due to  isohaemia or neuropathy, ulceration u ltim ately 
represents m icrocirculatory failure^. In addition, abnormal 
m icrovascular function may have a profound e ffect on the healing of 
fo o t ulcers, e.g. lim itation o f vasodilation could depress the acute 
inflam m atory response to  infection and trauma^.
Increased microvascular blood flow  is present in the skin at an early 
stage after diagnosis in patients w ith  IDDM^®. Much o f th is increased 
flo w  occurs through arterio-venous shunt vessels as suggested by both 
early experiments demonstrating histological artérialisation of the 
venous system in the foot^^ and partitioning of m i c r o s p h e r e s ^ ^  
more recent studies showing high foo t venous oxygen tension^S^ 
abnormal forward flo w  in diastole on Doppler sonography^^ and high 
flo w  in the toe pulp - an area rich in arteriovenous anastomoses - using 
laser Doppler fluximetry^®. There is also evidence for increased flo w  
through the nutritive skin capillaries using direct videomicroscopy^®, 
although it is unknown whether th is is adequate to meet the increased 
metabolic demands of the tissues due to  raised temperature and 
metabolic rate. M icrocirculatory overperfusion is associated w ith  poor 
glycaemic control and the presence of neuropathy^®'^^'^®, and 
im provement in diabetic control using continuous subcutaneous insulin 
infusion has been shown to redistribute blood flo w  in favour of the 
nutritive microcirculation^®.
Although microvascular overperfusion has been well characterised, 
capillary pressure measurements in patients w ith  diabetes have only 
recently been reported. Studies in IDDM patients have demonstrated 
an increase in skin nailfold capillary pressure which is present early in 
the course of the disease and is related to the degree of 
h y p e r g l y c a e m i a ^ 7  Capillary pressure is elevated in patients w ith  early 
evidence of nephropathy (microalbuminuria), in contrast to  those w ith
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a long disease duration but minimal evidence of m icrovascular 
complications, where capillary pressure values are similar to  those 
found in control subjects^®.
Increased microvascular flu id permeability has been demonstrated in 
the tissues o f the forearm in young IDDM patients w ith  a short duration 
o f diabetes even during reasonable glycaemic control, suggesting a 
primary change In permeability^®. In contrast, other early permeability 
changes, such as an elevated transcapillary escape rate of albumin, are 
improved w ith  glycaemic control®®. Permeability changes to  a variety 
o f solutes, including an increased capillary diffusion c a p a c i t y ® T 8 2  gnd 
increased transcapillary escape rates for albumin®® and immunoglobulin 
G®^ are found in patients w ith  longer disease duration, especially those 
w ith  microangiopathy.
In addition to  such haemodynamic changes under resting conditions, 
there is evidence for impairment of postural responses, such as 
postural vasoconstriction®®. This refers to the increase in precapillary 
resistance which occurs in the lower limb on standing, thereby lim iting 
the rise in capillary pressure resulting from  the vertical column o f blood 
between the heart and foo t. Postural vasoconstriction is principally 
mediated by a local sym pathetic axon reflex, the veno-arteriolar 
reflex®®. Ineffective postural vasoconstriction leads to  increased 
m icrovascular pressure and blood flo w  on dependency, w ith  increased 
flu id filtra tion  from  the m icrocirculation and u ltim ately oedema 
form ation. The postural vasoconstriction response is normally acquired 
during passage through puberty, yet children w ith  diabetes fail to  
develop th is protective reflex®^. Loss of th is and other protective 
mechanisms results in an increased haemodynamic burden during 
activ ity , which could further accelerate the rate o f m icrovascular 
damage.
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Despite microvascular overperfusion under resting conditions, there 
is lim itation of maximum perfusion in response to a number of stim uli. 
Assessment of skin microvascular hyperaemia using laser Doppler 
flux im etry  has shown a reduction in response to  local heating in IDDM 
patients after several years of diabetes®®. Similar reductions in 
maximum vasodilation have been demonstrated fo llow ing  m inor skin 
trauma induced by a needle prick®®'®®, and after arterial 
occlusion®®'®. Limited microvascular vasodilation has also been found 
in children who have had diabetes for several years®®, despite the rarity 
of clin ically detectable m icroangiopathy before puberty.
Diabetic neuropathy leads to  abnormalities o f neurogenic 
vasodilation such as the flare response®® which occurs on stim ulation 
of nociceptive C fibres and may be an im portant part o f the response to 
fo o t trauma. A decreased flare response to  iontophoretically applied 
acetylcholine has been demonstrated in the sole of the fo o t in patients 
w ith  neuropathic ulcers and Charcot's arthropathy®^; similar 
abnormalities are present in the skin of the dorsum o f the fo o t at an 
earlier stage of neuropathy as defined by a raised vibration sensory 
threshold®®.
Finally, there is evidence for impaired m icrocirculatory 
autoregulation®®. This has been related to  the amount of basement 
membrane thickening in term inal arteriolar walls®^, supporting the idea 
tha t arteriolar sclerosis may contribute to limited vasodilation.
M icrovascular function in other tissues:
There are considerable differences in the normal structure of 
individual m icrovascular beds in d ifferent tissues, allow ing
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specialisation of function, e.g. filtra tion in the glomerulus. Despite 
th is, similar haemodynamic abnormalities to those already described in 
skin, subcutaneous tissue and muscle are present in other tissues and 
organs in patients w ith  IDDM.
Kidney
In the kidney, an increase in glomerular filtra tion  rate is present at 
diagnosis in IDDM which relates to  glycaemic control. This glomerular 
hyperfiltration is due, in part, to increased renal plasma flo w  and an 
increase in filtra tion surface area®®. There is also compelling evidence 
in favour o f a rise in intraglomerular hydrostatic pressure®®, w hich is 
supported by the results o f direct m icropuncture studies in animal 
models®®. There is, at present, some controversy regarding the exact 
relationship of early glomerular hyperfiltration to the subsequent 
development of diabetic nephropathy. Glomerular permeability to  
macromolecules, as reflected by a rise in AER, is also increased at th is 
early stage®®. In advanced nephropathy, there is loss o f 
autoregulation of glomerular filtra tion  rate^®®.
Retina
Studies of m icrovascular function have been more lim ited in the 
retina; however, once again a rise in retinal blood flo w  has been 
detected at an early stage in IDDM''®'', along w ith  increased capillary 
leakage observed in a proportion of fluorescein angiograms and on 
vitreous fluorophotom etry, although the latter observation has not
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been confirmed in more recent studies using sensitive e q u i p m e n t ' '  
There is also some evidence suggesting an elevation in retinal perfusion 
pressure''®®. Loss of pericytes at an early stage in the course of 
diabetes may play a part in retinal vasodilation®®. A t a later stage, 
there is m aldistribution of retinal blood flo w , w ith  areas o f non­
perfusion adjacent to  areas of overperfusion, and loss of 
autoregulation''®^.
Peripheral nerve
There is now increasing evidence for the involvem ent of 
m icrovascular disease in the pathogenesis o f diabetic neuropathy. 
Decreased nerve blood flo w  and reduced oxygen tension have been 
observed in animal models of diabetic neuropathy^®® w ith  
improvements in nerve conduction velocity w ith  increases in arterial 
P0 2 'I®6 . Impaired nerve blood flow  w ith  arterio-venous shuntingl®7 
and reduced sural nerve oxygen tension"'®® have also been found in 
human diabetic neuropathy. Fibre loss is patchy in sural nerve biopsies 
from  diabetics w ith  neuropathy^®® suggesting local ischaemia. Some 
studies have demonstrated endothelial abnormalities''''® and increased 
capillary c losure ''’'"' in endoneurial vessels and others have related the 
degree of endoneurial vessel disease to  the severity o f the 
neuropathy®'^
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1 --5 Microvascular function in non-insulin-dependent diabetes.
Microvascular function in skin, subcutaneous tissue and muscle:
In contrast to  the large number of studies of skin m icrovascular 
function in IDDM, there have been few  studies in NIDDM patients to 
date, although some of these suggest tha t there may be differences in 
the pattern of functional abnormalities observed in the tw o  types of 
diabetes.
Microvascular overperfusion has been observed under resting 
conditions in patients w ith  NIDDM, particularly during poor glycaemic 
c o n tro l T® or in those w ith  neuropathy’' I m p r o v e m e n t  in diabetic 
control using intravenous insulin infusion has been shown to 
redistribute blood flo w  in favour of the nutritive m icrocircu la tion ''''4. |n 
contrast to  the marked changes described in IDDM77,78^ skin nailfold 
capillary pressure does not appear to  be elevated in normotensive 
NIDDM patients ’' ’'®. On the other hand, NIDDM patients have an 
abnormal capillary pressure waveform , w ith  a decreased systolic arrival 
tim e ’'"'®, indicative o f an increase in transmission ve locity  to  the 
capillary bed along stiffened large vessels as a result of reduced arterial 
wall compliance.
Permeability changes in the skin and subcutaneous tissues are less 
clear cut than in IDDM. Increased permeability to  sodium fluorescein in 
the skin ’'"'® has been described in a mixed group of IDDM and NIDDM 
patients, and a rise in the permeability/surface area product o f pentetic 
acid, a small lipophilic molecule, has been found in NIDDM’' 
Increased permeability of the forearm tissues to radio-labelled albumin 
has also been reported’' ’' ®: however, th is was most often related to  a
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slow  disappearance of albumin from  the tissues, reflecting a decrease 
in lym phatic w ashout rather than a true increase in permeability. In 
addition, th is abnormality was most marked in hypertensive NIDDM 
patients"' T®, and was only found in a m inority of normotensive 
patients, all of whom  had neuropathy and poor glycaemic controD "'®. 
Permeability to albumin assessed by another technique, the 
transcapillary escape rate of radiolabelled albumin fo llow ing  intravenous 
injection (which measures mainly extra-renal clearance) is not increased 
in normotensive NIDDM patients w ith  no clinical evidence of 
microangiopathy"'®®; whereas poor metabolic control, hypertension 
and m icroangiopathy have all been shown to independently increase 
th is parameter''®®.
The major functional abnormality found in the skin m icrocirculation 
in NIDDM is a marked reduction in maximal m icrovascular 
vasodilation''®^'^®®. This has been found to  be already present at 
diagnosis''®®, whereas in IDDM a similar degree of vasodilatory 
impairment may take several years to become apparent®®. In contrast, 
cutaneous vasodilation responses to  exercise of underlying muscle are 
similar in NIDDM patients and control subjects''®®, although it should 
be emphasised tha t th is is not a measure of maximum vasodilatory 
capacity. The mechanism for th is response, however, appears to  be 
d iffe rent in NIDDM patients and control subjects, involving increased 
capillary flo w  in the former and capillary recruitment in the latter''®®. 
A lthough no studies have looked specifically at m icrovascular blood 
flo w  in skeletal muscle in NIDDM, reductions in to ta l muscle blood 
flo w  after exercise''®T and insulin infusion''®® have been described. In 
contrast, there does not appear to  be impairment of muscle reactive 
hyperaemia fo llow ing arterial occlusion^®®.
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M icrovascular function in other tissues:
Regarding other m icrocirculatory beds, increased renal plasma flo w  
can be detected in new ly diagnosed NIDDM p a t i e n t s " ' 1 2 8  
increase in retinal blood flo w  has also been observed in patients w ith  
NIDDM using the technique of laser Doppler velocimetry"'®®, and can 
be reduced by an insulin-induced decrease in blood glucose
concentration. There is also reduced retinal vasoconstriction in 
response to  breathing 100%  oxygen"'®®. Finally, arteriovenous
shunting and reduced blood flo w  have been observed in the endoneurial 
microvessels o f NIDDM patients w ith  neuropathy"'®®.
There is no data on direct measurement of capillary pressure in other 
microvascular beds; however, indirect calculations of intraglomerular 
hydrostatic pressure from  changes in renal plasma flo w  and filtra tion  
fraction yield inconsistent results in NIDDM''®®'"'®®.
Clinically, marked exudative changes and macular oedema imply
tha t increased permeability is present in diabetic maculopathy;
however, a study in NIDDM patients who had no retinopathy, using 
the technique of vitreous fluorophotom etry, showed no evidence of 
increased retinal permeability at th is stage"'®^, suggesting th a t 
permeability changes may be secondary. In contrast, increased 
permeability to  both fluid and macromolecules seem to be present in 
the kidneys at an early stage in NIDDM: Some studies have found early 
glomerular hyperfiltra tion^®^'12 8 , 1 3 2  similar to  tha t found in IDDM, 
w hich reduces w ith  improved glycaemic control"'®^, although other 
studies have found glomerular filtra tion  rate to be normaD ®®'"'®' .^ Early 
increased urinary albumin excretion is found in some NIDDM patients®®, 
w hich may in part relate to  abnormal tubular function"'®®; nonetheless, 
even in the presence of normal albumin excretion, there appears to  be
2 0
an early loss of glomerular pore size s e l e c t i v i t y " ' a n d  reversible 
tubular dysfunction, as reflected by enzymuria"'®^. Finally, w ith  
increasing albumin excretion there is also loss of glomerular charge 
selectivity"' ®®.
M icrovascular function in impaired glucose tolerance:
To date, m icrovascular function remains largely unexplored in 
subjects w ith  IGT. Regarding blood flow , one study suggests a 
reduction in insulin-mediated increase in skeletal muscle perfusion in 
obese non-diabetic subjects"'®®, while there may be increased 
m icrovascular permeability, as reflected by the presence of 
m icroalbuminuria in some subjects w ith  IGT®®.
1 . 6  Mechanisms of abnormal microvascular function
The mechanisms underlying abnormal m icrovascular function at the 
molecular and cellular level in NIDDM remain to  be elucidated, and 
therefore the fo llow ing discussion is largely speculative.
The development o f diabetic m icroangiopathy is closely linked w ith  
poor glycaemic control. It therefore fo llow s tha t hyperglycaemia and 
its biochemical consequences are likely to  underlie changes in 
m icrovascular function. This is emphasised by the fa c t tha t 
m icrovascular complications are most marked in cells and tissues in 
w hich glucose uptake is largely independent o f insulin action, so tha t
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cellular glucose concentrations directly reflect blood levels. 
Hyperglycaemia has a direct tox ic  e ffect on endothelial cells in culture 
and reduces the rate of cell division^®®. There are several potential 
mechanisms through which hyperglycaemia could a ffect microvascular 
cell function: Firstly, hyperglycaemia may induce alterations in
intracellular enzyme systems such as increased protein kinase C activ ity  
w ith  subsequent widespread effects on cellular function"'40. in 
addition, increased activ ity  of the enzymes of the polyol pathway as a 
consequence of hyperglycaemia may be of relevance due to  the 
osm otic e ffects of increased sorbitol concentrations, depletion of 
m yoinositol or altered sodium-potassium ATPase activ ity"'41. Finally, 
increased non-enzymatic glycation of proteins"'42  ^ in addition to 
interfering w ith  cell enzyme activ ity , may also lead to  permeability 
changes via altered charge or structural properties of glycoproteins 
present in intercellular clefts and basement membrane®"'.
As m icrovascular disease can already be detected at the tim e of 
diagnosis in NIDDM, when there is only mild hyperglycaemia in some 
patients, it is unlikely tha t hyperglycaemia alone is responsible fo r the 
development of early m icrovascular abnormalities. Further evidence for 
th is comes from  studies of improved glycaemic control in patients w ith  
IDDM to similar levels of mild hyperglycaemia which have resulted in 
improved m icrovascular f u n c t i o n 7 6 , 8 0
Other metabolic abnormalities tha t could a ffect m icrovascular 
function in the early stages o f NIDDM include hyperinsulinaemia and 
lipid abnormalities. Patients w ith  IGT and NIDDM have peripheral 
hyperinsulinaemia due to increased endogenous insulin secretion as a 
result of insulin resistance, and, at a later stage in the disease, 
exogenous insulin therapy. It has been demonstrated tha t insulin 
stimulates proliferation of capillary endothelial cells, pericytes and
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smooth muscle cells in culture43,143-145. |n addition, basement 
membrane producing cells appear to be hypersensitive to the effects of 
insulin leading to increased type IV collagen and decreased heparan 
sulphate synthesis"'46^  the latter of these being important for the 
maintenance of the charge barrier that is a determinant of 
permeability®"'. Similarly, lipid abnormalities associated with NIDDM, 
such as hypertriglyceridaemia and oxidised lipoproteins"'47^  could alter 
cellular activity via effects on cell membrane structure and function. 
Regardless of the underlying biochemical mechanisms, abnormal 
endothelial cell function is a plausible candidate to contribute to altered 
blood flow, perhaps via an imbalance in the secretion of vasodilator 
and vasoconstrictor vascular mediators. Elevation of endothelium- 
derived relaxant factor (EDRF) levels®® early in the course of diabetes 
due to increased shear stress acting on the endothelium, could lead to 
initial vasodilation and overperfusion; and as endothelial damage 
accrues, limitation of EDRF production®® could contribute to impaired 
maximal vasodilation. Advanced glycation end products may also 
'quench' nitric oxide"'48^ providing a further mechanism for limitation 
of vasodilation. Although it is difficult to extrapolate findings from 
larger vessels to the microcirculation, intra-arterial infusion studies 
have demonstrated decreases in both endothelium-dependent and 
independent (i.e. myogenic) forearm vasodilation in NIDDM"'®®. The 
situation is liable to be far more complex as there is evidence for 
alteration in the secretion or action of numerous other mediators in 
diabetes, such as catecholamines and components of the renin- 
angiotensin system^49 Abnormalities of prostaglandin secretion may 
be important in the development of glomerular hyperfiltration"'®®, 
possibly via differential effects on afferent and efferent glomerular 
arteriolar tone. It has been proposed that oxidative stress due to
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increased free radical production may underlie abnormal microvascular 
cell function in d i a b e t e s " ' , and tha t this may be due to  an increase in 
the intracellular N ADH /N AD + ratio secondary to  abnormalities in many 
o f the biochemical pathways mentioned above - 'hyperglycaemic 
pseudohypoxia'"'®®. Increased free radical ac tiv ity  has been 
demonstrated in NIDDM patients, especially those w ith  
microalbuminuria"'®®.
Altered endothelial cell and platelet function also contribute to the 
prothrom botic changes reported in patients w ith  N I D D M " ' ® 4 , 1 5 5  
These, along w ith  changes in microvascular rheology, such as 
decreased red and w hite  cell deformability^®®, could contribute to  
disordered m icrocirculatory function; however, there is little  evidence 
correlating such in v itro  changes w ith  early changes in m icrovascular 
blood flo w , making it likely tha t such abnormalities are of more 
relevance in the presence of established microangiopathy.
In the presence of impaired autoregulation, fu rther damage to  the 
m icrocirculation may occur in the absence of hyperglycaemia. Loss of 
flo w  regulation in combination w ith  decreased perfusion fo llow ing 
improved glycaemic control may compromise tissue nutrition, thus 
explaining the acute deterioration in m icrovascular disease observed in 
some patients after marked improvements in control ('g lycaem ic re­
entry ' phenomenon). Likewise, during periods of hypoglycaemia, loss 
of pressure autoregulation may allow the transmission o f associated 
increases in systolic blood pressure directly to  the capillary bed, which 
along w ith  the prothrom botic changes w hich accompany 
hypoglycaemia, may further accelerate microvascular damage"'®^.
Metabolic abnormalities alone are not suffic ient to explain w hy 
m icrovascular complications only affect a proportion of patients w ith  
diabetes, making it likely tha t there is also a genetic component. In
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IDDM the tendency to nephropathy may be linked to  a genetic 
predisposition to  hypertension as some patients have a fam ily h istory o f 
this"'®®. In addition, increased red blood cell sodium-lithium  
countertransport activ ity , which is a marker fo r other cell membrane 
cation exchange pumps and is elevated in essential hypertension, has 
been reported in both patients w ith  nephropathy and their parents^®®. 
The exact genes involved in the pathogenesis o f m icroangiopathy in 
NIDDM have still to be identified.
JlJ . Effect of peripheral vascular disease and hypertension on
microvascular function.
Peripheral vascular disease:
Given the high prevalence of hypertension and peripheral arterial 
disease in NIDDM, it is im portant to consider the im pact o f these 
disease processes on microvascular function if m icrovascular behaviour 
in NIDDM is to  be properly understood.
Peripheral vascular disease leads to  several abnormalities o f 
m icrovascular function w hich have been best described in non-diabetic 
patients. The prime importance of the m icrocirculation in the 
pathogenesis o f critical limb ischaemia is emphasised by the fa c t th a t 
some patients w ith  significant large vessel disease, as m anifest by low 
toe systolic blood pressures, do not develop ischaemic lesions, while, 
conversely, others w ith  high toe systolic pressures do.
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Resting laser Doppler flux  and transcutaneous oxygen tension 
(tcP0 2 ) measurements are normal until the ankle : brachial pressure 
index falls below 0.3"'®®. In the presence of significant proximal arterial 
obstruction there is maldistribution of blood flo w  between the nutritive 
vessels and arterio-venous shunts’'®"'. Further evidence fo r th is comes 
from  fluorescein studies which have revealed a heterogeneous 
d istribution of microvascular perfusion in both tim e and space in 
patients w ith  severe lower limb ischaemia"'®®, although such patients 
may retain a normal skin capillary density on direct m icroscopy. Some 
patients w ith  critical limb ischaemia actually have a higher than normal 
to ta l fo o t blood flow  at rest"'®®, suggesting tha t a m aldistribution of 
flo w , or m icrovascular 's tea l', may be important in the development of 
ischaemic ulceration. A lthough the mechanism of th is m aldistribution is 
currently unclear, there is evidence for a disturbance of v a s o m o t i o n ^ ® 4  
which could explain the loss of dynamic equilibrium.
Postural vasoconstriction is impaired in those w ith  rest pain or ankle 
brachial pressure index less than 0.5 when compared to  controls^®®; 
or in those w ith  unilateral severe ischaemia, when compared to  the 
other leg"'®®. In addition, visible capillary density increases in the skin 
of severely ischaemic feet on dependency"'®®, a fac t which may 
explain the characteristic relief o f rest pain by lowering the foo t in such 
patients. The loss of postural vasoconstriction may be due to the build 
up of vasoactive metabolites, secondary to tissue ischaemia, leading 
to  local vasodilation of pre-capillary resistance elements. Such a 
response may be a compensatory mechanism to  maintain nutritional 
blood flo w  in the presence of proximal arterial obstruction.
Despite the fac t tha t there is overperfusion under resting conditions, 
there is, not surprisingly, a lim itation of maximum m icrovascular 
hyperaemia. Post-occlusive reactive hyperaemia is impaired in severely
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ischaemic limbs and seems to a ffect both the nutritive  and 
therm oregulatory m icrocirculation to  a similar degree''®"'. Maximum 
blood flo w  and tcP 0 2  measurements on locally heated skin are also 
reduced in the face of severe ischaemia"'®®.
These m icrovascular abnormalities appear to be functional as there 
is evidence tha t they are improved fo llow ing angioplasty or 
reconstructive arterial surgery"'®^.
Essential hypertension:
Studies of m icrovascular function in non-diabetic subjects w ith  
essential hypertension have shown tha t skin nailfold capillary pressure 
is increased in untreated subjects compared w ith  normotensive 
controls"'®®. In contrast to  the situation in both major form s of 
diabetes, studies o f maximum microvascular hyperaemia yield 
inconclusive results, w ith  some showing no r e d u c t i o n " ' ® ® ' " ' 70  ^ while 
others do show lim ited vasodilation"'^"'. In any case correction fo r 
elevated perfusion pressure in essential hypertension reveals increased 
structurally-based resistance to  blood flow"'®®'^^"' w hich probably 
represents an adaptive (structural) autoregulatory response to a 
sustained increase in intra-arterial pressure. Permeability changes, 
such as an increased transcapillary escape rate of albumin, have also 
been reported in essential hypertension"'^®.
in summary, it can be seen tha t peripheral vascular disease and 
hypertension can independently lead to  altered m icrovascular function, 
compounding the effects o f m icrovascular abnormalities due to diabetes 
itself, influences tha t need to  be appreciated given the high prevalence 
of hypertension and large vessel disease in NIDDM.
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1.8 Aims of Thesis.
Early functional changes in the m icrocirculation are thought to  be 
im portant in the pathogenesis of diabetic m icroangiopathy. In IDDM, 
there is a large body of evidence supporting a pivotal role fo r increases 
in pressure, blood flow  and permeability; whereas in NIDDM, there 
have been fe w  studies o f cutaneous microvascular function , w ith  the 
main abnormality found to  date being a reduction in m icrovascular 
hyperaemia at an early stage in the disease. Capillary pressure is 
reported to  be normal and there have been no studies of flu id 
permeability. The aims of th is thesis are to fu rther characterise 
cutaneous microvascular function in NIDDM through the fo llow ing  
studies:
1. Assessment of m icrovascular flu id permeability by venous occlusion 
plethysmography in patients w ith  NIDDM and control subjects 
(Chapter 3).
2. Further investigation of the lim ited microvascular hyperaemia 
reported in patients w ith  NIDDM;
a). Reconfirmation of original results in a group of patients w ith  
large vessel disease excluded by Doppler sonography (Chapter 4 .1).
b). Examination o f the e ffect of improved glycaemic control on 
microvascular hyperaemia in recently diagnosed NIDDM patients 
(Chapter 4.2).
c). Examination of the e ffect o f hypertension on m icrovascular 
hyperaemia in NIDDM (Chapter 4.3),
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3. Determination of microvascular hyperaemia in subjects at risk of 
developing NIDDM who have IGT (Chapter 5.1) and insulin resistant 
patients w ith  acromegaly (Chapter 5.2). Investigation of the 
relationships of R-cell dysfunction, insulin resistance,
hyperlipidaemia, microalbuminuria and 24-hour ambulatory blood 
pressure on m icrovascular hyperaemia in patients w ith  IGT
4. Investigation of the mechanism o f lim ited hyperaemia in subjects 
w ith  IGT by measuring endothelial-dependent, endothelial- 
independent (vascular smooth muscle) and neurogenic vasodilation 
(Chapter 6 ).
5. Assessment of capillary density in patients w ith  IGT and NIDDM, 
and control subjects, to  determine whether there is evidence of 
impaired development of the vasculature resulting in reduced 
capillary density which could contribute to  lim ited m icrovascular 
hyperaemia.
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CHAPTER 2
METHODS
2.1 Standard protocol for microvascular studies.
Standardised conditions of measurement are a prerequisite for 
studying the m icrocirculation in v iew  o f the marked e ffect tha t factors 
such as drugs, temperature and sym pathetic nervous system activ ity  
can have on measures of m icrovascular function, especially blood flow . 
The fo llow ing standard protocol was adopted to attem pt to  minimise 
such sources of variability.
Prior to  attendance at the laboratories, subjects were asked to 
refrain from  taking caffeine containing drinks and food fo r tw o  hours, 
no alcohol was allowed fo r a 24 hour period, and no smoking for four 
hours.
Subjects were allowed to  acclimatise for a period of 30 minutes in a 
controlled temperature laboratory at 2 2±0 .5®C,  lying supine and 
relaxed in a quiet environment, w ith  the limb under study supported at 
heart level. During th is tim e, room and skin temperature were 
monitored every five minutes using a thermocouple therm om eter (Fluke 
52, RS Components, Corby, UK), and no studies were started until 
both temperatures were stable.
In v iew  of the effects of hypertension and large vessel disease on 
m icrocirculatory function, subjects w ith  either of these were excluded 
from  study. The only exceptions to  th is were the study described in 
Chapter 4 .3 , w hich was designed specifically to look at the effects of
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hypertension on the m icrocirculation in patients w ith  NIDDM; and 
Chapter 5 .2 , where some hypertensive patients w ith  acromegaly were 
not excluded due to  the small sample size. No subjects were taking 
any vasoactive medication (except insulin or oral hypoglycaemic agents, 
and in Chapter 5.2 bromocriptine), and all had a random blood glucose 
concentration between 4  and 15 mmol.l'"' at the tim e of study. 
Diabetic subjects were excluded if there was a history of 
hypoglycaemia in the preceding 24 hours.
All studies were approved by the local Ethical Comm ittee and 
informed verbal consent was obtained from  all participants.
2 .2  Venous occlusion plethysmography.
Venous occlusion plethysmography involves the measurement of 
changes in distal limb volume as a result o f increasing venous pressure 
via a cu ff applied to  a more proximal part of the limb. The recorded 
response has a characteristic shape w ith  an initial rapid exponential 
component attributed to  the filling of venous vessels, and a concurrent 
linear phase thought to be due to fluid filtra tion  (see Fig 2 .2 .3 ). Several 
parameters, including arterial in flow , venous compliance and flu id 
filtra tion  can be determined from  this change in limb volume"'^®. The 
capillary filtra tion  coeffic ient (CFC), a measure of m icrovascular flu id 
permeability, can be derived from  measurements of flu id filtra tion .
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Capillary filtration coefficient
A sensitive strain gauge plethysmographic method, employing a 
computer-based logging and analysis system ''74,i75^ was used in 
Chapter 3 to  compare forearm CFC between patients w ith  NIDDM and 
control subjects (Fig 2 .2 .1 ). Previous studies using plethysmography 
may have given inaccurate results as CFC calculations were based on 
the flu id filtra tion  response fo llow ing a single large increase in venous 
pressure ( > 4 0  m m H g ) ® ® ' " ' w h i c h  is known to  invoke the veno- 
arteriolar r e f l e x " ' 7 7 ^  a protective local axon reflex activated by a rise in 
venous pressure which normally induces postural vasoconstriction, as 
previously discussed in section 1.4 (page 14). When the venoarteriolar 
reflex is activated, resultant arteriolar vasoconstriction leads to slower 
filling of microvessels in the area of study, thus risking inclusion of 
part of the vascular filling component o f the strain gauge response in 
the fluid filtra tion  s l o p e " ' ( s e e  page 38). This is im portant as 
abnormalities of the veno-arteriolar reflex have been demonstrated soon 
a fter diagnosis in patients w ith  diabetes®®. The smaller pressure steps 
used ( < 1 2  mmHg) in the modified plethysmographic technique are 
known to decrease the time course of this vascular filling component, 
by avoiding invoking the veno-arteriolar reflex"*^®, thus excluding any 
confounding effects of diabetes-related abnormalities in the veno- 
arteriolar reflex. In addition, basing the calculation of CFC on the 
responses to  several smaller pressure steps in the modified 
t e c h n i q u e " ' 7 5  may improve reproducibility by minim ising any error 
introduced by measurements from  a given step; and by defining at 
exactly w ha t cu ff pressure filtra tion  begins to  occur, it avoids the 
innaccuracy of having to  extrapolate back to  the origin from  a single
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Fig 2.2.1 The strain gauge plethysmography system used to measure 
forearm CFC
a = modified sphygmomanometer cuff 
b = strain gauge and gauge holder the forearm 
c = thermocouple thermometer 
d = air pump 
e = amplifiers
f = monitor and microcomputer
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point in determ ining the filtration slope.
Venous occlusion elevates microvascular pressure w ith in  the whole 
m icrovascular netw ork from  the venous end, thereby elim inating any 
e ffect o f differences in homogeneity o f tissue perfusion between 
diabetic patients and control subjects; however, a potential drawback 
o f the technique is th a t differences in forearm tissue composition 
between diabetic and control subjects could influence the results, as 
the major tissue contributing to flu id filtra tion  in the forearm is skeletal 
m u s c l e ^ T h e r e  are no recognised differences in muscle mass 
between NIDDM patients and non-diabetic subjects, although body fa t 
content is increased in a proportion o f NIDDM patients. Care was 
therefore taken to  ensure tha t forearm circumference and BMI were 
similar in NIDDM and control subjects.
In addition to  the inherent permeability characteristics of the vessel 
w all, flu id filtra tion  is dependent on the balance of opposing Starling's 
forces, tha t is, intravascular hydrostatic plus tissue oncotic pressures 
favouring filtra tion ; and plasma oncotic plus tissue hydrostatic 
pressures resisting f i l t r a t i o n ^ 6  o f  these, intravascular hydrostatic 
pressure is the most predominant^®, and it is th is which is raised 
during venous occlusion. It is assumed tha t a given rise in venous 
pressure w ill lead to a similar rise in m icrovascular pressure in both 
diabetic patients and control subjects as there is no evidence th a t post- 
capillary venous resistance is d iffe rent in the tw o  groups. Techniques 
for measuring tissue oncotic pressure, e.g. im plantation of 
subcutaneous w icks, are open to  criticism  and have not been used to 
study NIDDM patients, although reduced tissue oncotic pressure has 
been demonstrated in IDDM patients using the w ick  method'i^®. 
Currently, methods fo r measuring tissue hydrostatic pressure have not 
been fu lly  developed. A lthough there is little  inform ation on tissue
34
oncotic and hydrostatic pressure in NIDDM patients and control 
subjects, their contribution to  flu id filtra tion is likely to  be small. 
Lastly, care has been taken to  exclude system atic differences in 
plasma oncotic pressure between diabetic and control subjects by 
measuring its main determinant'*®, serum albumin concentration.
Protocol:
A six-inlet sphygmomanometer cu ff { A.C. Cesser, London, UK), 
w hich enabled rapid inflation, was wrapped around the upper arm and 
inflated using an air pump (Compton type 2D /351D M : Dawson
McDonald and Dawson Ltd, Ashbourne, Dorset, UK), equipped w ith  a 
multiple resistance air bleed, which permitted stepped increases in 
occlusion pressure to be appl i ed”* T h e  occlusion pressure was 
monitored close to  the cu ff using a pressure transducer (type 256-720 : 
RS Components, Corby, UK) coupled to a modified pressure indicator 
(type 256-758 : RS Components). An additional flexible but inelastic 
outer cu ff was used to  minimise cu ff compliance and thereby obtain 
rapid occlusion pressure transm ission inwards to the so ft tissues of the 
arm. The mercury-in-silastic strain gauge and gauge holder'*^® was 
applied to  the upper one third o f the forearm (Fig 2.2.2) and the 
response to  serial small increments in cu ff pressure (5-12 mmHg every 
5 min), up to a maximum less than diastolic blood pressure, was 
recorded on a m icrocomputer for subsequent analysis'*
Once the ambient venous pressure had been exceeded, each 
increase in cu ff pressure generated a characteristic response (Fig 
2 .2 .3 ): an initial rapid exponential phase, due to  filling o f the com pliant
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Fig 2 .2 .2  The mercury-in-sHastic strain gauge and gauge holder in 
position on the forearm
a = modified shygmomanometer cuff 
b = strain gauge in gauge holder 
c = calibration key for strain gauge
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Fig 2 .2 .3  Dfagramatic representation o f typical recording from the 
strain gauge in response to an increase in cuff pressure o f around 10 
mmHg (after ambient venous pressure has been exceeded)
A rro w  indicates onset of increased cu ff pressure. Fluid flux  is 
calculated from  the slope of the response between the fou rth  and fifth  
m inute.
Slope = f lu id flux
0
Time (minutes)
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venous vessels beneath the gauge, and a concurrent linear phase due 
to  flu id flux from  the m icrocirculation once pressure was high enough 
to  cause filtra tion. Values for fluid flux were obtained by least squares 
fittin g  of the volume response after the vascular compliance component 
was compl et ed”* C F C  (in m l.m in '^ IO O g  tissue"^. mmHg'^) was 
calculated from  the slope o f the linear relationship between the values 
for flu id flux and corresponding cu ff pressure^^^ (Fig 2 .2 .4 ).
Reproducibility:
CFC determined by th is method was found to be highly reproducible 
w ith  an intra-individual coeffic ient of variation of 8 .5%  fo r five 
measurements on tw o  subjects on separate occasions over a 6-month 
period (Table 2.2.1 ).
2 .3  Laser Doppler fluximetry.
Laser Doppler flux im etry is a non-invasive technique for the 
continuous measurement o f m icrovascular blood flow^80_ |ow power 
laser is used to generate a non-injurious beam of red light which is 
transm itted to  a small area of the skin surface via a flexible fibre optic 
probe where it penetrates the superficial layers o f the dermis. Photons 
are mostly back scattered by stationary cells, but some undergo a sh ift 
in frequency (due to  the Doppler effect) after contacting moving red 
blood cells. These Doppler shifts are photodetected by the fluxim eter
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Fig 2 .2 .4  The linear relationship between fluid flux and cuff pressure 
for each pressure step
The gradient o f the line represents CFC
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Table 2.2.1 Reproducibility of capillary filtration coefficient 
measurements
The table shows data fo r 5 separate measurements over a 6-m onth 
period in each of 2 subjects, plus summary statistics.
CFC {ml.min hlO O g tissue hmmHg h
S u b j e c t 1 2 3 4 5 M e a n SD CV
M 29yr 4.5 4 .8  4.1 4.1 4.-2 4 .3 0 .3 7%
IVI 32yr 6.9 5.7 6.3 5.4 5.8 6 .0 0 .6 10%
mean CV = 8 .5%
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and computed to  give a voltage signal which is d irectly proportional to  
superficial blood flow^^O The response measured depends on both the 
concentration and ve locity of red blood cells in the area of 
measurement^ 80 The technique has been validated against several 
established methods fo r measuring blood flow  and correlates 
well w ith  microsphere f lo w m e try l^ i  ^ l33xenon clearance‘s ^2^ 
plethysmography's 83 and thermal clearance's 88  ^ despite the fac t tha t
some of these do not exclusively measure skin m icrovascular blood 
flo w . In addition, laser Doppler fluxim etry shows broad agreement 
w ith  direct measurement of skin capillary blood flow's 84.
There are, however, several lim itations to the technique of laser 
Doppler fluxim etry:
1 ). Some doubt exists about the exact sampling depth of the 
instrument's 82,183^ which is partly determined by the wavelength o f 
laser light employed, e.g. the Periflux Pf2 model produces red laser 
light o f wavelength 6 3 2 .8nm which is thought to  penetrate the skin to  
a depth of 1 mmS 85. This means tha t arterio-venous shunt and 
subpapillary plexus flo w  are measured in addition to  capillary flowS86. 
There is no evidence, however, to  suggest tha t underlying muscle 
blood flo w  is measured^87 |p the current studies, th is problem has 
been partly overcome by choosing areas of skin (dorsum of foo t or 
volar aspect of forearm) where shunt vessels are absent, although th is 
does not exclude plexus flow .
2. Blood flo w  is measured in terms o f multidirectional 'f lu x ' and not in 
conventional volume flo w  u n its ''80, w ith  results being expressed in 
term s of arbitrary units or volts. In v iew  of th is, laser Doppler 
flux im etry  is best suited to  the study of relative changes in flo w  or 
measurement of maximum flow . Both these applications are used in 
the current studies.
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3. There are d ifficu lties w ith  standardisation o f flo w  measurements. 
This even applies to  comparisons of d ifferent instruments o f the same 
model, or o f readings from  an individual fluxim eter over tim e, due to  
variations in laser output and fibre optic probe p e r f o r m a n c e ' ' 80^ and 
currently there is no consensus on standardisation procedures. 
Recently, however, there has been some m ovement tow ards 
calibration against a 'm o tility  standard', consisting of a suspension of 
polystyrene microspheres in water, performed at a standard 
temperature prior to  each usage of the i n s t r u m e n t ' '8 0 .  This method of 
standardisation has been employed for both the Periflux and Moor laser 
Doppler fluxim eters used in the current studies.
4. Readings may be affected by anatomical factors, such as 
differences in skin thickness, skin pigmentation and capillary 
d e n s i t y ' ' 8 0 .  The possibility of variations in skin thickness has been 
minimised by the choice of measurement sites used in the current 
studies, i.e. the volar aspect o f the forearm and dorsum of foo t, 
although system atic differences between patients w ith  diabetes and 
control subjects could only be fu lly  excluded by skin biopsy which was 
not done. As all participants were Caucasian, variation in skin 
pigmentation between individuals should not have been a major factor, 
and would have applied equally to patient and control groups. The 
possibility o f differences in skin capillary density affecting measurement 
o f maximal hyperaemia is addressed in Chapter 7.
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Maximum hyperaemia to local heating
Direct heating of the skin to  a temperature of 42 -44 °C  has been 
shown to  induce maximal m icrovascular v a s o d i l a t i o n ' '88. xhe protocol 
used in the current studies is a m odification of tha t used by Rayman et 
a|88. A  Periflux Pf2 laser Doppler fluxim eter (Perimed, Stockholm , 
Sweden), which produces low  power (2-3mW) red laser ligh t o f 
wavelength 6 3 2 .8nm from  a Helium-Neon s o u r c e ' '80, was used to 
measure the maximum microvascular hyperaemic response and results 
were expressed arbitrarily in vo lts (V).
Protocol:
During the acclimatisation period, an area of skin on the dorsum of 
the right foo t was directly heated to 44°C  for a period o f 30 m inutes, 
using a small brass heater88 {diameter 9mm) which fitted  into a plastic 
collar secured to the skin surface using a double-sided adhesive disc 
(Fig 2.3.1 and 2 .3 .2 ). The heater had an eccentrically placed hole 
(diameter 2.5mm) through which the fibre optic laser probe was placed 
and the heater was rotated w ith in  its collar allow ing measurement in 
multip le sites under the heater, w ith  each being heated immediately 
prior to  recording flow88.
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Fig 2.3.1 Measurement o f maximum microvascular hyperaemia to local
heating
a = brass heater (in collar) 
b = fibre optic probe 
c = laser Doppler fluxim eter 
d = chart recorder
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Fig 2 .3 .2  Diagram o f skin heater assembly
3 c m
a
b
1/
a =  heater holder 
b =  brass heater 
c =  eccentric hole fo r probe 
d =  laser Doppler probe
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Fig 2 .3 .2  Section of typical experimental trace showing variability of 
maximum hyperaemic response recorded from different sites in the 
heated area
1-8 = adjacent heated sites 
m = movement a rte fact
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Table 2 .3 .1  Reproducibility o f m axim um  hyperaem ia m easurem ents
The table shows data for 5 separate measurements over a 3-month 
period in each of 2 subjects, plus summary statistics.
Ma x im u m  Hyperaemia (V)
Subject 1 2 3 4 5 M ean SD CV
M 29yr 2.56 2.08 1.96 2.67 2.36 2 .3 2 0 .3 0 13%
M 36yr 2.07 2.25 2 .49 2.65 2 .64 2 .4 2 0 .2 5 10%
mean CV -  11 .5 %
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Reproducibility:
There was considerable blood flo w  variation between d iffe rent sites 
in the heated area (Fig 2 .3 .3), as had been previously found^S; 
however, the reproducibility of the technique was improved 
considerably by averaging flo w  for 30 seconds in each of 8 equally 
spaced sites to  give a single value for maximum hyperaemia (Table 
2.3.1)88.
Iontophoresis
The technique of iontophoresis uses electrical charge to  transfer 
small quantities o f pharmacological agents directly across the skin 
surface. This is particularly suited to  studying m icrocirculatory control 
mechanisms as it avoids the effects of local trauma and any potential 
hazards of systemic drug administration. The quantity of drug delivered 
depends on the charge of the ion, its molecular w eight, the strength 
of the electrical current and the duration of current f lo w ''89. For a 
given drug, the amount delivered is directly proportional to the to ta l 
charge which migrates through the skin surface. This to ta l charge (Q) 
in m illicoulombs (mC) is calculated using Coulomb's law:
Q = It
where 1 is the current in milliamps (mA) and t  is the duration of current 
flo w  in seconds (s). It can be seen tha t the to ta l charge can be 
increased by either increasing current strength or duration o f current 
flo w ; however, current strengths above 0 .2m A  may cause significant 
electrically or therm ally induced local axon reflex vasodilation”' 89. |n
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v iew  o f th is , current strength was set at 0 .2m A  and to ta l charge was 
varied by altering the tim e interval fo r iontophoresis.
Pharmacological agents can either be iontophoresed d irectly  into the 
area o f measurement to  assess the ir local e ffect, or at a site adjacent 
to  the area of measurement in w hich case neurogenic vasodilation can 
be assessed. In Chapter 6 d irect iontophoresis o f acetylcholine (ACh) 
was used to  measure endothelium-dependent m icrovascular 
vasod ila tion ''89-191  ^ and sodium nitroprusside (NaNP) to  measure 
m yogenic vasodila tion 1 8 9 , 1 9 1   ^ while indirect iontophoresis o f ACh, 
through stim ulation of nociceptive C fibres and resultant local axon
reflex, allowed assessment o f neurogenic vasodila tion ’' 8 9 , 1 9 2 , 1 9 3  j | - , e
techniques employed were m odifications of those used by W esterman
(d irect)’'89 and W alm sley (indirect)  ^82
A com plete iontophoresis system (Fig 2 .3 .4 ), w hich had recently 
been developed by M oor Instrum ents Ltd, Axm inster, Devon, was 
used fo r all the iontophoretic studies. Briefly, the system  consisted of 
an active platinum loop electrode contained w ith in  an iontophoresis 
chamber (Fig 2 .3 .5 ), and an ind ifferen t electrode, both o f w hich were 
linked to a constant current generator (iontophoresis contro ller M IC1). 
A  laser Doppler flux im eter (MBF3D perfusion monitor) was used to  
measure the response, w ith  a hole through the centre o f the 
iontophoresis chamber acting as the fibre optic probe holder. The 
solution fo r iontophoresis was injected into a well inside the chamber. 
Time intervals and current strength could be set using the Laser 
Doppler flux im eter so ftw are . The MBF3D perfusion m onitor d iffered 
from  th a t used in previous iontophoresis studies in th a t it used laser 
ligh t o f longer wavelength (S lOnm ) generated by a sem iconductor laser 
diode. The laser diode is reported to  have technical advantages over 
gas lasers; however, tissue penetration o f the MBF3D is thought to  be
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Fig 2 .3 .4  The Moor iontophoresis system
%  ^
a = laser Doppler fluxim eter
b = fibre optic probe
c = iontophoresis controller
d = iontophoresis chamber on forearm
e = electrode wires
f = indifferent electrode
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Fig 2 .3 .5  Diagram o f direct iontophoresis chamber
\
3cm
r
X "
a = iontophoresis chamber 
b = active electrode 
c = drug well 
d = laser Doppler probe 
e = air outlet
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greater than tha t o f the Periflux Pf2 (Dr R Gush, Moor Instruments, 
personal communication), leading to  increased inclusion o f plexus flow . 
The output of the MBF3D is expressed in arbitrary units (AU) rather 
than volts.
1 % solutions of both ACh chloride (in water w ith  3%  mannitol - 
'M iocho l' ophthalm ic preparation. Cooper Vision Ltd, Southampton) 
and NaNP (in 5% dextrose - 'N ipride', Roche Ltd, W elwyn Garden 
City, Hertfordshire) were used for iontophoresis. The ACh solution is 
reported to be stable for only around tw o  hours (Miochol data sheet), 
and therefore a fresh solution was made up prior to each study. It was 
noted in prelim inary studies tha t the ACh solution retained some 
variable ac tiv ity  fo r several hours, presumably due to  vasoactive 
breakdown products of ACh. In contrast, NaNP solution is known to 
remain stable fo r a 24-hr period when protected from  light by fo il and 
kept refrigerated at 4 -8°C  (Nipride data sheet). A liquots of NaNP were 
therefore taken from  a stock solution which was made up daily, and 
heated to room temperature prior to usage.
In prelim inary studies using direct iontophoresis, marked intra- and 
inter-subject variations in the shape and time course of the response 
curve were observed (Fig 2 .3 .6 ). Examination of iontophoresis sites 
after drug transfer confirmed the heterogeneity of the iontophoretic 
response, w ith  the m ajority of sites being uniform ly red, although 
some were non-uniform ly red and others contained small blanched 
areas. The variability in measurement was much higher than previously 
reported by Westerman et ap89^ possibly due to  the deeper tissue 
penetration of the MBF3D. This was not improved by standardising 
skin temperature to  32-340C, despite the fac t tha t resting skin 
temperature is known to  influence the magnitude of the blood flo w  
r e s p o n s e ’' 8 4 ^  and a temperature > 3 2 °C  is required to  produce a
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maximal r e s p o n s e ’' 8 4  |n addition, the use of 2%  methylcellulose gel 
as a drug delivery vehicle ’' 89, instead of aqueous solution, was found 
to  be unhelpful, mainly due to problems w ith  air bubbles in the viscous 
solution, therefore aqueous solutions of drug were used throughout. 
In prelim inary studies 4mC was the highest charge w hich avoided an 
electrically induced response - much lower than the values reported by 
Westerman fo r transcutaneous electrical nerve s tim ula tion ’' 89. Despite 
th is, a fe w  subjects still had a minor electrical component to  the blood 
flo w  response using 4mC during the studies reported in Chapter 6. As 
th is contributed to less than 5% of the measured response and was 
present in a similar number o f patients and control subjects, it was 
ignored fo r the purposes of calculating blood flo w  responses.
In the light of these various factors, satisfactory reproducibility 
was obtained by calculating the mean area under the iontophoresis 
response curve in four adjacent sites, after correcting fo r basal flo w  
(see Fig 2.3.7).
Indirect iontophoresis posed less problems in prelim inary studies and 
satisfactory intra-individual reproducibility was obtained using a current 
of 0 .2m A  and a protocol sim ilar to  tha t of W a l m s l e y ’' 82. |n W alm sley's 
studies, th is level of current was found to  produce a submaximal flare 
response; however, others have shown tha t higher currents produce a 
significant electrical r e s p o n s e ’' 89, which may act by non-neurogenic 
mechanisms. A maximum current of 0 .2m A  was therefore used in the 
current studies to  avoid such problems.
A fte r indirect iontophoresis of ACh at 0 .2m A  for several m inutes, a 
spreading flare response was visible beyond the outer lim its o f the 
iontophoresis chamber and at the same time, a reproducible stable 
blood flo w  measurement was recordable from the laser Doppler probe 
positioned in the centre of the chamber. The results of indirect
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Fig 2 .3 .4  Variability o f direct iontophoresis response to acetyicholine
The figure show s superimposed experim ental traces from  4 adjacent 
sites on the righ t forearm of one individual recorded sequentia lly  on 
the same occasion.
A sim ilar va riab ility  was observed fo r responses to  sodium 
n itroprusside
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A -  baseline period 
B = iontophoresis period 
C =  response period
horizontal lines separate the d ifferent periods
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iontophoresis were therefore expressed as the mean flo w  during the 
last tw o  minutes of iontophoresis, rather than area under the curve.
Protocol;
Direct iontophoresis:
A t the start o f the acclimatisation period, the skin of the forearm 
was lightly cleansed w ith  70%  v/v  isopropyl alcohol to  remove sebum 
and reduce electrical resistance. The indifferent electrode was attached 
to  a rubber electrode receptacle (IER1, lomed Inc., Salt Lake City, Ut, 
USA) containing a dispersive gel pad (Hydro Pad, RDG Medical, 
Croydon, Surrey) and was applied to  the skin near the w ris t. The 
perspex iontophoretic chamber (Fig 2.3 .5) was attached to  the volar 
skin surface using a double-sided sticky disc, taking care to  gain a 
w aterproof seal, and the fibre optic laser probe was inserted through 
the centre o f the iontophoresis chamber. The solution fo r iontophoresis 
was injected into a well inside the chamber, taking care to  avoid the 
introduction of air bubbles which could interfere w ith  the laser signal or 
charge transfer. The active electrode was made either anodal (ACh) or 
cathodal (NaNP) depending on the polarity o f the drug being 
iontophoresed.
Following one m inute's recording of basal blood flo w , a to ta l charge 
of 4mC (0.2m A fo r 20s) was applied and blood flo w  response 
measured fo r four minutes (ACh) or 6 minutes (NaNP). A longer 
response period was recorded for NaNP as preliminary experiments had 
shown tha t the response to NaNP was of slower onset and longer 
duration than tha t to  ACh. The area under the curve fo r basal and
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Fig 2 .3 .5  Calcuiation o f area o f response following direct iontophoresis
o f acetylcholine
200
15 - 13 - 0 3 .
Time (30 second intervals)
200
100
A -  area of basal f lo w  
B -  to ta l area o f response
The iontophoresis response is calculated by subtracting the predicted 
area due to basal f lo w  (based on area A) from the to ta l area of 
response.
56
response periods was recorded automatically by the instrum ent using 
system software. Data was downloaded directly onto an IBM 
compatible PC using the M oorsoft softw are package (Moor 
Instruments, Axm inster, Devon), and a hard copy of the results 
obtained via the instrum ent's printer.
This whole process was repeated for a to ta l o f four sites on the 
right arm fo r ACh and four sites on the left arm for NaNP. A fifth  
iontophoresis site was used on each arm for a control solution (3% 
mannitol in de ionised w ater fo r ACh and 5% dextrose for NaNP). The 
responses were subsequently corrected for basal flo w  and then 
expressed in terms of AU.min"^ (Fig 2.3.7). The mean response for 
four sites was then calculated for each drug.
Indirect iontophoresis:
Following direct iontophoresis of ACh plus control solution, a sixth 
site on the right forearm was used for indirect iontophoresis of ACh 1 % 
solution. The chamber used for indirect iontophoresis is illustrated in 
Fig 2 .3 .8 . Basal flo w  was again recorded for one minute fo llow ed by 
iontophoresis at 0 .2m A  for ten minutes (Fig 2 .3 .9 ). Using the 
M oorsoft package, mean basal flow  was determined and maximal flo w  
was calculated as the mean flo w  over the last tw o  minutes of the 
iontophoresis period.
Reproducibility:
Using the above protocols, reproducibility o f the responses to  direct 
iontophoresis of Ach and NaNP were both 14% (Tables 2 .3 .3  and
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Fig 2 .3 .8  Diagram of indirect iontophoresis chamber
)0
3 c m
W i
1 -c ,
a =  iontophoresis chamber 
b == active electrode 
c =  drug well 
d =  laser Doppler probe 
e = air outlet
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Fig 2 .3 .6  Experimental trace of response to indirect iontophoresis o f
acetylcholine
The figure  show s tha t a stable response Is reached after 3-4  m inutes 
o f ion tophoresis.
200
Z)<
I  100
w—
OjD
D.i
Time (45 second intervals)
A = baseline period 
B = ion tophoresis period
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Table 2 .3 .2  Reproducibility of direct iontophoresis response to 
acetyichoiine
The table shows data fo r 4 separate measurements over a 2-month 
period in each of 2 subjects, plus summary statistics.
Io n t o p h o r e s is  Re s p o n s e  (A L i.m in-i)
S u b j e c t 1 2 3 4 M e a n SD CV
M 29yr 2311 2370 1976 1962 2155 216 10%
M 29yr 1560 1050 1621 1357 1397 257 18%
mean CV = 14%
Table 2 .3 .3  Reproducibiiity of direct iontophoresis response to sodium 
nitroprusside
The table shows data for 4 separate measurements over a 2-month 
period in each of 2 subjects, plus summary statistics.
Io n to p h o re s is  Response (AU.min-i)
SUBJECT 1 2 3 4 M e a n SD CV
M 29yr 632 696 787 834 737 91 12%
M 29yr 928 1204 1175 865 1043 172 16%
mean CV = 14%
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Table 2 .3 .4  Reproducibility o f indirect iontophoresis response to
acetylcholine
The table shows data for 4 separate measurements over a 2-month 
period in each of 2 subjects, plus summary statistics.
Io n t o p h o r e s is  Re s p o n s e  (AU)
S u b j e c t 1 2 3 4 MEAN SD CV
M 29yr 28 31 27 33 2 9 .8 2 .7 9%
M 29yr 33 38 42 36 3 7 .2 3 .7 10%
mean CV =  9 .5 %
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2.3 .4 ), while tha t to  indirect iontophoresis o f Ach was 9 .5%  (Table
2 .3 .5 ).
2 .4  Capillary videomicroscopy.
The technique of capillary videomicroscopy'* allows direct 
visualisation and recording of blood flow  in the superficial dermal 
capillaries through the relatively transparent epidermis. Capillary 
videom icroscopy was used to  determine skin capillary density in 
patients w ith  acromegaly and control subjects in Chapter 5 .2 ; and 
patients w ith  NIDDIVI, pre-diabetic and control subjects in Chapter 7.
The equipment required for capillary videomicroscopy is illustrated in 
Fig 2 .4 .1 . A custom made Leitz system was used. The finger under 
study was illuminated under an objective lens (Leitz, Leica, London, 
UK; final magnification X200) using a mercury vapour lamp and 
fibreoptic cable (Leitz 100W  type 307-072 .042 , Leica, London, UK). 
The mercury vapour lamp has an emission spectrum of the same 
wavelength as the absorption spectrum of haemoglobin (370-450nm ), 
producing maximum contrast between the moving column of red blood 
cells which can be seen as dark areas against the neutral background 
produced by surrounding s t r u c t u r e s ^^6 The capillary wall itse lf is 
indistinguishable from  other structures and so no estimate of capillary 
wall dimensions can be made using th is technique.
Images are recorded directly onto video tape via a video camera 
(CCD camera model LD H 0703/30, Philips, London, UK) and recorder 
(model AG7350-B SVHS, Panasonic, London, UK), w ith  a time-date
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Fig 2.4.1 Equipment used for capillary videomicroscopy
y
Picture shows subject lying supine w ith  dorsum of middle finger 
illuminated under the capillary microscope, 
a = capillary microscope 
b = video camera 
c = monitor
d = mercury vapour lamp 
e = fibre optic cable
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Fig 2 .4 .2  Dîagram atic representation o f capillary videomicroscopy 
system
skin c a p i l l a r i e s
monitor
c a m e r a
mount
video camera
focussing block
lens turret
source
t ime date  
g e n e r a t o r
f \  r \  
n  A  
A  A  ^
v id eo  r e c o rd e r
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generator (For-A model VTG, Video South Ltd., Bath, Avon, UK) 
being incorporated in the circuit (Fig 2 .4 .2). A m onitor (Hitachi 9" 
monochrome monitor, model VM -920K, Leica UK, London, UK) 
linked to  the video system allows real tim e and play back view ing of 
the images being recorded on video tape (Fig 2.4.3).
Capillary density
Both basal capillary density and capillary recruitment were measured 
in case there were any differences in basal capillary perfusion between 
the d iffe rent groups investigated. Initial studies to assess reactive 
hyperaemia fo llow ing arterial occlusion using a finger cu ff gave poor 
reproducibility; however, local venous occlusion provided a 
reproducible measure of capillary recruitment, w ith  capillary density 
values approaching the maximum observed fo llow ing arterial occlusion.
Protocol:
A small inflatable cu ff (w idth 1.6cm, Mini-Penile pressure cu ff 
DC1.6, PMS Instruments, Maidenhead, UK) was positioned loosely 
around the base of the le ft middle finger. Following th is, the middle 
phalanx was positioned under the microscope objective lens, and the 
dorsal skin surface coated w ith  a thin layer of nail varnish to  reduce 
light sca tte ring 'll^ . One minute video recordings were made in each of 
six adjacent sites fo llow ing a grid pattern. Venous occlusion was 
induced by inflating the finger cu ff to  35mmHg, using a standard
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Fig 2 .4 .3  Photograph o f monitor screen showing skin nailfold 
capillaries
Capillaries lie perpendicular to  the skin surface in areas other than the 
nailfold, so tha t only the apices of the capillary loops are visible.
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mercury shygmomanometer, and after a period o f 5 m inutes video 
recordings were repeated in the same six sites.
Capillary number was determined by counting the to ta l number of 
visible capillaries in each one minute period, which lay w ith in  a grid 
attached to  the fron t of the television monitor tha t covered the major 
part o f the screen surface and represented an area of 0 .25m m ^. 
Capillary density was expressed as capillaries per mm^.
Reproducibility:
There was some variability in the number of capillaries between 
each of the six sites {mean CV = 21% ); however, reproducibility of 
the measurement was improved considerably by taking the mean value 
fo r the six sites as the capillary density (basal CV = 5% (Table 2 .4 .1) 
and post venous occlusion CV = 7% (Table 2.4.2)).
2 .5  Statistics
As small numbers of subjects were used in each study, it could 
not be assumed tha t data were normally distributed. Summary 
sta tistics have therefore been expressed as median and range and non- 
parametric tests have been used throughout. The Mann-W hitney U 
Test or Kruskal-Wallace Test were used for unrelated samples; and 
W ilcoxon Rank Sum Test for tw o  related samples, as appropriate. 
Associations between d ifferent variables were determined using tw o -
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Table 2.4.1 Reproducibility o f basal capillary density measurements
The table shows data fo r 3 separate measurements over a 2-month 
period in each of 2 subjects, plus summary statistics.
C a p i l l a r y  D e n s i t y  ( c a p s . m m  2)
S u b j e c t 1 M E  A  
N
SD CV
M 29yr 
F 35yr
105
86
103
91
102
101
103  1 .6 2%
93 7 .6  8%
mean CV = 5%
Table 2 .4 .2  Reproducibility o f capillary density measurements after 
venous occlusion
The table shows data for three separate measurements over a 2-month 
period in each of tw o  subjects, plus summary statistics.
C A P I L L A R Y  D E N S I T Y  (caps.mm-2)
S u b j e c t 1 2 3 M e a n S D C V
M 29yr 117 106 114 112 5.7 5%
F 35yr 95 103 113 104 9 .0 9%
mean CV — 7%
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tailed Spearman Rank Correlations or multiple regression analysis. All 
statistica l analyses were carried out on an IBM compatible 
m icrocom puter using the SPSS/PC + statistical package (SPSS Inc, 
Chicago, III., USA).
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CHAPTER 3
MICROVASCULAR FLUID PERMEABILITY IN 
NON-INSULIN-DEPENDENT DIABETES
As discussed in Chapter 1, altered microvascular permeability may 
be one of the functional changes associated w ith  the development o f 
diabetic m icroangiopathy. In patients w ith  IDDM, increased 
m icrovascular permeability to  fluid and a variety of solutes is present 
from  an early stage in a variety o f tissues (Chapter 1.4, page 14); 
however in NIDDM there have been less studies on m icrovascular 
permeability and results have been conflicting (Chapter 1.5, page 18). 
In addition, there have been no studies looking specifically at 
m icrovascular fluid permeability in NIDDM.
In th is chapter, forearm capillary filtra tion coeffic ient (CFC) has 
been determined, as a measure of microvascular flu id permeability, in 
NIDDM patients and control subjects using a sensitive strain gauge 
plethysmographic method, employing a computer based logging and 
analysis system''
Subjects and Methods:
Subjects
Tw enty four NIDDM patients (15 M : 9 F, age 64 (39-78) years, 
duration of diabetes 6 (0.5-30) years, median and range) and 24  age- 
and sex-matched control subjects recruited from  the local com m unity
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were studied (Table 3.1). W ith th is sample size the study had a 90%  
power at the 5% level (2-tailed) to  detect a difference in CFC of 1.5 x 
1 0"^ m l.m in '^ l OOg tissue"^ .m m H g'^. A previous study using the same 
technique to  compare CFC in young IDDM patients and control subjects 
had shown a median difference of around 4.0 x 10 '^ ml.min"^ .1 OOg 
tissue"^ .mmHg'^ between the tw o  g r o u p s ^ G .
NIDDM patients were recruited consecutively from  the diabetic clinic 
o f the Royal Devon and Exeter hospital. The diabetic patients were 
treated w ith  diet alone (n = 3), or diet plus oral hypoglycaemic agents 
(n = 9) or insulin (n = 12), and were on no other potentially 
vasoactive medication. There were seven ex-smokers and three current 
smokers in the NIDDM group, and eight ex-smokers amongst the 
control subjects.
Each patient was assessed for the presence of m icrovascular 
complications (Table 3.2). The retinae were examined by direct 
ophthalmoscopy through dilated pupils and appearances categorised as 
no retinopathy, background retinopathy, maculopathy or proliferative 
retinopathy. Vibration perception threshold (VPT) was measured on the 
tip  of the great toe using a biothesiometer (Biomedical Instrument Co, 
Newbury Oh, USA) to assess large fibre function (readings o ff scale 
recorded as 50); and thermal sensory thresholds fo r warm ing and 
cooling were determined on the sole of the foo t using a computerised 
thermal testing system (developed and supplied by the Middlesex 
Hospital, London, UK'*^^) to  assess small fibre function (warm 
threshold o ff scale recorded as 8). Patients were classed as having 
neuropathy if they had an age-adjusted VPT greater than the 95th 
centile fo r a normal population^98 and/or thermal sensory threshold for 
warm ing or cooling greater than 2SD above the age-
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Table 3.1 Clinical Characteristics o f diabetic patients and non-diabetic 
control subjects
N id d m CONTROL
N  (M/F} 15/9 15/9
AGE (yr) 64 (39-78) 61 (37-79)
D u r a t io n  o f  d ia b e t e s  (yr) 6 (0.5-30) -
B o d y  m a s s  i n d e x  ( k g . m - 2 ) 27.5 (21-36) 26 (21-31)
Pl a s m a  g l u c o s e  (m m o l.|- i) 10.1 (6.2-14.9) 5.0 (3 .9-5.8)
S e r u m  f r u c t o s a m in e  ( //m o i.i- i) 316 (258-441) -
S e r u m  a l b u m in  (g .l- i) 41 (38-47) 42 (37-46)
BLOOD p r e s s u r e  (m m H g)
Sy s t o l ic 143 (111-160) 138 (119-158)
D ia s t o l ic 81.5 (70-94) 83 (72-90)
Fo r e a r m  c ir c u m f e r e n c e  (m m ) 280 (210-308) 265 (235-315)
D a ta  are sh ow n  as m edian and range
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Table 3 .2  Microvascular complications in the NIDDM  patients
N M e d ia n  (Ra n g e )
Re t in o p a t h y
N o n e 17 -
BACKGROUND 5 -
M a c u l o p a t h y 1 -
Pr o l if e r a t iv e 1 -
N e p h r o p a t h y ^
A C R < 2 .5 10 1.8 (1 .0-2.4) mg.mmol"''
A C R > 2 .5 6 7.0 (3 .8-32.5) mg.mmol
N e u r o p a t h y
A b s e n t 14 -
VPT 15 (8-20) V
TT (COOL) 0 .4  (0 .2-1.3) OC
TT (WARM) 1.3 (0.5-5.0) OC
Pr e s e n t 10 -
VPT 38 (25-50) V
TT (COOL) 1.1 (0 .4-3.1) OC
TT (WARM) 4.3  (0.5-8.0) OC
^ data only available for 1 6 patients
(ACR = albumin creatinine ratio; VPT = vibration perception 
threshold; TT = thermal threshold)
73
adjusted m e a n ' ' 9 7 .  An estimation o f urinary albumin excretion was 
obtained by measurement of the albumin : creatinine ratio (urinary 
albumin m g.1-1 divided by urinary creatinine mmol.h'') in an early 
morning urine sample. In all subjects w ith  a raised ACR, urinary trac t 
infection was excluded by culture of a mid-stream specimen of urine.
None of the subjects had hypertension (brachial blood pressure >  
160/100  mmHg), significant renal impairment (serum creatinine 
ou tw ith  normal range, i.e. > 1 2 0  jL/mol.|-i), or a history of ischaemic 
heart disease, cerebrovascular disease or peripheral vascular disease.
Methods
During the 30 minute acclimatisation period average brachial blood 
pressure was determined from  the mean of 3 readings using an 
automated blood pressure recorder (Dynamap 845: Critikon Inc,
Tampa, FI., USA). Forearm CFC was derived from  measurements o f 
flu id filtra tion  using venous occlusion plethysmography w ith  stepped 
increases in venous pressure as described in Chapter 2 .2  (page 32). A t 
the end of each study, a venous blood sample was taken fo r 
estimation of plasma glucose concentration, serum albumin and 
fructosam ine (colorimetric method, Fructosamine Test Plus, Roche 
Diagnostics, W elwyn Garden City, Herts., UK) concentrations.
Results:
There was no difference in median CFC between NIDDM patients 
(5.3 (3.2-9.1) X 10"^ m l.m in '1 .1 OOg tissue 'l .mmHg'1) and control 
subjects (5.4 (3.5-8.0) x 10"^ mi.min"1.1 OOg tissue'^ .mmHg 1 ;
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Fig 3.1 Capillary filtration coefficient in N IDDM  patients and  control 
subjects (horizontal bars represent median values)
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p = 0 .98 , Mann-Whitney) (Fig 3.1). CFC did not correlate w ith  age in 
either the control or diabetic subjects. In the diabetic patients, there 
was no correlation of CFC w ith  plasma glucose (p = 0.3) or 
fructosam ine (p = 0.4) concentrations, BMi (p = 0.1), blood pressure 
(p = 0.1), vibration (p = 0.4) or thermal (p = 0.3) sensory 
thresholds, or ACR (p = 0.7) (Spearman Rank Correlation); and there 
were no relationships between CFC and the degree o f retinopathy (p = 
0 .8), type of diabetic treatm ent (p =  0.9), or duration of diabetes (p 
= 0.9) (Kruskal-Wallis).
Diabetic and control subjects were well matched for baseline 
characteristics (Table 3.1), although VPT was significantly higher in 
the NIDDM patients (19 (8-50) V vs 13 (6-32) V control subjects, 
p <  0.03). In particular, there were no significant differences in serum 
albumin concentration (p = 0.6), BMI (p = 0.1), or forearm 
circumference (p = 0.4).
Discussion:
This study has demonstrated tha t capillary filtra tion  coeffic ien t is 
not increased in patients w ith  NIDDM of short to  long disease duration, 
in marked contrast to  the situation in IDDM where CFC is elevated at 
an early stage^^. In the present study there was no relationship of CFC 
w ith  glycaemic control, which accords w ith  the findings in a group of 
young IDDM patients who had good glycaemic contro l^^. There are 
some potential confounding factors which could have obscured real 
differences in m icrovascular flu id permeability between the diabetic 
patients and control subjects. As the major tissue contributing to  flu id 
filtra tion in the forearm is skeletal muscle, differences in tissue
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composition (e.g. increased adipose tissue in the diabetic patients) may 
have affected the results; however, this is unlikely in v iew  of the 
sim ilarities in BMI and forearm circumference in the tw o  groups (Table
3.1 ). In addition, it does not seem likely tha t any differences in plasma 
oncotic pressure could be contributing to the observed results, as 
serum albumin concentrations are similar in the tw o  groups. As 
discussed in Chapter 1.2 (page 7), there is currently much interest in 
the role of impaired early development o f the vasculature in the 
pathogenesis of vascular disease^®, and as CFC is dependent on the 
surface area available for flu id exchange and the permeability per unit 
surface area^^^, it is possible tha t reduced skeletal muscle capillary 
density could have led to an apparently normal CFC by reducing surface 
area in the presence of increased permeability per unit surface area. 
There are, however, no data to suggest a reduction in skeletal muscle 
or skin capillary density in N ID DM H ^. The issue of skin capillary 
density is further investigated in Chapter 7. It therefore seems
probable tha t the results o f th is study reflect a true sim ilarity in
microvascular flu id permeability in patients w ith  NIDDM and control
subjects, which contrasts w ith  the increases in permeability to sodium 
fluorescein and radio-labelled albumin reported in previous
studies^ 1®. As protein movement across the capillary wall is 
thought to  accompany tha t of fluid by the process of solvent dragl 9^  
the increased capillary permeability to  albumin appears to  be 
inconsistent w ith  the results of the present study; however, th is was 
most often related to a slow disappearance of radioactive albumin from  
the tissues, reflecting reduced lymphatic w ashout rather than true 
increased permeability 11^. In addition, the abnormality was most 
marked in hypertensive NIDDM pa tien tsU ^, and was only found in a 
m inority of normotensive patients, all of whom had neuropathy and
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poor glycaemic con tro lU ^.
A smaller difference in CFC than 1.5 x 10"^ m l.m in"^. 1 OOg tissue  ^
.mmHg"l between diabetic and control subjects may not have been 
detected w ith  the sample size used; however, as a previous study 
showed a median difference of around 4 .0  x 10“^ m l.m in‘ i . 10Og 
tissue'1 .mmHg'1 between young IDDM patients and control subjects^^, 
it seems unlikely tha t any im portant increase in CFC in the NIDDM 
patients was missed. As the patients in the present study were 
normotensive, relatively free of microvascular complications and had 
acceptable glycaemic control, the results do not preclude significant 
changes in m icrovascular flu id permeability in NIDDM patients w ith  
hypertension, more advanced m icroangiopathy, or marked 
hyperglycaemia.
In summary, capillary filtra tion  coeffic ient is not increased in 
normotensive NIDDM patients w ith  reasonable glycaemic control, in 
contrast to  findings in patients w ith  IDDM, making it unlikely tha t 
alterations in fluid permeability are of primary importance in the 
pathogenesis of m icrovascular disease in NIDDM.
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CHAPTER 4
MAXIMUM MICROVASCULAR HYPERAEMIA IN 
NON-INSULIN-DEPENDENT DIABETES
As mentioned in Chapter 1.5 {page 19), the major abnormality of 
skin m icrovascular function identified to  date in patients w ith  NIDDM 
has been a reduction in maximum vasodilation in response to  a variety 
o f stimuli. In th is chapter the microvascular hyperaemic response to 
local heating is further explored in NIDDM patients w ith  no evidence of 
large vessel disease, and the influence of glycaemic control and 
hypertension on microvascular vasodilation is investigated.
4.1 Microvascular hyperaemia in NIDDM patients with large vessel 
disease excluded by Doppler sonography
The major abnormality o f skin microvascular function identified to  
date in patients w ith  NIDDM is a reduction in hyperaemic 
r e s p o n s e s ’! 21,122. major criticism  of previous studies was tha t the 
criteria used to exclude large vessel disease, namely, the ankle 
systolic pressure index, may have been inadequate200, leading to the 
possibility tha t reduced hyperaemia in some NIDDM patients may have 
been due to  undetected peripheral vascular disease. D ifficulties arise in 
interpreting ankle systolic blood pressure in diabetic patients, as th is 
can be falsely elevated in a m inority of patients due to  decreased
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vascular c o m p l i a n c e ^ O I  secondary to  sclerosis or calcification of the 
vessel wall202 Several other techniques can be employed to  overcome 
th is d ifficu lty , such as oscillotonometry^OG, Doppler waveform  
analysis or pulse-wave velocity204^ or arteriography. In the present 
study measurements of maximal hyperaemic response to  local heating 
of the foo t skin were repeated in a group of NIDDM patients in whom  
large vessel disease had been rigorously excluded using Doppler 
waveform  analysis.
Subjects and methods:
Subjects
Eleven NIDDM patients (7M : 4F, age 62 (50-70) years, duration 8 
(5-24) years, median and range) (Table 4.1), were recruited 
consecutively from  a larger cohort o f NIDDM patients attending the 
Royal Southants Hospital, Southampton, who were taking part in a 
prospective study of cardiovascular risk factors and vascular disease. 
None of the subjects studied had clinically evident large vessel disease 
as determined by a history suggestive of vascular disease, absent 
pedal pulses, or ankle : brachial systolic pressure index <  1.0. Large 
vessel disease was then more rigorously excluded by continuous wave 
Doppler assessment (Sonicaid Vasoview scanner, Sonicaid Medical Inc, 
V irginia, USA) of arterial pulse waveform  shape, turbulence and 
damping in the femoral, popliteal, posterior tibial and dorsalis pedis 
arteries.
The NIDDM patients were treated w ith  diet alone (n =  1), or 
oral hypoglycaemic agents (n = 10). Eleven age- and sex-matched
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Table 4.1.1 Clinical Characteristics of diabetic patients and non­
diabetic control subjects
N id d m C o n t r o l
N  (M/F) 7 /4 7 /4
A ge  (yr) 62 (50-70) 61 (50-70)
DURATION OF DIABETES (yr) 8 (5-24) -
Bo d y  m a s s  in d e x  (kg.m-2) 25 (22-30) 25 (21-29)
Pl a s m a  GLUCOSE (m m o l.|- i) 9.6 (5.1-12.3) 4 .6  (3.8-5.8)
H bA-ic  (%) 7.7 (5.3-8.6) -
Bl o o d  p r e s s u r e  (m m H g)
S y s t o l ic 138 (116-158) 138 (114-159)
D ia s t o l ic 82 (62-88) 80 (64-89)
PLASMA in s u l in  (//U .m |-1 ) 35.8  (13.6-67.1) -
D ata  are sh o w n  as m edian and range
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control subjects were also studied. None of the participants had 
evidence o f significant renal impairment (serum creatinine >  120 
jt/mol.l"l, or proteinuria), or hypertension (brachial blood pressure > 
160/90  mmHg). There were three ex-smokers and one current smoker 
in the diabetic group, and three ex-smokers amongst the control 
subjects.
The NIDDIVI patients were screened fo r the presence of 
m icrovascular complications using dilated fundoscopy, biothesiometry 
and ACR determ ination as defined in Chapter 3 (pages 71 and 74). 
Three had background retinopathy and one had maculopathy; tw o  had 
a raised VPT (35 and 41V  respectively); and tw o  had an elevated ACR 
(4 .la n d  6.5 mg.mmol'1), but none dipstick positive proteinuria.
Methods
During the acclimatisation period, a small area o f skin on the 
dorsum of the right foo t was heated to 44^C  using a brass heater 
attached to  the skin surface as described in Chapter 2 .3  (page 43), 
and brachial blood pressure was recorded as the mean of 3 readings 
using an automated device (Dynamap 850, Critikon Inc., Tampa, FI., 
USA). Maximum blood flo w  was determined by laser Doppler 
flux im etry (Perimed Pf2; Perimed , Stockholm, Sweden) as the mean 
reading of 8 sites in the heated areals, expressed arbitrarily in volts 
(V).
A t the end of the study a venous blood sample was obtained for 
assessment of ambient plasma glucose concentration, and in the 
diabetic subjects HbA-jg (a ffin ity column chromatography; normal 
range 4-6% ). Fasting plasma insulin was also measured in the NIDDM
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patients using a specific 2-site EL1SA204 which had minimal cross­
reactiv ity w ith  pro-insulin and other insulin-like molecules {normal range 
1-15 //U.ml-1).
Results:
Maximum hyperaemia was significantly reduced in the NIDDM 
patients (0.82 (0 .42-1.41) V, vs 1.40 (0 .89-2.13) V control subjects; 
p < 0 .005 , Mann-Whitney) (Fig 4 .1 .1 ). There was no significant 
correlation of maximum hyperaemia w ith  diabetes duration (p -  0 .8), 
blood pressure (p = 0.6) or glycaemic control (p = 0 .8  fo r both 
glucose and HbA ig, Spearman Rank). In contrast, there was a 
negative correlation between maximum hyperaemia and fasting plasma 
insulin (Rg = -0 .6 3 , p < 0 .0 4 ) (Fig 4 .1 .2 ).
There were no significant differences between NIDDM patients and 
control subjects w ith  respect to  BMI (p = 0.8) or blood pressure (p = 
0.6) (Table 4 .1 .1 ).
Discussion:
This study confirms the finding of reduced maximal microvascular 
hyperaemia in patients w ith  NIDDM, as has been demonstrated 
p r e v i o u s l y ' ^  2 0 , 1 2 1  _ on  th is occassion large vessel disease was excluded 
by Doppler waveform  analysis, so tha t impaired vasodilation must be 
due to  an intrinsic m icrovascular defect. M icrovascular function in non­
diabetic subjects w ith  peripheral vascular disease has been found to  
remain normal until the atheromatous process is at an advanced
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Fig 4.1.1 Maximum microvascular hyperaemia in NiDDM patients and 
centrai subjects {horizontal bars represent median values)
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Fig 4 .1 .2  Correlation between maximum hyperaemia and fasting 
piasma insuiin concentration in NIDDM patients
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stage^G()'TG1,165^ and it is interesting to note tha t the actual values for 
hyperaemia in the current study were not dissimilar from  those found 
previously in NIDDM patients selected on the basis o f a normal ankle 
systolic pressure indexl22 Doppler sonography is tim e consuming, 
requires specialised equipment and a skilled operator. In addition, all 
subjects who were thought to be free from  large vessel disease on the 
basis of clinical criteria were subsequently found to  have normal 
Doppler waveform  assessments. In view  of these points it was decided 
tha t ankle systolic pressure index was a simple and adequate method to 
exclude significant large vessel disease in the absence o f sym ptom s, 
when taken in conjunction w ith  intact peripheral pulses, and was the 
method employed in the remainder of studies in th is thesis.
No significant correlation could be found between glycaemic control 
and microvascular hyperaemia in th is small number o f subjects. The 
associations between microvascular vasodilation and glycaemic control 
and hypertension are further explored in the other studies in th is 
chapter. In contrast, there was a significant negative association 
between fasting plasma insulin concentration and maximal hyperaemia 
and th is theme is further explored in Chapter 5.3.
In summary, these results confirm  the previous findings o f reduced 
m icrovascular hyperaemia in NIDDM, in a group of patients in which 
large vessel disease had been rigorously excluded by Doppler 
sonography.
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4 .2  E ffect o f qlycaemiG control in recently diagnosed NIDDM patients
Reduced m icrovascular hyperaemia in response to  local heating o f 
the foo t skin has been shown to  be already present at the tim e o f 
diagnosis in patients w ith  NIDDIVI^22 w ith  the degree o f impaired 
vasodilation being sim ilar to  tha t found in IDDM patients o f a sim ilar 
age, but w ith  a disease duration o f several years^^. Recently much 
a tten tion  has focused on the role o f improved glycaem ic contro l in 
reducing the rate of m icrovascular com plications in IDDM w ith  
publication o f the results of the Diabetes Control and Com plications 
T r i a | 2 0 5  W hether improved glycaemic control w ill produce sim ilar 
benefits in patients w ith  NIDDM remains uncertain, and the observed 
differences in the epidem iology o f m icrovascular com plications in 
NIDDM compared w ith  IDDM argue against extrapolating d irectly  from  
the results o f the Diabetes Control and Complications Trial to  NIDDM 
patients. Hopefully th is  question w ill be clarified w hen the United 
Kingdom Prospective Diabetes S t u d y 2 0 6  results are published in the 
near fu ture .
Short term  im provem ent in glycaemic control has been shown to  
influence the d istribution of peripheral blood flo w  in poorly controlled 
NIDDM patients^® and those w ith  neuropathy^ and to  reduce to ta l
limb blood flo w  in new ly diagnosed patients'* There are, however,
no studies o f the e ffects  o f sustained im provem ents in glycaem ic 
contro l on m icrovascular function  in NIDDM. In th is section, therefore, 
the e ffects  of one year of improved glycaem ic contro l on m icrovascular 
hyperaemia in response to  local heating o f the fo o t skin, have been 
determ ined in a group of recently diagnosed NIDDM patients.
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Subjects and m ethods:
Subjects
Tw elve NIDDM patients (6M : 6F, age 51 .5  (27-66) years, median 
and range) from  the Exeter cohort o f the United Kingdom Prospective 
Diabetes S tudy were fo llow ed from  diagnosis (Table 4 .2 .1 ). This is a 
m ulticentre  study looking at the e ffects  of glycaem ic contro l on the 
developm ent o f vascular com plications in NIDDM, and w hether th is  
process is influenced by d iffe ren t trea tm ent m o d a l i t i e s 2 0 6 _  Patients 
w ere recruited consecutive ly from  referrals to  the clin ic w ho had no 
evidence o f hypertension or sign ificant renal im pairm ent as previously 
defined (page 82). Large vessel disease was excluded on the basis o f 
absence of sym ptom s suggestive o f vascular disease, palpable pedal 
pulses, and ankle : brachial systo lic pressure index >  1.0. Nine 
partic ipants were non-smokers and tw o  were ex-smokers. Patients 
were treated w ith  d iet and if necessary sulphonylurea and/or insulin 
therapy according to  the study p r o t o c o | 2 0 6  s ix  patients had been 
randomised to an 'active control poiicy'206 aiming fo r a fasting  plasma 
glucose concentration <  6 m m ol.l"^, and the others to  'less s tric t 
con tro l' (fasting plasma glucose concentration < 1 5  m m ol.h^ )206
A t entry to  the study, the presence of diabetic re tinopathy was 
determ ined by a com bination o f ophthalm oscopy and retinal 
photography^^; and ACR was measured in an early morning urine 
sample to  screen fo r m icroalbum inuria as previously described (page 
74). To detect asym ptom atic neuropathy, VPT w as measured using a 
b iothesiom eter (page 71), w hile  autonom ic nerve function  was 
assessed using standard cardiovascular reflex tests^o?.
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Using the above criteria, there was minimal clin ical evidence o f 
m icroangiopathy, w ith  three subjects having m inimal background 
retinopathy, one having m icroalbum inuria (ACR = 4 .0  mg.mmol"'*), 
one having mild large fibre neuropathy (VPT = 20 V), and none having 
cardiovascular autonom ic neuropathy.
M ethods
Subjects were seen every 3 m onths in a special UKPDS clin ic. 
G lycaemic contro l was assessed by measurement o f fasting  venous 
plasma glucose and H b A lc  concentrations (High perform ance liquid 
chrom atography; Biorad Laboratories Ltd, Hemel Hempstead, Herts., 
UK; normal range 4 .3 -6 .1 % ) and treatm ent altered to  meet the study 
targets as previously defined.
Maximal m icrovascular hyperaemia was measured (as described in 
Chapter 2 .3 , page 43) w ith in  a fe w  weeks of diagnosis, a t the end of 
a 3 m onth period of therapy w ith  diet alone, and after one year of 
trea tm ent. A  record was taken o f the exact positioning o f the heated 
site on the fo o t fo r each subject, so tha t the same site could be used 
fo r sequential measurements. During the acclim atisation period brachial 
blood pressure was calculated as the mean o f 3 measurements using 
an automated device (Dynamap 845 ; Critikon Inc, Tampa, FI., USA).
Results:
The low  maximum m icrovascular hyperaemic response present at 
diagnosis in the NIDDM patients was unchanged after the initial three 
m onth period o f d ietary trea tm ent (0 .97 (0 .22 -2 .17) V baseline vs 0 .99
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(0 .3 8 -2 .7 4 ) V at three m onths; p = 0 .2 4 , W ilcoxon Rank Sum) (Fig
4 .2 .1 ) despite a s ign ificant im provem ent in glycaemic contro l (9 .6  (6 .6- 
17.3) mmol h'* baseline vs 8.1 (5 .4 -13 .1 ) mmol |-1 at three m onths; 
p <  0 .005 ) and BMI (28 (23-47) kg m~2 baseline vs 25 (23-44) kg m 2 
at three m onths; p < 0 .0 5 )  (Table 4 .2 .1 ). A t one year how ever, there 
was a s ign ificant im provem ent in the maximum m icrovascular 
hyperaemic response (1 .20  (0 .51 -3 .29 ) V ; p < 0 .0 5  vs baseline) (Fig
4 .2 .2 ), and there had also been a fu rther im provem ent in glycaem ic 
contro l (Table 4 .2 .1 ). Despite th is , there was only a borderline change 
in BMI (p =  0 .06) and no s ign ificant change in blood pressure (p = 0.6) 
a fte r one year o f trea tm ent (Table 4.2.1 ).
A lthough the number o f subjects in each group was small, there 
was no s ign ificant d ifference in the im provem ent in m icrovascular 
hyperaemia achieved in those allocated to  the 'ac tive ' contro l po licy (% 
change relative to  baseline value + 11  (-21 to + 5 3 ) %) compared w ith  
those allocated to  less s tr ic t control (% change relative + 3 0  (-10 to  + 
129) %, p = 0.11 ). Surprisingly, glycaemic contro l in the la tte r group 
did not d iffe r s ign ificantly  from  th a t in the group allocated to  active 
contro l (fasting plasma glucose concentration 6.7 (5 .2 -13 .0 ) mmol h'* 
vs 7.1 (5 .6 -9 .4 ) mmol I"'* active contro l, p = 0 .8 ; H bA i Q 6 .0  (5 .0-
7 .2 )%  vs 5 .8  (5 .3 -7 .7 )%  active, p = 0.9).
There was no sign ificant correlation o f maximum m icrovascular 
vasodilation w ith  fasting plasma glucose concentration, plasma 
glucose concentration at the tim e o f measurement o f hyperaemic 
response, HbA-j g, blood pressure or BMI, at baseline or one year. 
There was however an association between the im provem ent in 
maxim um  hyperaemia over one year and the im provem ent in glycaem ic 
contro l (Rg = 0 .5 3 , p <  0 .05) (Fig 4 .2 .3 ), whereas there was no
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Fig 4 .2 .1  Maximum microvascular hyperaemia a t diagnosis and after 3
months therapy in NiDDM patients
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Fig 4 .2 .2  Maximum microvascular hyperaemia at diagnosis and after 1 
year of treatment in NiDDM patients
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Fig 4 .2 .3  Correlation between improvement in maximum hyperaemia 
over one year and improvement in glycaemic contra!
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Table 4 .2 .1  Changes in glycaemic controf BM! and bioodpressure 
over 1 year o f improved diabetic control
Diagnosis 3 months 1 year
Fasting Plasma glucose (mmol 1' )^ 9 .6 (6,6-17.3) 8.1 (5 .4-13.1)3 6.4  (5.9-10.8)b
Study plasma glucose (mmol 7.4  (5.5-13.5) 6.3 (4 .0-14.4)3 6.5 (4.6-10.6)
H bA lc (%) 8.6 (6.1-13.3) 6.1 (5.9-10.8)3 5.7 (5.3-7.7)d
BMI (kg m“2) 28 (23-47) 25 (23-44)3 26 (23-42)
Systolic BP (mmHg) 125 (99-138) 126 (98-142) 123 (94-148)
Diastolic BP (mmHg) 75 (59-85) 73 (59-84) 73 (58-87)
Data shown as median and range
^ p <  0 .0 0 5  vs value at diagnosis 
b p <  0 .0 0 5  vs value at 3 months 
c p <  0 .05  vs value at diagnosis 
d p < 0 .0 5  vs value at 3 months
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correlation w ith  the decrement in either fasting plasma insulin level 
{excluding those tha t were insulin treated) (p = 0 .4) or BMI (p = 0 .9 ).
Discussion:
This study has dem onstrated tha t the lim ited m icrovascular 
vasodilation present at diagnosis in patients w ith  NIDDM may improve 
over the course of one year o f improved glycaemic contro l. W hether 
th is  im provem ent is sustained over a longer period remains to  be 
determ ined. There was no difference in the im provem ent achieved 
between those allocated to  tig h t contro l and those to  less s tr ic t contro l, 
although both groups achieved a sim ilar level o f glycaem ic contro l at 
one year. Im provem ent in maximum m icrovascular hyperaemia was 
found w ith  all the therapeutic strategies employed in th is study, 
although the numbers in each group were too small to  determ ine 
w hether any one type of diabetes trea tm ent was superior to  the others.
Im provem ent in m icrovascular vasodilation was associated w ith  
improved glycaemic contro l but not decrement in fasting plasma insulin 
concentration and BMI. No change in hyperaemic response was 
apparent after three months o f improved glycaemic contro l, suggesting 
a s low ly  reversible process w hich would favour a structura l change in 
the vessel w all. The exact nature o f th is remains to  be determ ined, 
bu t possible candidates are vascular smooth muscle cell hypertrophy 
and basement membrane th ickening. The la tter o f these was previously 
though t to  be a largely irreversible process; however, some studies do 
show  a reduction in basement membrane th ickness w ith  improved 
glycaem ic control208,209^ despite some debate about the 
methodologies usedT Future studies combining m easurement of
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m icrovascular hyperaemia w ith  skin biopsy and m icrovascular h is to logy 
w ill be required to  establish the relationship between improved d iabetic 
contro l and changes in m icrovascular structure and function .
In summary, there is an increase in m icrovascular vasodilation in 
recently diagnosed NIDDM patients w ho improve the ir glycaem ic 
contro l.
4 .3  Effect of hypertension
The preceding studies have demonstrated th a t m icrovascular 
hyperaemic responses are reduced in patients w ith  NIDDM, confirm ing 
the find ings o f previous s t u d i e s ’* 21/122 |n contrast, studies using laser 
Doppler flux im e try  In non-diabetic patients w ith  essential hypertension 
yield inconsistent results, w ith  some showing no reduction in
m icrovascular hyperaemic responses’* 20  ^ w hile  others d o ^^^ . This
is despite the fac t th a t increased structurally-based resistance to  blood 
flo w  has been dem onstrated in essential h y p e r t e n s i o n ^  ^9 As 
hypertension and NIDDM com m only co-exist, th is study looks at the 
e ffec ts  o f hypertension on maximal hyperaemia and resistance to  blood 
flo w  in the skin m icrocirculation of patients w ith  NIDDM.
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Subjects and M ethods:
Subjects
Nine untreated hypertensive NIDDM patients {brachial blood 
pressure consistently >  160 /90  mmHg), 9 norm otensive NIDDM 
patients and 9 norm otensive non-diabetic contro l subjects were 
studied. The groups were age- and sex-matched and sum m ary details 
are show n in Table 4 .3 .1 . Patients were recruited consecutive ly from  
the d iabetic clin ic o f the Royal Devon and Exeter hospital and contro l 
subjects from  a panel o f healthy volunteers. None o f the  partic ipants 
had evidence o f s ign ificant renal im pairm ent or large vessel disease as 
previously defined {pages 82 and 88). The NIDDM patients were 
screened fo r the presence o f m icrovascular com plications (pages 71 
and 74) Five o f the hypertensive NIDDM patients had re tinopathy (3 
background, 2 treated m aculopathy), three had large fibre neuropathy 
(VPT > 30V , no h istory o f fo o t ulceration) and four had
m icroalbum inuria (ACR >  2.5 m g .m m o l'’’ ); whereas three o f the 
norm otensive NIDDM patients had retinopathy (2 background, 1 
maculopathy), three had large fibre neuropathy and three had 
m icroalbum inuria.
M ethods
The protocol and equipm ent used fo r skin heating, brachial blood 
pressure measurement and determ ination o f maximal hyperaemia was 
as previously described (page 43). As blood pressure depends on 
cardiac ou tou t and to ta l peripheral resistance, it is possible to  get an 
estim ate o f resistance to  flo w  in a m axim ally vasodilated
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Table 4 .3 .1  Clinical characteristics of hypertensive and normotensive 
diabetic patients and non-diabetic control subjects
N i d d m C o n t r o l
H y p e r t e n s iv e N o r m o t e n s i v e
N  {M/F) 6/3 6 /3 6/3
A g e  (yr) 62 (48-65) 60 (47-66) 59 (45-68)
DURATION OF DIABETES (yr) 9 (4-17) 7 (4-19) -
D ia b e t e s  t r e a t m e n t  (n )
D ie t  a l o n e 0 3 -
O r a l  h y p o g l y c a e m i c 4 6 -
In s u l in 5 0 -
b o d y  m a s s  in d e x  (k g .m -2 ) 28 (24-36) 26 (21-34) 27 (23-30)
Pl a s m a  g l u c o s e  (m m ol.I  “1) 6.9  (4 .0 -13.1) 8.7 (5 .1 -14 .9 ) 4 .8  (3 .9 -5 .8 )
HBA-| Q (%) 7.5  (6 .5 -11.1) 7 .5  (5 .3 -12 .2 ) -
Bl o o d  p r e s s u r e  (m m H g )
S y s t o l ic 182 (162-228) 136 (116-158) 138 (126-148)
D ia s t o l ic 98 (94-114) 78 (58-84) 76 (66-86)
MAP 125 (118-149) 99 (84-109) 99 (88-105)
Data are shown as median and range
MAP = mean arterial pressure
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m icrocircu la tory bed by divid ing mean arterial pressure (in mmHg) by 
maximal hyperaemia (in V), results being expressed in arb itrary units of 
m m H g.V  ^
A t the end of the study a venous blood sample was obtained fo r 
assessment o f ambient plasma glucose concentration, and in the 
d iabetic subjects HbA^g (determined by a ffin ity  column 
chrom atography; normal range 4-6% ).
Results;
The maximal m icrovascular hyperaemic response w as reduced in 
both the hypertensive (1 .05 (0 .70 -1 .42) V) and norm otensive (1 .04  
(0 .79 -1 .63 ) V) NIDDM patients when compared w ith  contro l subjects 
(1 .40  (1 .26 -2 .13) V; p <  0.01 fo r hypertensive and p <  0 .05  fo r 
norm otensive patients respectively, Mann-W hitney) (Fig 4 .3 .1 ); 
however, maximal hyperaemia was sim ilar in both groups o f diabetic 
patients (p = 0 .82 ). In contrast, resistance to  blood flo w  was 
s ign ifican tly  greater in the diabetic patients w ith  hypertension (127 .2  
(8 7 .5 -181 .3 ) m m Hg.V"'’ vs 84 .7  (61.9-1 23.0) m m H g.V 'l norm otensive 
diabetic patients; p <  0 .02) (Fig 4 .3 .2 ). in addition, resistance to  
blood flo w  was greater in the normotensive NIDDM patients than in the 
contro l subjects (70.7  (44 .7 -79 .9 ) mmHg.V"'’ ; p <  0 .05) (Fig 4 .3 .2 ).
BMI was sim ilar in the d iffe ren t groups (p = 0 .2) (Table 4 .3 .1 ). 
There were no sign ificant differences in ambient plasma glucose 
concentration at the  tim e of study (p = 0 .4 ), or longer term  glycaem ic 
contro l, as reflected by HbA^^ measurements (p = 0 .9 ), between the 
hypertensive and normotensive NIDDM patients (Table 4 .3 .1 ); 
however, there were s ign ificant differences in diabetes trea tm ent
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Fig 4 .3 .1  Maximum microvascular hyperaemia in hypertensive NIDDM  
patientSr normotensive NIDDM patients and normotensive non-diabetic 
control subjects (horizontal bars represent median values)
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Fig 4 .3 .2  Calculated resistance to blood flow in hypertensive N IDDM  
patients^ normotensive NIDDM patients and normotensive non-diabetic 
control subjects (horizontal bars represent median values)
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between the tw o  groups w ith  insulin being used in the m ajority  o f 
hypertensive patients but none o f the normotensive patients (Table
4 .3 .1 ).
Discussion:
This study has dem onstrated th a t patients w ith  NIDDM w ith  and 
w ith o u t hypertension have sim ilar values fo r maximal hyperaemia in 
response to  local heating o f the skin. In both cases maximal 
hyperaemia was reduced in comparison to  values obtained in contro l 
subjects. Resistance to  blood flo w , however, w as increased in 
hypertensive when compared to  the normotensive NIDDM patients. 
Heating the skin to  a tem perature of 44 °C  has been shown to  induce 
maxim um  m icrovascular vasodila tion ’’ Under such conditions, blood 
flo w  is entirely dependent on the pressure gradient and structura l 
vascular resistance^ The resistance calculation used in th is  study 
assumes th a t venous pressure was zero and th a t brachial artery 
pressure was equal to  arteriolar pressure in the area o f study. The 
form er assumption leads to  a s ligh t overestimate of the pressure 
gradient as venous pressure is likely to  be around 10 m m H g l^ ; 
whereas, in the supine position, the latter assumption is likely to  hold. 
These errors are small and system atic and are therefore unlikely to  
influence the observed results. The site of increased resistance to  flo w  
is likely to  lie on the arteriolar side of the capillary bed, although there 
is some evidence th a t the post-capillary segment contribu tes in 
essential hypertens ion^io .
The m ajority  o f the hypertensive NIDDM patients were treated w ith  
insulin therapy, whereas none o f the normotensive NIDDM patients
102
w as. it is interesting to speculate th a t peripheral hyperinsulinaemia 
may relate to  increased vascular resistance, especially in v iew  o f the 
correlation observed between hyperinsulinaemia and maximal 
hyperaemia in Chapter 4 .1 . It is also possible th a t insulin trea tm ent 
equated w ith  poorer past glycaem ic control in the hypertensive group 
and th is  could have influenced the results, although in previous studies 
of NIDDM patients, no correlation has been found between past 
g lycaem ic contro l and reduced hyperaemic r e s p o n s e s T 2 l . 1 2 2  despite 
the im provem ents observed in hyperaemic responses associated w ith  
improved glycaem ic contro l in recently diagnosed NIDDM patients 
observed in Chapter 4 ,2 . A lternative ly, arterial hypertension per se 
may have induced secondary structura l changes in the m icrocircu la tion 
as previously described’’ ®^. As the prevalence o f d iffe ren t 
m icrovascular com plications was sim ilar in the hypertensive and 
norm otensive NIDDM patients, it is unlikely th a t the observed 
differences in resistance to  flo w  re flect differences in the severity o f 
m icroangiopathy in the tw o  groups.
In summary, these results suggest tha t hypertension is associated 
w ith  an additional rise in pre-capillary vascular resistance in NIDDM 
w hich , while protecting the m icrocirculation from  the e ffec ts  o f 
increased arterial pressure, may fu rther dim inish pro tective  hyperaemic 
responses.
Summary
The studies in th is chapter have confirmed th a t there is a reduction 
in m icrovascular hyperaemia in response to  local heating in patients
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w ith  NIDDM. This lim ited vasodilation is not due to  occu lt large vessel 
disease, is present at the tim e o f diagnosis o f diabetes, and improves 
in recently diagnosed patients w ho achieve good glycaem ic contro l, 
providing a further reason fo r striv ing fo r optimal contro l. In NIDDM 
patients w ith  hypertension, hyperaemic responses are not fu rthe r 
impaired, but there is a rise in estim ated resistance to  blood flo w . Such 
a rise in vascular resistance is o f clinical relevance in the diabetic fo o t, 
w here reduced hyperaemia is likely to  contribute  to  impaired 
in flam m atory responses to  in fection and tissue injury, and also to  a 
s low  healing ra te s 'll. In patients w ith  NIDDM, therefore, the  e ffe c t o f 
hypertension may add to  the burden o f intrinsic m icrovascular disease, 
increasing the chances of m icrovascular failure and tissue necrosis.
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CHAPTER 5
M AXIM U M  MICROVASCULAR HYPERAEMIA IN 
INSULIN RESISTANT STATES
The m icrovascular hyperaemic response to  local heating o f the fo o t 
skin is already reduced in new ly diagnosed NIDDM patients'* 22. This 
could arguably reflect a prolonged phase o f undiagnosed diabetes 
and/or the e ffects  o f metabolic abnormalities other than hyperglycaem ia 
(e.g. hyperinsulinaemia) on the m icrocirculation. The w ork  in th is 
chapter a ttem pts to  c larify  th is question by studying m icrovascular 
hyperaemia in subjects at high risk o f developing NIDDM w ho have IGT; 
by exploring the relationship of hyperinsulinaemia to  m icrovascular 
vasodilation in patients w ith  acromegaly - a disease sta te  associated 
w ith  insulin resistance; and by relating blood pressure and m etabolic 
abnormalities during the pre-diabetic phase to  maximal hyperaemic 
responses in subjects w ith  IGT.
5.1 Impaired glucose tolerance.
Both structura l m icroangiopathy25 and abnormal m icrovascular 
f u n c t i o n ’ 22 are detectable at the tim e of diagnosis in patients w ith  
NIDDM. Prior to the developm ent of NIDDM, it is possible to  define a 
'pre-d iabetic ' phase, o therw ise known as IGT (Chapter 1 .2, page 7), 
on the basis o f an abnormal blood glucose profile fo llow ing  a standard
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75g oral glucose tes t (OGTT)2’ 2. A lthough the OGTT remains the 
'gold standard' fo r defining IGT, it shows poor intra-individual 
reproducib ility2 ’ 3, and recently it has been argued th a t glucose 
to lerance can be characterised as reliably, and more sim ply, on the 
basis of a fasting plasma glucose leve|2’ 4 Regardless o f th is , there is 
little  evidence of structura l m icroangiopathy in subjects w ith  IGT64,65 
and little  inform ation on m icrovascular function  (Chapter 1.5, page 
21). As reduced m icrovascular hyperaemia is present a t diagnosis in 
N I D D M ’ 22^ t h e  aim o f th is study was to  determine w hether abnormal 
vasodilation is already present in subjects w ith  IGT.
Subjects and M ethods:
Subjects
Subjects at risk o f developing NIDDM were recruited from  the 
Oxford cohort o f the Fasting Hyperglycaemia Study, a m ulticentre 
prospective randomised study comparing the e ffects  o f d ie t and 
exercise, w ith  or w ith o u t sulphonylurea treatm ent, on IGT. This 
group had been recruited from  a high risk population w ho all had one or 
more risk facto rs fo r the developm ent o f NIDDM (affected firs t degree 
relative, previous gestational diabetes, marked obesity, known IGT). 
All had a fasting venous plasma glucose concentration between 5.5 
and 7.8 mmol.I ’  (i.e. greater than 95 th  centile fo r the  normal
population and less than WHO defin ition fo r d i a b e t e s 2 ’ 2 )  on tw o  
occasions prior to  entry to  the study, and all had normal fasting  serum 
cholesterol and trig lyceride levels.
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M icrovascular function  was assessed in all suitable subjects w ith  
fasting  hyperglycaemia attending the study clin ic in a 1 m onth period. 
This amounted to  11 subjects (5 male : 6 female; age 52 (40-73) 
years, median and range) (Table 5 .1 .1 ), o f w hom  six had been 
randomised 1 to  3 m onths beforehand to  trea tm ent w ith  placebo 
tab le ts, or the sulphonylurea gliclazide, in a dose o f 8 0 -16 0  mg daily, 
plus a d ie t and exercise program. The remaining five  subjects were all 
studied at the ir f irs t c lin ic v is it prior to  any therapy random isation. 
Eleven age- and sex-matched control subjects w ith  no fam ily  h is to ry o f 
NIDDM were studied fo r comparison (Table 5 .1 .1 ). None o f the 
partic ipants had hypertension, renal im pairm ent or large vessel disease 
as previously defined (pages 82 and 88), and none were taking 
vasoactive medication. Tw o o f the subjects w ith  IGT were ex-smokers 
and tw o  were current smokers, w hile  three o f the contro l subjects 
were ex-smokers.
All subjects w ith  fasting hyperglycaemia were screened fo r 
m icrovascular disease as previously described (pages 71 and 74). None 
o f those w ith  IGT had evidence o f retinopathy, tw o  had mild large fibre 
neuropathy (VPT = 22 and 30 V), and none had m icroalbum inuria.
M ethods:
During the acclim atisation period, brachial blood pressure was 
calculated as the mean o f 3 measurements using an autom ated device 
(Takeda U A -751 , A&D Engineering Inc., M ilp itas, Ca, USA). 
Subsequently, measurements o f maximum m icrovascular hyperaemia 
were carried out on the dorsum o f the right fo o t (page 43).
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Table 5.1.1 Clinical characteristics of subjects with impaired glucose 
tolerance and non-diabetic control subjects
IGT C o n t r o l
N  (M /F ) 5 / 6 5 / 6
A g e  {yr) 5 2  ( 4 0 - 7 1 ) 5 3  ( 4 0 - 7 1 )
B M I  ( k g .m -2 ) 2 7  ( 2 4 - 3 7 ) 2 5  ( 1 9 - 3 1 )
Pl a s m a  g l u c o s e  (m m o l . I -1) 6 . 4  ( 5 . 2 - 7 . 1 ) 4 . 5  ( 4 . 0 - 5 . 2 )
S e r u m  c h o l e s t e r o l  (m m ol.I 5 . 6  ( 4 . 0 - 5 . 8 ) 5 . 2  ( 4 . 3 - 5 . 5 )
S e r u m  t r ig l y c e r id e s  (m m ol.I  - i ) 1 . 2  ( 0 . 8 - 1 . 3 ) 1.1 ( 0 . 7 - 1 . 5 )
Bl o o d  p r e s s u r e  (m m H g )
S y s t o l ic 1 3 2  ( 1 1 7 - 1 5 4 ) 1 3 2  ( 1 2 2 - 1 4 8 )
D ia s t o l ic 7 6  ( 6 8 - 9 0 ) 7 2  ( 6 6 - 8 8 )
D a ta  are s h o w n  as m ed ian  and range
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Results:
The m axim um  hyperaemic response was s ign ificantly  low er in the 
subjects w ith  IGT than in control subjects (1.01 (0 .7 1 -1 .5 7 ) V vs 1.41 
(1 .3 2 -2 .1 3 ) V, p <  0 .0 0 1 , M ann-W hitney) (Fig 5 .1 .1 ). Values fo r 
maxim um  hyperaemia were sim ilar in those already randomised to  
trea tm en t and those w ho were not (0 .98 (0 .76 -1 .18) V vs 1.01 (0 .71-
1 .57)V ; p = 0 .4). Median fasting plasma glucose concentration on 
the day o f s tudy was 6 .4  (5 .2 -7 .1 ) mmol.h^ in the group w ith  IGT (vs
4 .5  (4 .0 -5 .2 ) m m ol.l'^ in control subjects; p <  0 .0 0 0 2 ), w ith  tw o  
subjects having improved on therapy to  fasting normoglycaem ia. There 
were no sign ificant d ifferences in blood pressure (p = 0 .7 ), BMI (p -  
0 .1 ), serum cholesterol (p = 0 .5 ), or trig lycerides (p =  0 .6 ) between 
the subjects w ith  fasting hyperglycaemia and contro l subjects (Table
5 .1 .1 ).
Discussion:
This study has dem onstrated th a t functional m icrovascular 
abnormalities, such as reduced maximal hyperaemia, may already be 
present in subjects w ith  IGT, w ho are at risk o f developing NIDDM. 
The observed degree of im pairm ent is similar to  th a t seen in new ly 
diagnosed NIDDM p a t i e n t s ’' 2 2 .
The mechanism fo r lim ited vasodilation seems unlikely to  be related 
to  the  m odest elevations in plasma glucose present in these subjects 
w ith  IGT, w hich are sim ilar to  optimal treatm ent levels fo r both IDDM 
and NIDDM patients. This v iew  is supported by the results of Chapter 
4 .2 , in w hich sustained im provem ent in glycaem ic contro l to
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Fig 5.1.1 Maximum microvascular hyperaemia in subjects with fasting 
hyperglycaemia and non-diabetic controi subjects (horizontal bars 
represent median values)
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sim ilar levels in new ly diagnosed NIDDM patients was associated w ith  
marked im provem ent in m icrovascular vasodilation. Once more th is  
raises the possib ility th a t reduced m icrovascular hyperaemia may relate 
to  the e ffects  o f other metabolic abnormalities occurring in the pre­
diabetic state, such as hyperlipidaemia, or hyperinsulinaemia as a 
result o f insulin resistance. In the current study, hyperlipidaemia did 
no t seem to  be o f much importance as there was no s ign ificant 
e levation in either serum cholesterol or trig lycerides in the subjects w ith  
IGT w ho had reduced m icrovascular vasodilation. The interactions o f 
hyperinsulinaemia and insulin resistance w ith  m icrovascular vasodilation 
are fu rthe r explored in Chapters 5 .2  and 5.3 .
5 .2  Acrom egaly
Acrom egaly is a disease caused by excess circulating g row th  
hormone (GH) levels, usually as a result o f hypersecretion from  a 
p itu ita ry  adenoma^lG q]-\ excess results in m etabolic e ffects  mediated 
by various g row th  factors, in particular insulin-like g row th  fa c to r-1 
(lGF-1 )215. One feature of th is  is the development of insulin resistance 
and hyperinsulinaemia, w ith  the result th a t around 25%  o f patients 
w ith  acromegaly develop IGT and 15%  frank d i a b e t e s ^ i G .  Acrom egaly 
is also associated w ith  a high prevalence of hypertension and increased 
cardiovascular m o r t a l i t y 2 l 7 .
As sim ilar metabolic abnormalities are present in acromegaly and the 
pre-diabetic state, maximum m icrovascular hyperaemia was 
determ ined in patients w ith  acromegaly to  investigate the influence o f
111
hyperinsulinaemia on the m icrocirculation. In v iew  o f possible 
differences in dermal structure between patients w ith  acromegaly and 
contro l subjects, basal skin capillary density was also determ ined.
Subjects and M ethods:
Subjects
All acromegalic patients (n = 19) attending the Endocrine clin ic at 
the Royal Devon and Exeter Hospital were identified and invited to  
partic ipate in the study. Three patients w ith  known diabetes mellitus 
were excluded, along w ith  tw o  who had evidence of large vessel 
disease and three w ho were taking potentia lly  vasoactive medication 
fo r other reasons. Tw o fu rthe r patients were unw illing  to  participate, 
leaving nine patients w ith  acromegaly (3M : 6F; age 68 (52-70) years, 
median and range) w ho were suitable fo r study (Table 5 .2 .1 ). Nine age- 
and sex-matched contro l subjects selected from  a panel o f healthy 
volunteers were studied fo r comparison (Table 5 .2 .1 ). Acrom egaly had 
been treated in a variety o f w ays (Table 5 .2 .2 ). Four o f the selected 
acromegalic patients were being concurrently treated w ith  
brom ocriptine and five  had mild hypertension, but were included in the 
study to  obtain an adequate sample size.
The acromegalic patients were screened fo r the presence of 
m icrovascular com plications (pages 71 and 74). None had evidence of 
re tinopathy; three had a raised VPT (25, 28 and 36 V); and one had 
elevated ACR (6.1 mg.mmoh^). Tw o of the acromegalic patients were 
current smokers and tw o  of the contro l subjects were ex-smokers.
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Table 5.2.1 Clinical characteristics o f patients with acromegaly and 
control subjects
A c r o m e g a l ic C o n t r o l
N  (M/F) 3 / 6 3 / 6
A g e  (yr) 6 8  ( 5 2 - 7 0 ) 6 5  ( 5 0 - 6 9 )
BMI (kg.m-2) 2 8  ( 2 2 - 3 5 ) 2 5  ( 1 9 - 2 9 )
PLASMA GLUCOSE (m m ol.|-1 ) 4 . 8  ( 4 .1 - 5 .8 ) 4 . 6  ( 3 . 2 - 5 . 6 )
S e r u m  c h o l e s t e r o l  (m m o l .h ’') 5 .5  ( 4 .1 - 5 .9 ) 5 . 2  ( 3 . 9 - 5 . 7 )
SERUM t r ig l y c e r id e s  (m m o l. l  )^ 1.1 ( 0 .8 - 1 .3 ) 0 . 9  ( 0 . 7 - 1 . 2 )
P l a s m a  INSULIN (yc/U.m!-’') 1 0 . 2  ( 3 . 1 - 3 3 .0 ) -
S e r u m  IGF-1 (U .m l-1) 1 . 7 2  ( 0 . 8 6 - 4 . 2 4 ) -
Bl o o d  p r e s s u r e  (m mFIg)
Sy s t o l ic 1 4 8  ( 1 1 3 - 1 5 6 ) 1 3 5  ( 1 3 0 - 1 4 2 )
D ia s t o l ic 8 8  ( 6 5 - 1 0 4 ) 7 8  ( 6 6 - 8 9 )
Data are show n as median and range
Table 5 .2 .2  Details of main form of treatment for acromegaiy in 
patients studied
T r e a t m e n t N
Brom ocriptine 4
Transphenoidal hypophysectom y^ 2
Radiotherapy 1
H ypophysectom y plus radiotherapy*^ 1
Untreated 1
SQne male subject additionally on testosterone replacement therapy 
^Subject additionally on thyroxine replacement therapy
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M ethods:
Follow ing an overnight fast, the acromegalic patients had a 
standard 75g OGTT to  assess glucose tolerance status2i2^ w ith  basal 
blood samples being collected fo r measurement o f plasma insulin (using 
a sensitive 2-site ELISA method204- normal fasting range 1-15 //U .m h 
1), plasma glucose, and serum lipid concentrations, and a 2-hour 
sample fo r plasma glucose concentration. In the patients w ith  
acromegaly, serum IGF-1 levels were measured by RIA218 (normal 
range varies w ith  age and sex, upper lim it o f normal around 1.5 U.ml  ^
fo r the subjects in th is  study) to determ ine disease a c tiv ity2 i 9. IGF-1 
w as measured in preference to  GH itse lf, as serum levels are re lative ly 
cons tan t2 l9  in contrast to  the pulsatile nature of GH secretion, thus 
avoiding the need to  measure GH profiles over the course o f 12 or 24 
hours.
On a separate occasion, maximum m icrovascular hyperaemia was 
measured on the dorsum o f the right fo o t (page 43), and basal skin 
capillary density determ ined on the dorsal surface of the m iddle phalanx 
of the le ft m iddle finger (page 65). Bromocriptine was w ithe ld  fo r a 
period of 24  hours, and antihypertensive medication fo r 48 hours 
before the study. During the acclim atisation period brachial blood 
pressure was determ ined as the mean of 3 readings using an 
autom ated device (Dynamap 845; Critikon Inc, Tampa, FI., USA).
Results:
M axim um  m icrovascular hyperaemia was s ign ificantly  reduced in the 
acromegalic patients (0 .96  (0 .56 -1 .70) V vs 1 .46  (1 .2 4 -2 .1 3 ) V
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contro l subjects; p <  0 .0 5 , Mann-W hitney) (Fig 5 .2 .1 ), although 
there was no d ifference in basal skin capillary density (92 (76-120) 
c a p s . m m - 2  acromegalic patients vs 90 (74-136) c a p s . m m  2 contro l 
subjects; p = 0.8) (Fig 5 .2 .2 ). In the acromegalic patients there was 
no correlation between maximum hyperaemia and IGF-1 concentration 
(p =  0 .4 ), but there was a tendency tow ards a negative association 
betw een maxim um  hyperaemia and fasting plasma insulin concentration 
(Rs =  -0 .6 3 ; p = 0 .0 6 , Spearman Rank) (Fig 5 .2 .3 ).
There were no sign ificant differences between acromegalic patients 
and contro l subjects w ith  respect to  BMI (p = 0 .2 ), serum cholesterol 
(p = 0 .2 ), serum trig lycerides (p = 0 .3 ), or blood pressure (p -  0 .1 ). 
There was no correlation between maximum hyperaemia and blood 
pressure (p = 0.2) or plasma glucose (p = 0 .5 ), serum cholesterol (p 
= 0.4) and serum trig lyceride (p =  0.4) concentrations.
Tw o acromegalic patients had IGT (fasting plasma glucose 
concentration <  7 .8  mmol.I"'' and 2-hour glucose concentration 7 .8 -
11.1 m m ol.h ’')2 l2^ w hile  the others had normal glucose tolerance 
(Table 5 .2 .2 ). These tw o , plus another one patient, had fasting 
hyperinsulinaemia (defined as a fasting plasma insulin concentration 
greater than the upper lim it o f the normal range, i.e. > 1 5  ^/U.mh'l, 
w ith  a normal fasting plasma glucose concentration) (Table 5 .2 .3 ). 
Despite trea tm ent, six patients had evidence of active acromegaly on 
the basis o f elevated IGF-1 levels (Table 5 .2 .1 ).
Discussion:
M axim um  m icrovascular hyperaemia is reduced in patients w ith  
acromegaly, a disease w hich may be associated w ith  insulin resistance
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Fîg 5.2.1 Maximum microvascular hyperaemia in patients with 
acromegaly and control subjects (horizontal bars represent median 
values)
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Fig 5 .2 .2  Basai skin capiiiary density in patients with acromegaiy and 
controi subjects (horizontal bars represent median values)
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Fig 5 .2 .3  Correlation of maximum hyperaemia with fasting plasma 
insulin concentration in the acromegalic patients
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Table 5 .2 .3  Details o f hyperinsuUnaemic acromegalic patients
S u b j e c t
OGTT PLASMA GLUCOSE 
(mnnol.l“  ^) 
F a s t i n g  2 - H o u r
Pl a s m a
in s u l i n
(//U.I-1)
BMI
(l<g.m“2)
Bl o o d
PRESSURE
(mmHg)
F 6 9 y r 5 . 8 6 . 8 3 3 . 0 2 9 1 5 4 / 1 0 0
F 6 8 y r 4 . 7 1 0 . 4 1 6 . 2 3 3 1 5 6 / 8 4
F 6 8 y r 4.1 1 1 . 0 2 7 . 8 2 8 1 4 8 / 9 0
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and hyperinsulinaemia due to  the antagonistic e ffects  o f g row th  
hormone on insulin ac tiona ls . Three of the acromegalic patients 
included in th is  study had fasting hyperinsulinaemia in the face o f a 
normal fasting plasma glucose concentration, and tw o  patients had 
IGT. There was a tendency tow ards a negative association between 
fasting  plasma insulin level and m axim um  hyperaemic response, sim ilar 
to  the relationship observed in Chapter 4 .1 .
The metabolic abnormalities o f insulin resistance, impaired glucose 
to lerance, hypertension, hyperlipidaemia and obesity o ften occur in 
c o m b i n a t i o n ^ 7 ^  making it d ifficu lt to  assess the individual con tribu tion  
o f each to  lim ited m icrovascular vasodilation. There was no s ign ificant 
d ifference between acromegalic patients and contro l subjects w ith  
respect to  blood pressure, despite the fac t th a t five  of the acromegalic 
patients were known to  have mild hypertension. This may re flect a 
type  2 sta tistica l error due to  small sample size; how ever, the 
inclusion o f some subjects w ith  mild hypertension is unlikely to  have 
biased the results as m ost studies in patients w ith  essential 
hypertension have shown no reduction in maximal hyperaemia when 
compared w ith  matched control s u b j e c t s ’’ Sim ilarly in Chapter
4 .3  no fu rther reduction in hyperaemic response was observed in 
NIDDM patients w ith  hypertension when compared to  normotensive 
patients, although hypertension is associated w ith  an increased 
resistance to  blood flo w .
In keeping w ith  the results in patients w ith  IGT (Chapter 5 .1), 
hyperlipidaemia does not seem to be an im portant determ inant o f 
lim ited m icrovascular vasodilation in patients w ith  acromegaly, as there 
w as no difference in either plasma cholesterol or trig lyceride 
concentrations compared to  control subjects, and no s ign ificant 
correlation o f lipid levels w ith  maximum hyperaemia.
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Although BMI appears sim ilar in the acromegalic patients and contro l 
subjects, BMI and body w e igh t may not be reliable indicators o f the 
exten t or d istribu tion o f obesity in patients w ith  acromegaly, as much 
o f the ir increased w e igh t is derived from  hypertrophy o f internal organs 
and body tissues such as liver and skeletal muscle215^ and not from  
excess adipose tissue. In addition, some acromegalic patients have ta ll 
stature due to  onset o f the disease prior to  fusion o f the epiphyses o f 
long bones2l5 |t |g therefore d ifficu lt to  exclude differences in body 
com position , w ith  respect to  adipose tissue, between patients w ith  
acromegaly and contro l subjects. It is possible th a t w a is t-h ip  ratio 
w ou ld  be a more meaningful indicator o f body com position in patients 
w ith  acromegaly, although it was not measured in the current s tudy 
and may be open to  the same critic ism s as above.
Six o f the acromegalic patients had evidence of active disease and it 
is possible th a t th is  may have influenced m icrovascular hyperaemia due 
to  e ffects  of GH or IGF-1 on the m icrocirculation, although it is 
n o te w o rth y  th a t there was no correlation between serum IGF-1 
concentration and maximal hyperaemia.
Marked so ft tissue hypertrophy is a feature o f acrom egaly^’’ 
suggesting th a t d ifferences in dermal tissue structure between patients 
w ith  acromegaly and control subjects could be contribu ting  to  the 
observed results. This possib ility  is made less likely by the  fa c t th a t no 
difference was found in skin capillary density between patients w ith  
acromegaly and contro l subjects. The relationship between skin 
capillary density and maximum hyperaemia is fu rthe r explored in 
Chapter 7.
It was not possible to  be as rigorous w ith  selection criteria in the 
current study as in the other studies in th is thesis. Acrom egaly is a 
very rare disease and after exclusion o f diabetes and large vessel
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disease, the m ajority o f patients le ft suitable fo r study were taking 
brom ocriptine or antihypertensive medication, both of w h ich  could 
a ffec t m icrovascular reactiv ity  and although these were d iscontinued 
fo r a period before measurement o f maximum hyperaemia, a prolonged 
e ffe c t o f either drug on the m icrocirculation cannot be ruled out. 
Ideally repeating the study using normotensive new ly diagnosed 
acromegalic patients w ould elim inate many o f these problems, 
although th is w ould be im practicable o u tw ith  a specialist centre w ith  a 
particular interest in the  management o f acromegaly.
In summary, despite the d ifficu lties  w ith  patient selection, 
maxim um  m icrovascular hyperaemia is reduced in patients w ith  
acromegaly, and may be related to  fasting insulin concentration.
5 .3  Relationship of insulin resistance. R-cell dysfunction and blood 
pressure to microvascular hyperaemia in IGT
The studies in Chapters 4.1 and 5 .2  have suggested an association 
between increased plasma insulin concentration and reduced 
m icrovascular hyperaemia in patients w ith  NIDDM and acromegaiy 
respectively. This chapter fu rthe r explores the interactions of 
hyperinsulinaemia, insulin resistance and R-cell dysfunction  w ith  lim ited 
m icrovascular vasodilation in a larger group of subjects w ith  IGT.
Insulin sensitiv ity  and 6-cell function may be studied in v ivo using a 
varie ty o f techniques. It is possible to  gain some inform ation regarding 
insulin secretion and action using an intravenous glucose infusion w ith  
measurement o f glucose and insulin levels during the infusion, and
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m athem atical modelling o f the results. An example o f such a technique 
is Continuous Infusion o f Glucose w ith  Model Assessm ent (CIGMA)220^ 
w h ich  has been used in th is  chapter. Such relatively simple techniques 
give results w hich are comparable to  those o f more com plex 
euglycaem ic hyperinsuUnaemic, and hyperglycaem ic clamp s t u d i e s 2 2 0 _  
Subjects partic ipating in the m ajority o f studies in th is  thesis were 
deemed to  be normotensive on the basis o f discrete blood pressure 
recordings taken using a standard sphygm om anom eter or autom ated 
device. Such discrete measures may lead to  more subtle abnorm alities 
o f blood pressure being missed and recently 24-hour am bulatory blood 
pressure m onitoring has been used to  detect unrecognised hypertension 
or loss of the normal diurnal rhythm  of blood pressure, w hereby low er 
values are found during sleep. An abnormal diurnal rhythm  has been 
found in some patients w ith  NIDDM221 and has been related to  the 
presence of m icrovascular com p lica tions22 i. Loss o f diurnal rhythm  
could therefore be associated w ith  altered m icrovascular function . 24- 
hour am bulatory m onitoring has therefore been employed to  assess 
w hether abnormal blood pressure profiles are related to  reduced 
m icrovascular hyperaemia.
Subjects and Methods:
Subjects
T w e n ty  four subjects w ith  IGT {13M  : 1 1F; age 4 6 .5  (36-64) 
years, median and range) (Table 5 .3 .1 ) were recruited consecutive ly 
from  the Exeter cohort o f the Fasting Hyperglycaemia S tudy. The 
details o f th is study and patient selection are described in Chapter 5.1
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Table 5.3.1 Clinical characteristics o f subjects with impaired glucose 
tolerance
I G T
N  ( M / F ) 1 3 / 1 1
A g e  ( y r ) 4 6 . 5  ( 3 6 - 6 4 )
B M I  ( k g . m ' 2 ) 2 8  ( 2 2 - 3 4 )
P l a s m a  g l u c o s e  ( m m o i . i - ’ ) 5 . 8  ( 4 . 8 - 7 . 1 )
H b A i c  ( % ) 5 . 7  ( 5 . 0 - 7 . 3 )
T o t a l  C h o l e s t e r o l  ( m m o i . r ' ’ ) 4 . 9 8  ( 3 . 3 1 - 7 . 8 3 )
H D L  C h o l e s t e r o l  ( m m o i . i - ’ ) 1 . 0 9  ( 0 , 7 7 - 1 . 9 8 )
L D L  C h o l e s t e r o l  ( m m o i . r ' ' ) 3 . 1 0  ( 1 . 4 5 - 4 . 7 7 )
T r i g l y c e r i d e s  ( m m o i . r ’ ) 1 . 0 6  ( 0 . 4 6 - 5 . 4 8 )
B L O O D  P R E S S U R E  ( m m H g )
S y s t o l i c 1 2 3  ( 9 7 - 1 4 6 )
D i a s t o l i c 7 0 . 5  ( 5 1 - 8 3 )
Data are shown as median and range
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(page 106). Fifteen were allocated to  tab let therapy w ith  placebo or 
gliclazide 8 0 -160  mg daily and the others to  a d iet and exercise 
program alone. Three subjects were current and four subjects ex­
smokers.
All subjects were screened fo r m icrovascular disease as previously 
described (pages 71 and 74). None had retinopathy, one had mild and 
one marked large fibre neuropathy (VPT 23 and 45 V respectively) and 
tw o  had m icroalbum inuria.
Methods
Prior to  therapy random isation and fo llow ing  an overnight fas t, an 
intravenous glucose tolerance te s t was carried out on each subject 
using CIGMA to  determ ine 6-cell function  and insulin r e s i s t a n c e ^ ^ o  
Basal values fo r plasma glucose, C-peptide and insulin were 
determ ined from  the mean o f three samples taken at five m inute 
intervals before an infusion o f 10%  Dextrose was started. Dextrose 
w as infused at a dose of 5 mg.kg ideal body w e igh t"’ .m in"’ over 60 
m inutes, w ith  fu rthe r blood samples taken fo r glucose, C-peptide and 
insulin measurement at 50, 55 and 60 m inutes. Blood samples were 
collected from  an indwelling venous cannula in the forearm  w hich  was 
flushed w ith  0 .9%  Sodium Chloride between samples, a heating 
blanket around the forearm  ensuring artérialisation o f venous blood prior 
to  co llection. Plasma insulin was measured using a sensitive 2-site 
ELISA m e t h o d 2 0 4  (normal fasting range 1-15 //U .m h ’ ), and C-peptide 
by RIA222 CIGMA data fo r 6-cell function  and insulin resistance were 
then derived from  the plasma glucose, C-peptide and insulin 
concentrations using com puter based mathematical m o d e l l i n g 2 2 0 ^  w ith
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results expressed as a percentage of predicted normal. Basal blood 
samples were also collected to measure fasting serum lipids.
24-hour am bulatory blood pressure m onitoring was carried out on a 
separate occasion. A m bula tory blood pressure recordings were made 
on the le ft arm using the Takeda TM -2420  device (A&D Engineering 
Inc., M ilp itas, Ca, USA). A fte r careful positioning and taping of the 
blood pressure cu ff and tub ing, three tes t readings were taken using 
the TM -2420  device and compared w ith  three sim ultaneous readings 
from  the righ t arm taken using an automated device (Takeda U A-751, 
A & D  Engineering Inc., M ilp itas, Ca, USA). The positioning was 
deemed sa tis facto ry  if both systo lic and diastolic blood pressures 
d iffered by less than 5mmHg between the tw o  d e v i c e s 2 2 3  This 
procedure was repeated at the end o f the 24-hour recording to  check 
the re liab ility  o f the data, w h ich  was only accepted if the difference 
between the tw o  devices remained less than 5mmHg. Subjects kept a 
diary in w hich they recorded the ir daily activ ities including tim e o f going 
to  sleep and wakening. Mean 24-hour blood pressure, and mean 
daytim e and nocturnal blood pressures were calculated fo r each 
subject.
A t a final v is it, by w hich tim e subjects had been randomised to  
trea tm ent, m icrovascular hyperaemia in response to  local heating was 
measured on the dorsum o f the righ t fo o t as previously described (page 
43).
Results;
A spectrum  of values was observed fo r insulin sensitiv ity  and 6-cell 
function  in the subjects w ith  IGT (Table 5 .3 .2 ). M axim um
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m icrovascular hyperaemia showed a sign ificant negative correlation 
w ith  fasting plasma insulin concentration (Rg = -0 .7 0 ; p <  0 .0 0 1 ) {Fig 
5 .3 .1 ) and positive correlation w ith  insulin sensitiv ity  (Rg = 0 .5 2 ; 
p <  0 .02) (Fig 5 .3 .2 ). M ultip le regression analysis w ith  m axim um  
hyperaemia as the dependent variable and fasting plasma insulin 
concentration and insulin sensitiv ity  as the independent variables 
confirm ed a s ign ificant relationship between lim ited vasodilation and 
insulin level (t = -4 .5 3 , p < 0 .0 0 0 5 ), whereas insulin sens itiv ity  no 
longer showed a s ign ificant association (t = 1 .021 , p = 0 .3 ), 
probably as a result o f the relationship between fasting plasma insulin 
and insulin sensitiv ity  (Rg = -0 .56 , p <  0 .05 ). There w as no 
association o f maximum hyperaemia w ith  6-cell function  (p = 0 .5 ), 
plasma glucose concentration (p = 0 .8), w aist-h ip  ratio (0 .9), BMI 
(0.9) or serum lipid concentrations (p = 0.1 fo r to ta l cholesterol and 
HDL cholesterol; p = 0 .4  fo r LDL cholesterol; and p = 0 .8  fo r 
trig lycerides).
None of the subjects w ith  IGT had undetected hypertension on 24- 
hour am bulatory m onitoring and all had a normal diurnal rhythm  fo r 
arterial blood pressure, w ith  low er values during sleep (Table 5 .3 .2 ).
Discussion:
This study has fu rther explored the interactions o f c ircu la ting insulin 
w ith  m icrovascular function  in subjects w ith  IGT. Hyperinsulinaemia 
was associated w ith  reduced m icrovascular hyperaemia, in agreement 
w ith  the results o f Chapters 4.1 and 5.2 . Furthermore estim ated 
insulin sensitiv ity  has an inverse relationship w ith  lim ited vasodilation.
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Table 5 .3 .2  Insulin sensitivity^ B-ceii function and biood pressure in 
subjects with impaired glucose tolerance
F A S T I N G  P L A S M A  I N S U L I N  { / v U . m r ’ ) 9.3 (4 .6 -19 .3 )
I n s u l i n  s e n s i t i v i t y  ( % ) 8 0 .7  (1 9 .5 -178 .8 )
6 - c e l l  f u n c t i o n  ( % ) 87.1 (3 8 .5 -169 .4 )
D a y t i m e  m e a n  b l o o d  p r e s s u r e  ( m m H g ) 97 .3  (8 1 .6 -110 .2 )
N o c t u r n a l  m e a n  b l o o d  p r e s s u r e  ( m m H g ) 77.1 (67 .2 -97 .3 )
Data are shown as median and range
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Fig 5.3.1 Correlation between maximum hyperaemia and fasting 
plasma insulin concentration in subjects with impaired glucose tolerance
Z)a
co
c0)ocoo
3wc
CDE
CO
_CD
CL
25
20
15
10
R s  =  - 0 . 7  
P  <  0 . 0 0 1
0
À A
A A
A
A
0.60 0.80 1.00 1.20 1.40 1.60 1.80 2.00
Maximal hyperaemic response (V)
129
Fig 5 .3 .2  Correlation between maximum hyperaemia and calculated 
insulin sensitivity in subjects with impaired giucose tolerance
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In contrast 6-cell dysfunction  does not seem to  be an im portant 
determ inant o f reduced m icrovascular hyperaemia.
In the current study, there was little  evidence th a t other facto rs 
associated w ith  the insulin resistant state had any relationship to  
impaired m icrovascular function . There was no evidence o f undetected 
hypertension or loss o f diurnal rhythm  of arterial blood pressure on 24- 
hour am bulatory m onitoring, making it unlikely th a t such facto rs 
contribute  to  lim ited m icrovascular vasodilation. Plasma glucose levels 
were only s ligh tly  elevated (Table 5 .3 .1 ) and were below the trea tm ent 
ta rge t levels proposed fo r both IDDM and NIDDM patients. In v iew  o f 
th is  and also the lack o f association between plasma glucose 
concentration and reduced m icrovascular hyperaemia, th is  w ould not 
seem to  be a major determ inant o f lim ited vasodilation in subjects w ith  
IGT. Sim ilarly, there was no association between serum lipid levels 
and reduced hyperaemia, although only a fe w  subjects in the current 
s tudy had elevated cholesterol or trig lyceride levels (Table 5 .3 .1 ). The 
subjects w ith  IGT tended to  be overw eight, although again there was 
no association w ith  lim ited vasodilation and BMI or w aist-h ip  ratio 
(Table 5.3.1 ).
These results lend suggest th a t raised circulating levels o f insulin, 
as a result o f insulin resistance, may be having a detrim ental e ffe c t on 
m icrovascular cell function  in subjects w ith  IGT. A sim ilar association 
between plasma insulin and m icrovascular hyperaemia was observed in 
NIDDM patients in Chapter 4.1 and in insulin resistant patients w ith  
acromegally in Chapter 5 .2 . The m icrocircu la tory e ffects  o f insulin may 
be mediated through stim ulation o f m icrovascular cell p ro liferation, 
paralleling the e ffects  observed in cell culture e x p e r i m e n t s ^ S ,  1 4 3 - 5 ;  or 
via other pathways such as disturbances o f normal vasodilator
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mechanisms at a biochemical leve|25-28^ The mechanism o f impaired 
m icrovascular vasodilation is fu rthe r examined in Chapter 6.
Sum m ary
The studies in th is  chapter have demonstrated th a t abnormal 
m icrovascular function , in the fo rm  o f lim ited vasodilation, can be 
dem onstrated in the pre-diabetic phase in subjects w ith  IGT w ho are at 
risk o f developing NIDDM, and also in insulin resistant patients w ith  
acromegaly. There was no evidence o f abnormal 24-hour blood 
pressure profiles w hich could potentia lly  be related to  altered 
m icrovascular function  in the subjects w ith  IGT. The major facto rs 
related to  reduced m icrovascular hyperaemia at th is  stage are 
hyperinsulinaemia and insulin resistance, whereas mild hyperglycaemia 
and lipid abnormalities do not seem to  play a major role.
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CHAPTER 6
MECHANISM OF REDUCED MICROVASCULAR HYPERAEMIA
The preceding chapters have demonstrated th a t the major 
m icrovascular functional abnorm ality present in patients w ith  NIDDM, 
and in subjects at risk o f developing NIDDM who have IGT, is reduced 
m icrovascular hyperaemia. Impaired vasodilation may arguably be due 
to  abnormal neurovascular cell function  and/or s tructura l changes in the 
m icrocircu la tion. This chapter explores the role o f abnormal 
neurovascular cell function  in causing reduced maximum m icrovascular 
hyperaemia.
The mechanism o f m icrovascular vasodilation in response to  local 
heating o f the skin in normal subjects is unknown. Theoretica lly, it 
could be due to  one or more o f endothelium-dependent, endothelium - 
independent (myogenic), or neurogenic vasodilator m e c h a n i s m s ^ ^ s  |t 
is possible to  look at the in tegrity  of these mechanisms using the  
technique of iontophoresis^ w hich allows the transfer o f vasoactive 
substances d irectly  across the skin surface. This has advantages over 
other methods of adm inistration of pharmacological mediators in the 
study of the m icrocirculation, such as local in jection w hich  may itse lf 
cause hyperaemia due to  local traum a, and intra-arterial adm inistration 
w hich  may have e ffects  on proximal larger blood vessels. As 
previously discussed (Chapter 1.6, page 23), endothelium -dependent 
vasodilation occurs due to  the release o f EDRF, the major com ponent 
o f w h ich  has now  been identified as nitric oxide25. This acts on 
vascular sm ooth muscle cells to  cause vasodilation^^. Acetylcholine 
(ACh) is known to  stim ulate EDRF release from  endothelial cells, and 
iontophoresis o f ACh was therefore used to  assess endothelial
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dependent v a s o d i l a t i o n ^ 8 9 - 1 9 l  Sodium nitroprusside (NaNP) acts 
d irec tly  on vascular sm ooth muscle cells to  cause vasodilation and can 
therefore be used to  study endothelium-independent (or myogenic) 
v a s o d i l a t i o n ' * . Finally, iontophoresis o f ACh at a distance from  
the  site o f measurement leads to  an axon flare response and th is  can be 
used to  assess neurogenic v a s o d i l a t i o n ' *
In order to  try  and determ ine the earliest changes underlying 
impaired m icrovascular vasodilation, subjects w ith  IGT but not frank 
NIDDM were used in the studies in th is  chapter.
Subjects and M ethods:
Subjects
Seven subjects w ith  IGT (3M : 4F, age 62 (42-67) years, median 
and range) (Table 6.1) recruited consecutive ly from  the Exeter cohort o f 
the Fasting Flyperglycaemia Study (see Chapter 5.1) were studied. Six 
o f these had been randomised 1 to  3 months beforehand to  trea tm en t 
w ith  placebo tab lets, or the sulphonylurea gliclazide, in a dose of 80- 
1 60 mg daily, plus a diet and exercise program. The remaining subject 
had been randomised to  diet and exercise therapy alone. Seven age- 
and sex-matched non-diabetic contro l subjects w ith  no fam ily  h istory o f 
diabetes were selected from  a panel o f healthy volunteers and studied 
fo r comparison (Table 6.1).
None o f the partic ipants had hypertension, renal im pairm ent, or 
large vessel disease as previously defined (pages 82 and 88), and none 
were taking vasoactive m edication. Three of the subjects w ith  IGT
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Table 6.1 Clinical characteristics of subjects with impaired glucose 
tolerance and non-diabetic control subjects
IGT C o n t r o l
N  (M/F) 3 /4 3 /4
AGE (yr) 62 (42-67) 61 (45-66)
BMl (kg.m-2) 30 (24-32) 27 (25 -30 )
P la s m a  g lu c o s e  {m m ol.I -"*) 6.0  (5.1-6.8)9 5 .K 4 .8 -5 .4 )
Bl o o d  pr essu r e  (mmFIg)
Sy s t o l ic 124 (112-146) 122 (114-150)
D ia s t o l ic 72 (62-82) 70 (60-84)
Ba s a l  sk in  b lo o d  f l o w  (AU) 13.1 (6 .2 -23.5) 10 .0  (5 .1 -20 .8 )
Data are shown as median and range 
a p < 0 .0 2  vs control subjects
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were ex-smokers, w hile  one of the control subjects was a current 
sm oker and one an ex-smoker.
A ll subjects w ith  IGT were screened fo r m icrovascular disease, as 
previously described (pages 71 and 74) and in addition had retinal 
photography carried out^S. None had retinopathy or m icroalbum inuria, 
but one had evidence of mild (VPT = 23 V) and another moderate (VPT 
= 30 V) large fibre neuropathy.
M ethods
Iontophoresis was carried out on both forearms as described in 
Chapter 2 .3  (page 55) using the Moor iontophoresis system  and 
MBF3D perfusion m onitor (Moor Instrum ents Ltd, Axm inster, Devon). 
During the 30 m inute acclim atisation period average brachial blood 
pressure was determined from  the mean of three readings using an 
autom ated blood pressure recorder (Dynamap 845: C ritikon Inc,
Tampa, FI., USA). Data on mean basal blood flo w  (averaged from  all 
measurement sites fo r each subject) is given in Table 6 .1 . A t the end 
o f the s tudy a venous blood sample was taken to  measure am bient 
plasma glucose concentration.
Results:
The iontophoretic response to  ACh was s ign ificantly  reduced in the 
subjects w ith  IGT (518 (410-905) AU.min""* vs 1236 (875 -1588) 
AU .m in'^ control subjects, median and range; p <  0 .0 0 3  Mann- 
W hitney) (Fig 6.1). In contrast there was no sign ificant d ifference in 
the  ion tophoretic response to  NaNP (683 (301-1175) AU .m in'^ vs 898
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Fig 6.1 Iontophoretic response to acetylcholine in subjects With IG T
and contra! subjects (horizontal bars represent median values}
p <  0 .0 0 5
c
‘ E
<
0)«coato<D
TDO
CÛ
1800
1600
1400
1200
1000
800
600
400
200
0
▲
▲
▲
▲
▲
Control
subjects
IGT
subjects
137
Fig 6 .2  Iontophoretic response to sodium nitroprusside in subjects
with IG T and control subjects (horizontal bars represent median values)
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Fig 6 .3  Neurogenic vasodilation in response to AcetyichoUne in
subjects with IG T and control subjects (horizontal bars represent
median values)
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Fig 6 .4  Basal blood flow in subjects with IGT and control subjects 
(horizontal bars represent median values)
ID<
T 3O_oX»
“c5(OccGO
30
25
20
15
10
0
0 .5
A
A
A
A
Control
subjects
IGT
subjects
140
(303-998) AU.min"'* control subjects; p = 0.5) (Fig 6.2) or the 
neurogenic flare response to  ACh ( 61 (31-109) AU vs 46  (37-146) 
contro l subjects; p = 0.8) (Fig 6.3).
There was no d ifference in blood pressure (p = 0 .7 ), BMl (p = 0.4) 
or basal blood flo w  (p =  0.5) (Fig 6.4) between subjects w ith  IGT and 
contro l subjects, although plasma glucose concentration was 
s ign ificantly  higher in those w ith  IGT (6.0 (5 .1-6 .8) mmol.I"'* vs 5.1 
(4 .8 -5 .4 ) mmol.I"'*; p <  0 .02) (Table 6.1).
Discussion:
Endothelium-dependent vasodilation was reduced in subjects w ith  
IGT compared to  age- and sex-matched control subjects, suggesting 
the presence o f endothelial cell dysfunction. This is in agreement w ith  
the results o f previous studies looking at larger forearm  vessels in 
patients w ith  NIDDM using the technique of plethysmography^ 26 |p,
contrast, there was no reduction in myogenic or neurogenic 
vasodilation, although studies in larger vessels have show n reduced 
myogenic vasodilation in N I D D M " * 2 6 .  |n  view  o f the small sample size 
used, it is not possible to  exclude small d ifferences in m yogenic and 
neurogenic vasodilation between subjects w ith  IGT and contro l 
subjects, however, such changes would not be likely to  have a 
s ign ificant pathophysiological e ffec t in v iew  o f the major reduction in 
endothelium -dependent vasodilation.
There w as no d ifference in mean basal blood flo w  between subjects 
w ith  IGT and control subjects, suggesting th a t the results re flect a true 
reduction in endothelium -dependent vasodilation, rather than an
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apparent reduction due to  overperfusion under resting conditions in 
subjects w ith  IGT.
The molecular mechanisms underlying th is endothelial dysfunction  
are d iff ic u lt to  elucidate fu rthe r in v ivo. Hyperglycaemia-induced cell 
damage w ould not seem likely to  be a major factor, fo r although 
plasma glucose was s ign ificantly  higher In the IGT subjects, th is  was 
only elevated to  a m inor degree and was w ith in  the range associated 
w ith  an im provem ent in maximum m icrovascular hyperaemia in patients 
w ith  NIDDM described in Chapter 4 .2 . A lte rnative ly, it is possible th a t 
m inor degrees o f hyperglycaemia could lead to  more subtle changes in 
endothelial cell function  by activating or inhibiting various intracellular 
enzyme system s leading perhaps to an imbalance o f vasodilator and 
vasoconstric to r mediators. The ability o f insulin to cause m icrovascular 
cell hyperplasia has been previously discussed and it is possible th a t 
hyperinsulinaemia could lead to  reduced endothelium -dependent 
vasodilation by driving cells dow n a path tow ards cell division at the 
expense of secretory function . These potential mechanisms at the 
cellular level w ill require fu rther investigation in v itro  using cell culture 
techniques.
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CHAPTER 7 
SKIN CAPILLARY DENSITY
In addition to  defective neurovascular cell function , d ifferences in 
skin m icrovascular density could potentia lly contribute  to  dim inished 
hyperaemic responses, as an increased flo w  through a reduced number 
of capillaries could lead to  an underestimate of the blood flo w  response 
measured by laser Doppler flux im e try  due to  there being less change in 
to ta l flux. As mentioned in Chapter 1.2 (page 7), there is currently  
much interest in the role of impaired early vascular developm ent in the 
pathogenesis o f adult cardiovascular disease, and low  birth w e igh t has 
been associated w ith  hypertension^^ and premature death from  
ischaemic heart disease^G. Low birth w eigh t has also been associated 
w ith  an increased prevalence o f NIDDM and IGT in adult life*^®, 
possibly due to  m aldevelopment o f the pancreatic B-cells or islet 
vasculature.
The studies in th is chapter look at w hether there is decreased skin 
capillary density in subjects w ith  IGT and NIDDM. In addition to  
determ ining capillary density under basal conditions, measurements 
were repeated after a period o f venous occlusion in an a ttem pt to  
achieve a measure o f maximum capillary density, in order to  avoid 
confounding e ffects  o f potential d ifferences in basal tissue perfusion in 
the d iffe ren t groups.
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Subjects and Methods:
Subjects
Fifteen patients w ith  NIDDM (7M : 8F, age 57 (35-70) years, 
duration 5 (0 .5-14) years, median and range), 15 subjects w ith  IGT, 
and 15 non-diabetic contro l subjects were studied (Table 7.1). The 
groups were age- and sex- matched. W ith th is sample size the study 
had a 90%  power at the 5%  level o f detecting a d ifference in capillary 
density of 12 caps.m m ‘ 2. Patients w ith  NIDDM were recruited 
consecutive ly from  the Diabetic Clinic at the Royal Devon and Exeter 
Hospital, w hile  subjects w ith  IGT were recruited from  the Fasting 
Hyperglycaemia Study clin ic, and control subjects from  a panel of 
healthy volunteers.
None of the partic ipants had hypertension renal im pairm ent or large 
vessel disease as previously defined (pages 82 and 88). There were 
four ex-smokers and tw o  current smokers in the NIDDM group; five  ex­
smokers and one current smokers in the IGT group; and four ex­
smokers and one current smoker amongst the contro l subjects. Four 
NIDDM patients were treated w ith  d iet alone, five  w ith  oral 
hypoglycaem ic agents and six w ith  insulin; w hile  eleven of the 
subjects w ith  IGT were being treated w ith  gliclazide or placebo tab lets 
and the remainder w ith  a d iet and exercise program as described 
previously (page 106 and 107).
All o f the NIDDM patients and subjects w ith  IGT were assessed fo r 
the presence o f m icrovascular com plications (pages 71 and 74). Five 
NIDDM patients had retinopathy (3 background, 2 treated 
m aculopathy), three had large fibre neuropathy (VPT >  30 , w ith o u t 
previous fo o t ulceration) and four had m icroalbum inuria; whereas none
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Table 7.1 Clinical characteristics o f NIDDM patients, subjects with 
impaired glucose tolerance and non-diabetic control subjects
NIDDM IGT C o n t r o l
N  (M/F) 7/8 7/8 7/8
A g e  (yr) 57 (35-70) 54 (36-64) 57 (35-66)
BMl (k g .m -2 ) 27 (22-33) 27 (23-33) 25 (23-30)
Pl a s m a  GLUCOSE (mmol.I-"*) 7.6 (4.8-11.5) 5.7 (4.8-6.7) 4 .9  (4.2-5.5)
BLOOD p r e s s u r e  (mmFIg)
S y s t o l ic 136 (108-159) 123 (97-147) 128 (104-158)
DIASTOLIC 74 (62-89) 69 (51-82) 74 (64-88)
S k in  t e m p e r a t u r e  (^C) 32.1 (29.8-33.6) 32.0 (28.4-34.8) 32.2  (31.7-34.1 )
Data are shown as median and range
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o f the subjects w ith  IGT had retinopathy or m icroalbum inuria, and one 
had mild large fibre neuropathy (VPT = 25).
Methods
Capillary videom icroscopy was used to record images of the 
capillaries in the dorsal skin overlying the middle phalanx o f the  le ft 
m iddle finger. Recordings were made under basal conditions and 
fo llow ing  10 m inutes venous occlusion at 35 mmHg using an inflatable 
cu ff positioned around the proximal phalanx (Chapter 2 .4 , page 65). 
Mean capillary density (number o f capillaries in Im m ^) was determ ined 
from  measurements in six adjacent sites as described in Chapter 2 .4  
(pages 65 and 67).
A t the end of the study a venous blood sample w as obtained fo r 
assessment o f am bient plasma glucose concentration, and in the 
d iabetic subjects HbA-j^ (determined by a ffin ity  column 
chrom atography; normal range 4-6% ).
Results:
There were no s ign ificant differences between the three groups o f 
subjects in either basal capillary density (112 (71-144) caps.mm"^ 
NIDDM patients vs 107 (76-140) caps.m m ’ 2 IGT subjects vs 112 (76- 
138) caps.m m '2 control subjects; p =  0 .9  Kruskal Wallis) (Fig 7 .1), or 
capillary density after venous occlusion (122 (87-157) caps.m m ‘2 
NIDDM patients vs 121 (90-143) caps.mm'2 IGT subjects vs 123 (81- 
147) caps.mm"2 contro l subjects; p =  0.9) (Fig 7 .2). In addition, there 
w ere no differences in intra-individual variab ility  in basal capillary
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Fig 7.1 Basal capillary density in N IDDM patients, subjects with IGT,
and control subjects (horizontal bars represent median values)
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Fig 7 .2  Capillary density following venous occlusion in N IDDM  patients,
subjects with IGT, and control subjects (horizontal bars represent
median values)
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Fig 7 .3  Mean intra-individual variability in basal capillary density in
N ID D M  patients, subjects with IGT, and control subjects (horizontal
bars represent median values)
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density between the 6 sites in the d iffe ren t subject groups (CV = 7 .3  
(4 .2 -13 .0 ) % NIDDM patients vs 6.8 (4 .4 -11.2) % IGT subjects vs 6 .2  
(4 .0 -12 .5 ) % control subjects; p = 0.3) (Fig 7 .3).
A ll the groups were well matched fo r baseline characteristics w ith  
no differences in blood pressure (p = 0.1) or BMl (p = 0 .4 ), although 
plasma glucose concentration was sign ificantly higher in the NIDDM 
patients (Table 7.1). There w as no s ign ificant d ifference in skin 
tem perature (p = 0.3) between the three groups.
Discussion:
This study has demonstrated tha t there are no d ifferences in 
capillary density between patients w ith  NIDDM, subjects w ith  IGT or 
control subjects under basal conditions or fo llow ing  venous occlusion. 
The la tter was carried out in an a ttem pt to  assess m axim um  capillary 
density in case there were differences in basal tissue perfusion between 
the groups w hich m ight have masked a real d ifference. In addition, 
there was no difference in the hom ogeneity of perfusion under basal 
conditions between the three groups, as the median intra-individual CV 
fo r each group was sim ilar.
These results are in agreement w ith  those from  other studies, none 
o f w hich support the hypothesis o f impaired early m icrocircu la tory 
developm ent in skin or other tissues in patients w ith  NIDDM. In one 
study, derived skin capillary density calculated from  combined 
123xenon and  ^  ^  ^Indium-Pentetic acid clearance appeared, if anything, 
to  be increased in NIDDM p a t i e n t s ' *  * * 7 _  j p ,  the kidney, no decrease in 
glomerular number has been found in both IDDM and NIDDM patients 
w ith  nephropathy when compared to  non-diabetic subjects w ith  normal
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renal function , except in IDDM patients w ith  severe n e p h r o p a t h y 2 2 4 _  
In contrast, reduced skeletal muscle capillary density has been found in 
m orphom etric studies in obese subjects w ith  normal glucose 
t o l e r a n c e 2 2 5 , 2 2 6  although there are no data suggesting a sim ilar 
reduction in non-obese patients w ith  NIDDM or IGT.
This study had a 90%  power at the 5%  level o f detecting a 
difference in capillary density o f 1 2  c a p s . m m “2 .  Although a smaller 
d ifference in capillary density may have been missed, th is  w ould be 
unlikely to  be o f any practical im portance as it w ou ld  represent a 
d ifference o f less than 15%  in capillary number, and, if it is assumed 
th a t all capillaries are of sim ilar cross sectional area, a sim ilarly small 
d ifference in to ta l cross sectional area, thereby exerting only a 
negligible influence on blood flo w .
The dorsal skin o f the middle phalanx of the middle finger was 
chosen as the site of measurement in the current study as th is w as an 
easy area to  record. A lthough the site o f maximal hyperaemia response 
measurement was the dorsum of the foo t, there is no reason to  expect 
th a t comparison o f capillary density in tha t area between the groups 
would yield d iffe ren t results, as the changes of d iabetic m icrovascular 
disease are ubiquitous.
It is possible th a t d ifferences in epidermal or dermal skin th ickness 
could have masked differences in capillary density between the groups 
of subjects. A lthough no m orphom etric measures o f skin th ickness 
were made in the subjects in th is study, there is little  evidence from  
previous w ork  in patients w ith  diabetes to  suggest th a t d ifferences in 
skin th ickness exist227
In summary, these results do not support the concept th a t there is 
impaired early developm ent of the skin m icrocirculation in patients w ith  
diabetes or in subjects at risk o f developing diabetes in the fu tu re , and
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suggest th a t the observed differences in maximum m icrovascular 
hyperaemia do not relate to  reduced capillary density.
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CHAPTER 8
CONCLUSIONS
8.1 Sum m ary o f Results.
The w ork  in th is  thesis has explored the pathophysio logy of 
m icrovascular disease in NIDDM, by determ ining the presence o f early 
functional abnormalities in the skin m icrocirculation. In contrast to  the 
find ings in patients w ith  IDDM77,79^ patients w ith  NIDDM do not 
appear to  have elevated skin nailfold capillary pressure'*'*^ or increased 
forearm  m icrovascular flu id permeability (Chapter 3). The major early 
m icrovascular abnorm ality found in patients w ith  NIDDM is reduced 
vasodilation in response to  a varie ty o f s t i m u l i ' * 21,122^ and w hich is 
already present at d i a g n o s i s ' * 22. This does not appear to  be due to  
occu lt large vessel disease (Chapter 4.1) and may im prove after a 
prolonged period of good glycaemic control in recently diagnosed 
NIDDM patients (Chapter 4 .2 ). The presence o f hypertension in 
addition to  NIDDM does not lead to  a fu rther reduction in hyperaemic 
responses, but does result in increased resistance to  blood flo w  
(Chapter 4 .3).
A  sim ilar reduction in hyperaemic responses has been found in 
subjects at risk o f developing NIDDM w ho have IGT (Chapter 5 .1), and 
also in insulin resistant acromegalic patients (Chapter 5 .2). Limited 
vasodilation does not seem to  relate to  hyperglycaemia or 
hyperlipidaemia, but is associated w ith  hyperinsulinaemia and insulin 
resistance (Chapters 4 .1 , 5 .2 , and 5.3). The underlying mechanism 
of reduced m icrovascular hyperaemia appears to  involve a de fect in
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endothelium -dependent vasodilation (Chapter 6), in the context of 
normal skin capillary density (Chapter 7).
8 .2  Critical appraisal of the studies
The w ork  o f th is  thesis is based on the skin m icrocirculation w hich  
is ideal fo r non-invasive in vivo studies. This provides a useful model o f 
w ha t may be happening in other vascular beds, although specialisation 
o f function  in individual tissues means th a t results cannot be d irectly  
extrapolated. Studies of the skin m icrocirculation are o f some direct 
clin ical relevance in tha t fo o t ulceration, w hich is the com m onest 
cause of hospital admission in patients w ith  diabetes, u ltim ate ly 
represents local skin m icrovascular failure, albeit usually secondary to  a 
com bination o f neuropathy and large vessel disease plus superadded 
infection. L im itation o f protective m icrovascular hyperaemic responses 
w ill a ffec t the inflam m atory response to  infection and tissue damage, 
and w ill also contribute to  s low  ulcer healing^Ti.
M ost of the techniques used in th is thesis provide indirect measures 
o f m icrovascular function  and although they have been thoroughly 
validated against d irect techniques, fo r some there remains a degree o f 
debate about the interpretation of w ha t is actually being measured. For 
instance laser Doppler flux im e try  is thought to  measure to ta l 
m ultid irectional red cell flu x  w ith in  a volume o f tissue, w h ich  is 
obviously d iffe ren t to  unidirectional flo w , although in the absence of 
d ifferences in capillary density between control subjects and those w ith  
NIDDM and IGT (Chapter 7), th is is unlikely to  be of any practical 
im portance. Sim ilarly, assessment o f flu id perm eability using 
p lethysm ography may be critica lly  dependent on forearm  tissue
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com position and care was therefore taken to  ensure th a t no such 
differences existed between NIDDM patients and contro l subjects 
(Chapter 3). Great care was taken to  ensure the intra-individual 
reproducib ility over a period of tim e of all the techniques used (Chapter 
2 ).
Study design was cross-sectional and results w ill therefore require 
confirm ation in a prospective study. In v iew  o f the subject groups 
studied and the nature of the research, sample sizes were necessarily 
small. In Chapters 3 and 7, where no differences were found between 
patients and contro l subjects, preceding power calculations ensured 
th a t a clin ically relevant d ifference was not missed due to  small sample 
size.
Future studies are likely to  be enhanced by the emergence of new 
and more sophisticated techniques fo r assessing m icrovascular 
function . In the fu tu re  it is likely th a t simultaneous assessment of 
flo w , pressure and permeability in single capillaries in v ivo  w ill become 
possible, along w ith  technology allow ing in vivo assessment o f tissue 
oncotic pressure. W ith  regard to  the techniques used in th is thesis, 
more refined methods fo r the assessment of ion tophoretic responses 
such as a w ide area probe, or a laser Doppler scanner are already 
available, and prelim inary w ork  w ith  the latter holds great p r o m i s e 2 2 8
8 .3  A Unifying hypothesis to explain the pathophysiology and 
epidemiology of microvascular disease in NIDDM
In IDDM poor glycaem ic control results in precapillary vasodilation 
w ith  increased resting m icrovascular blood flo w  and pressure. In 
NIDDM increased m icrovascular pressure is attenuated w h ils t at the
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same tim e maximal vasodilatory capacity is severely lim ited at 
diagnosis o f the disease. This spectrum o f m icrocircu la tory 
abnorm alities is consistent w ith  an early rise in arteriolar resistance in 
NIDDM th a t is already present at diagnosis and w hich lim its  increases 
in capillary pressure and flu id filtra tion  when hyperglycaemia induces 
d ilation o f more distal, im m ediately pre-capillary, resistance elements 
{Fig 8.1). A t an early stage, in subjects w ith  IGT, hyperinsulinaemia 
may be the predom inant metabolic factor leading to  impaired 
vasodilation due to  its e ffects on m icrovascular cell pro liferation; w ith  
the emergence of NIDDM, hyperglycaemia may assume increasing 
im portance leading to  fu rther m icrovascular cellular dysfunction. This 
sequence o f events is in contrast to  the situation in IDDM, where 
hyperglycaemia is the major early m etabolic abnorm ality, although it is 
n o tew orthy  th a t after several years of diabetes, insulin resistance 
emerges in those patients prone to  develop nephropathy229 and a 
consequent increase in vascular resistance may help to  explain w hy  
there is no fu rther increase in capillary pressure in IDDM patients w ith  
advanced nephropathy230 compared to  those w ith  m icroalbum inuria^^ 
despite there being more marked hypertension in the form er group.
In NIDDM a rise in arteriolar resistance th a t antedates the diagnosis 
o f the  disease may partly explain the high prevalence of hypertension in 
th is  form  of diabetes, as well as the modified expression o f d iabetic 
m icroangiopathy w hich is apparent from  epidemiological studies. It is 
quite plausible th a t the m odifying influence of an early rise in arteriolar 
resistance may vary in d iffe ren t vascular beds, w ith  the m ost marked 
im pact being observed in skin and muscle, but less e ffec t in the 
kidney. This w ould not be surprising given tha t the glomerulus is a 
specialised structure w ith  both an afferent and an e fferent arteriole. 
A lthough capillary pressure at rest appears to  be normal in NIDDM,
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Fig 8.1 Postulated role of hyperinsulinaemia and hyperglycaemia in the 
pathogenesis of abnormal microvascular function in NIDDM
The pa thw ay outlined in bold is the dominant mechanism  in the  pre­
d iabetic state, while  hyperglycaemia may assume increasing 
im portance w ith  the development o f frank diabetes.
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such a finding does not negate the haemodynamic hypothesis in th is 
type  of diabetes. Despite the presence o f structural remodelling at an 
arteriolar level in response to  elevated arterial p r e s s u r e ^ ^ 9 ^  essential 
hypertension (in the absence of diabetes) is associated w ith  capillary 
hypertension^®^, i.e. the protection o f the capillary bed from  raised 
arterial pressure is incomplete. Arterial hypertension is com m on in 
NIDDM and assuming th a t autoregulation is sim ilarly incom plete in th is 
condition capillary hypertension may prevail in the hypertensive 
subpopulation who are at highest risk o f m i c r o a n g i o p a t h y ^ ^ i
Several fu ture lines of research are suggested on the basis o f the 
results of th is thesis and the above hypothesis. To fu rther explore the 
influence o f hyperinsulinaemia on m icrovascular function , studies of 
insulin resistant subjects w ith  normal glucose tolerance are required In 
addition, studies of other hyperinsulinaemic groups such as females 
w ith  po lycystic ovarian disease w ould be interesting. As previously 
discussed, there is a need fo r cell culture experiments to  look at the 
interactions o f hyperinsulinaemia and endothelial dysfunction  in v itro .
The abnormalities observed in the skin m icrocirculation require 
confirm ation in other m icrovascular beds in subjects w ith  IGT, and it 
w ould be possible to  look fo r abnormalities in retinal blood flo w  and 
retinal function  (e.g. colour vision); neurophysiology and nerve blood 
flo w ; and renal haemodynamics and glomerular charge and size 
se lectiv ity  using available techniques.
The role of raised capillary pressure in hypertensive NIDDM patients 
deserves fu rther consideration. Finally, it should be possible to  
investigate the association of reduced hyperaemia w ith  basement 
membrane or other structura l changes in skin using m orphom etric 
studies a fte r skin biopsy.
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In summary, the pattern o f disordered m icrovascular physiology in 
NIDDM d iffe rs from  th a t found in IDDM, w ith  the predom inant 
abnorm ality being an early reduction in vasodilation. It is hypothesised 
th a t th is may relate to  the e ffects of hyperinsulinaemia in the pre­
diabetic state and could partly explain the high prevalence of 
hypertension in NIDDM, and also the modified expression o f diabetic 
m icroangiopathy w hich is apparent from  epidemiological studies. W ith  
the onset o f NIDDM, hyperglycaemia may lead to fu rthe r functional 
and structura l changes in the m icrocirculation compounded by the 
e ffects  o f arterial hypertension and large vessel disease w hich are 
common in th is form  o f diabetes.
159
REFERENCES
1. Williamson JR, Kilo C. Current status of capillary basement-membrane 
disease in diabetes mellitus. Diabetes 1977; 26: 65-73.
2. Ajjam ZS, Barton S, Corbett M, Owens D, Marks R. Quantitative 
evaluation of the dermal vasculature of diabetics. Q J  M ed  1985; 54: 229- 
239.
3. Sueki H. Diabetic microangiopathy in subcutaneous fatty tissue. J  Cutan 
PathoJ ^Q87■ 14: 217-222.
4. Vracko R. Skeletal muscle capillaries in diabetics: a quantitative analysis.
Circu/ation  ^970} 41: 271-283.
5. Ledet T, Neubauer B, Christiansen NJ, Lundbaeck K. Diabetic cardiopathy. 
Diabeto/ogia '1979; 16: 207-209.
6. Malik RA, Newrick PG, Sharma AK et al. Microangiopathy in human 
diabetic neuropathy : relationship between capillary abnormalities and the 
severity of neuropathy. Diabetologia  ^989; 32: 92-102.
7. Jaap AJ, Tooke JE. Is microvascular disease important in the diabetic foot? 
In: Boulton AJM, Connor H, Cavanagh PR eds. The Foot in Diabetes 2nd 
Edn. John Wiley and Sons, Chichester, UK, 1994. 49-56.
8. Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual 
handicap in the West of Scotland. Br J  Ophthalmol ^988;  67: 209-213.
9. Rettig B, Teutsch SM. The incidence of end-stage renal disease in Type I 
and Type 2 diabetes mellitus. Diabetic Nephropathy 1984; 3: 26-27.
10. Panzram G. Mortality and survival in Type 2 (non-insulin-dependent) diabetes 
mellitus. Diabetoiogia ^987;  30: 123-131.
11. Greenfield ADM. The circulation through the skin. In: Hamilton WF ed.
Handbook o f Physiology - Circulation //. American Physiological Society, 
Washington DC, USA, 1963: 1325-1351.
160
12. Mescon H, Hurley J, MorettI G. The anatomy and histochemistry of the 
arteriovenous anastamosis in human digital skin. J  Invest Derm atol 1956; 
27: 133-144.
13. Grant RT, Bland EF. Observations on arteriovenous anastamoses in human 
skin and in the bird's foot with special reference to reaction to cold. Heart 
1931; 15: 385-411.
14. Hales JRS. Skin arteriovenous anastamoses, their control and role in
thermoregulation. In: Johansen K, Burggren WW eds. Cardiovascular
Shunts. Munksgaard, Copenhagen, Denmark, 1985. 433-451.
15. Vascular structure. In: Williams PL, Warwick R, eds. Gray's Anatom y,
36th edn. Churchill Livingstone, Edinburgh, London, Melbourne, New  
York, 1980. 622-630.
16. Levick JR. Solute transport between blood and tissues. In: An Introduction  
to Cardiovascular Physiology. Butterworth's, London, 1991. 117-141.
17. Martinez-Hernandez A, Amenta PS. The basement membrane in pathology. 
Lab Invest  ^988)  48: 656-677.
18. Levick JR. Circulation of fluid between blood, interstitium and lymphatics. 
In: An Introduction to Cardiovascular Physiology. Butterworth's, London, 
1991. 142-170.
19. Renkin EM. Relation of capillary morphology to transport of fluid and large 
molecules: a review. A cta  Physio! Scand ^919)  463: 81-91.
20. Curry FE, Michel CC. A fiber matrix model of capillary permeability. 
Microvascular Res ^980)  20: 96-99.
21. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed- 
Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno 
Hypothesis. Diabetologia \ 989 )  32: 219-226.
22. intaglietta M. Vasomation and flowmotion : physiological mechanisms and 
clinical evidence. Vase M ed Rev  ^990; 1: 101-112.
161
23. Johansson B. Myogenic tone and reactivity : definitions based on muscle 
physiology. J  Hypertens ^989)  7 (Suppl 4): 55-58.
24. Harder DR. Pressure-induced myogenic activation of cat cerebral arteries is
dependent on intact endothelium. Circ Res ^981)  60: 102-107.
25. Griffith TM, Edwards DH, Davies RLI, Harrison TJ, Evans KT. EDRF co­
ordinates the behaviour of vascular resistance vessels. Nature 1987; 329: 
442-445.
26. Kilbom A, Wennmalm A. Endogenous prostaglandins as regulators of blood
flow in man: effect of indomethacin on reactive and functional hyperaemia.
J  Physiol ^918)  247: 109-121.
27. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor
peptide produced by vascular endothelial cells. Nature 1988; 332: 411-
415.
28. Porta M, La Selva M, Molinatti P, Molinatti GM. Endothelial cell function in 
diabetic microangiopathy. Diabetologia 1987; 30: 601-609.
29. Kruithof EKO. Plasminogen activator inhibitors - a review. Enzyme 1988; 
40: 113-121.
30. Vanhoutte PM. Serotonin, adrenergic nerves, endothelial cells and vascular 
smooth muscle. Prog A pp i M icrocirc  1986; 10: 1-11.
31. Orlidge A, D'Amore PA. Inhibition of capillary endothelial cell growth by 
pericytes and smooth muscle cells. J  Cell Biol 1987; 105: 1455-1462.
32. Kuwabara T, Cogan DG. Retinal vascular patterns. VI. Mural cells of the 
retinal capillaries. Arch Ophthalmol ^998)  69: 492-502.
33. Takahashi K, Brooks R, Kanse 8 et al. Production of endothelin 1 by 
cultured bovine retinal endothelial cells and presence of endothelin receptors 
on associated pericytes. Diabetes  ^989)  38: 1200-1202.
34. Gall MA-, Rossing P, Skott P et al. Prevalence of micro- and macro­
albuminuria, arterial hypertension, retinopathy and large vessel disease in 
European Type 2 diabetic patients. Diabetologia 1991; 34: 655-661.
162
35. UK Prospective Diabetes Study 6. Complications in newly diagnosed Type 2 
diabetic patients and their associations with different clinical and biochemical 
risk factors. Diabetes Res 1990)  13: 1-11.
36. United Kingdom Prospective Diabetic Study III. Prevalence of hypertension 
and hypotensive therapy in patients with newly diagnosed diabetes. 
Hypertension 1985; 7 (Suppl 2): 8-13.
37. Reaven GM. Insulin resistance in human disease. Diabetes 1988; 37:
1595-1607.
38. Cahill GF Jr. Beta-cell deficiency, insulin resistance, or both? N  Eng! J  M ed  
1988; 318: 1268-1270.
39. Jarrett RJ, Keen H, Fuller JH, McCartney M. Worsening to diabetes in men 
with impaired glucose tolerance ('borderline diabetes'). Diabetologia 1979; 
16: 25-30.
40. Fuller JH, Shipley MJ, Rose G, Jarret RS, Keen H. Coronary-Heart- 
Disease-Risk and impaired glucose tolerance : The Whitehall Study. Lancet 
1980; I: 1373-1376.
41. Jarrett RJ, McCartney P, Keen H. The Bedford Study : Ten year mortality 
rates in newly diagnosed diabetics, borderline diabetics, and 
normoglycaemic controls and risk indices for coronary heart disease in 
borderline diabetics. Diabetologia 1982)  22: 79-84.
42. Strand ness D Jr, Priest RF, Gibbons GE. Combined clinical and pathological 
study of diabetic and non-diabetic peripheral arterial disease. Diabetes 1964; 
13: 366-372.
43. Stout RW. Insulin as a mitogenic factor: Role in the pathogenesis of
cardiovascular disease. Am  J  M ed 1991)  90 (Suppl 2A): 625-655.
44. Barker DJP, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size 
and risk of hypertension in adult life. Br M ed J  1990; 301: 259-262.
45. Barker DJP, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in 
infancy and death from ischaemic heart disease. Lancet 1989; I: 577-580.
163
46. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS. Type
2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia 
(Syndrome X) : relation to reduced fetal growth, Diabetologia 1993; 36:
62-67.
47. Klein R, Klein BEK, Moss SE, Davies MD, DeMets DL. The Wisconsin 
Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of 
diabetic retinopathy when age of diagnosis is less than 30 years. Arch  
Ophthalmol 1Q8A-) 102: 520-526.
48. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T.
Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: An
epidemiological study. Diabetologia 1983)  25: 496-501.
49. Melton LJ, Dyck PJ. Epidemiology. In: Dyck PJ, Thomas PK, Asbury AK, 
Winegrad Al, Porte Jr D, eds. Diabetic Neuropathy. WB Saunders, 
Philadelphia, 1987. 27-35.
50. Ziegler D, Mühlen H, Gries FA. Neurophysiological tests in Type 1 (insulin-
dependent) and Type 2 (non-insulin-dependent) diabetic patients with 
subclinical and symptomatic neuropathy. Diabetologia 1992; 35: 1099-
1100 .
51. Hendriksen PH, Oey PL, Wieneke GH, Bravenboer B, Banga JD. Subclinical 
diabetic neuropathy : similarities between electrophysiological results of 
patients with Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) 
diabetes mellitus. Diabetologia 1992) 35: 690-695.
52. Sima AAF, Nathaniel V, Bril V, McEwen TAGJ, Greene DA. 
Histopathological heterogeneity of neuropathy in insulin-dependent and non- 
insulin-dependent diabetes and demonstration of axo-glial dysjunction in 
human diabetic neuropathy. J  d in  Invest 1988; 81: 349-364.
53. Lehtinen JM, Uusitupa M, Siitonen 0 , Pyorala K. Prevalence of neuropathy 
in newly diagnosed NIDDM and non-diabetic control subjects. Diabetes 
1989; 38: 1307-1313.
164
54. Lehtinen JM, Niskanen H, Hyvonen K, Siitonen O, Uusitupa M. Nerve 
function and its determinants in patients with newly diagnosed Type 2 (non­
insulin-dependent) diabetes mellitus and control subjects. Diabetologia 1993; 
36: 68-72.
55. Ziegler D, Gries FA, Spühler M, Lessmann F. Diabetic Cardiovascular 
Autonomic Neuropathy Multicenter Study Group. The epidemiology of 
diabetic neuropathy. J  Diab Comp 1992] 6: 25-33.
56. Schmitz A, Vaeth M. Microalbuminuria : a major risk factor in non-insulin- 
dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic 
M ed 1988) 5: 126-134.
57. Tung P, Levin SR. Nephropathy in non-insulin-dependent diabetes mellitus. 
A m  J  Med 1988)  85 (Suppl 5A): 131-136.
58. Fabré J, Balant LP, Dayer PG, Fox HM, Vernet AT. The kidney in maturity 
onset diabetes: a clinical study of 570 patients. Kidney In t 1982)  21: 730- 
738.
59. Friedman R, Gross JL. Evolution of glomerular filtration rate in proteinuric 
NIDDM patients. Diabetes Care 1991)  14: 355-359.
60. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. 
Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent 
diabetes mellitus. Lancet 1982; i: 1430-1432.
61. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ. 
Microalbuminuria predicts mortality in non-insulin-dependent diabetes. 
Diabetic M ed 198A^) 1: 17-19.
62. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early 
mortality in maturity-onset diabetes. N Engl J  M ed 198A) 310: 356-360,
63. Knowler WC, Pettitt DJ. Six-year incidence of microvascular complications 
confirms the need to reassess diagnostic criteria for diabetes, Exerpta M ed  
in t Congr Ser 1919)  481: 122-123.
165
64. Klein R, Barrett-Connor EL, Blunt BA, Wingard DL. Visual impairment and 
retinopathy in people with normal glucose tolerance, impaired glucose 
tolerance and newly diagnosed NIDDM. Diabetes Care 1991; 14: 914-918.
65. Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC. 
Albuminuria in Type 2 (non-insulin-dependent) diabetes mellitus and impaired 
glucose tolerance in Pima Indians. Diabetologia 1989', 32: 870-876.
66. Kuroda N, Taniguchi H, Baba S, Yamamoto M. The pupillary light reflex in 
borderline diabetics. J  in t M ed Res 1989)  17: 205-211.
67. Parving H-H, Viberti GC, Keen H, Christiansen JS, Lassen NA. 
Haemodynamic factors in the genesis of diabetic microangiopathy. 
Metabolism 1988)  32: 943-949.
68. Tooke JE. Microvascular haemodynamics in diabetes mellitus. CUn Sci  
1986; 70: 119-125.
69. Zatz R, Brenner BM. Pathogenesis of diabetic microangiopathy: the
haemodynamic view. A m  J  Med 1989) 80: 443-453.
70. Gundersen HJG. Peripheral blood flow and metabolic control in juvenile 
diabetes. Diabetologia 191A^) 10: 225-231.
71. Popoff NW. The digital vascular system. Arch Pathoi 198A) 18: 295-330.
72. Partsch H. Neuropathies of the ulceromutilating types. Clinical aspects, 
classification, and circulatory measurements. Vasa 1977; Suppl 6: 1-48.
73. Boulton AJM, Scarpello JHB, Ward JD. Venous oxygenation in the diabetic 
neuropathic foot : evidence of arteriovenous shunting? Diabetologia 1982; 
2 2 : 6- 8 .
74. Corbin DOC, Young RJ, Morrison DC et al. Blood flow in the foot, 
polyneuropathy and foot ulceration in diabetes mellitus. Diabetologia 1987; 
30: 468-473.
75. Flynn MD, Edmonds ME, Tooke JE, Watkins PJ. Direct measurement of 
capillary blood flow in the diabetic neuropathic foot. Diabetologia 1988; 31: 
652-666.
166
76. Tymms JA, Tooke JE. The effect of continuous subcutaneous insulin 
infusion (CSII) on microvascular blood flow in diabetes mellitus. In t J  
M icrocirc d in  Exp 1988; 7: 347-356.
77. Sandeman DD, Shore AC, Tooke JE. Relation of skin capillary pressure in 
patients with insulin-dependent diabetes mellitus to complications and 
metabolic control. N  Engl J  M ed 1992]  327: 760-764.
78. Shore AC, Jaap AJ, Tooke JE. Capillary pressure in insulin dependent 
diabetic patients of long disease duration with and without microangiopathy. 
Diabetic M ed 1992)  9 (Suppl 2): S11. (Abstract).
79. Jaap AJ, Shore AC, Gartside IB, Gamble J, Tooke JE. Increased
microvascular fluid permeability in young Type 1 (insulin-dependent) diabetic 
patients. Diabetologia 1993; 36: 648-652.
80. Parving H-H, Noer I, Deckert T et al. The effect of metabolic regulation on 
microvascular permeability to small and large molecules in short-term juvenile 
diabetics. Diabetologia 1976)  12: 161-166.
81. Leinonen H, Matikainen E, Juntunen J. Permeability and morphology of 
skeletal muscle capillaries in Type 1 (insulin-dependent) diabetes mellitus. 
Diabetologia 1982) 22: 158-162.
82. Alpert JS, Coffman JD, Balodimos MC, Koncz L, Soeldner JS. Capillary
permeability and blood flow in skeletal muscle of patients with diabetes
mellitus and genetic prediabetes. N Engl J  Med 1972) 286: 454-460.
83. Parving H-H, Munkgaard Rasmussen S. Transcapillary escape rate of 
albumin and plasma volume In short- and long-term juvenile diabetics. Scand 
J  d in  Lab Invest 1973; 32: 81-87.
84. Parving H-H, Rossing N. Simultaneous determination of transcapillary escape
rate of albumin and IgG in normal and long-term juvenile diabetic subjects. 
Scand J  Clin Lab Invest 1973; 32: 239-244.
85. Rayman G, Hassan A, Tooke JE. Blood flow in the skin of the foot related
to posture in diabetes mellitus. Br M ed J  1986; 292: 87-90.
167
86. Hassan AAK, Tooke JE. Mechanism of the postural vasoconstrictor 
response in the human foot. Cf/n Sci 1988)  75; 379-387.
87. Shore AC, Price KJ, Sandeman DD, Tripp JH, Tooke JE. Abnormalities of 
the postural vasoconstriction response in diabetic children and adolescents. 
Diabetic M ed 1990)  7 (Suppl 2): 34A. (Abstract).
88. Rayman G, Williams SA, Spencer PD, Smaje LH, Wise PH, Tooke JE. 
Impaired microvascular hyperaemic response to minor skin trauma in Type 1 
diabetes. Br Med J  1986;  292: 1295-1298.
89. Walmsley D, Wales JK, Wiles PG. Reduced hyperaemia following skin 
trauma : evidence for an impaired microvascular response to injury in the 
diabetic foot. Diabetologia 1989;  32: 736-739.
90. Tooke JE, Ôstergren J, Lins P-E, Fagrell B. Skin microvascular blood flow 
control in long duration diabetics with and without complications. Diabetes 
/?es 1987; 5: 189-192.
91. Walmsley D, Wiles PG. Myogenic microvascular responses are impaired in 
long-duration Type 1 diabetes. Diabetic M ed 1990;  7: 222-227.
92. Shore AC, Price KJ, Sandeman DD, Green EM, Tripp JH, Tooke JE. 
Impaired microvascular hyperaemic response in children with diabetes 
mellitus. Diabetic M ed 1991;  8: 619-623.
93. Lembeok F. Sir Thomas Lewis' nocifensor system, histamine and substance 
P-containing primary afferent nerves. Trends Neurosci 1983; 6: 106-108.
94. Parkhouse N, Le Quesne PM. Impaired neurogenic vascular response in 
patients with diabetes and neuropathic foot lesions. N Engl J  M ed 1 988; 
318: 1306-1309.
95. Walmsley D, Wiles PG. Early loss of neurogenic inflammation in the human 
diabetic foot. CUn Sci 1991;  80: 605-610.
96. Tooke JE, Lins P-E, Ôstergren J, Fagrell B. Skin microvascular 
autoregulatory responses in Type 1 diabetes: the influence of duration and 
control. In t J  M icrocirc d in  Exp 1986;  4: 249-256.
168
97. Kastrup J, Norgaard T, Parving H-H, Lassen NA. Decreased distensibility of 
resistance vessels of the skin in Type 1 (insulin-dependent) diabetic patients 
with microangiopathy, d i n  Sci 1981;  72: 123-130.
98. Christiansen JS, Gammelgaard J, Frandsen M, Parving H-H. Increased 
kidney size, glomerular filtration rate, and renal plasma flow in short-term 
insulin-dependent diabetics. Diabetologia 1981; 20: 451-456.
99. Zatz R, Dunn R, Meyer TW, Anderson S, Rennke HG, Brenner BM. 
Prevention of diabetic glomerulopathy by pharmacological amelioration of 
capillary hypertension. J  d in  Invest 1986;  77: 1925-1930.
100. Parving H-H, Kastrup H, Smidt DM, Andersen AR, Feldt-Rasmussen BF, 
Sandahl Christiansen J. Impaired autoregulation of glomerular filtration rate 
in Type 1 (insulin-dependent) diabetic patients with nephropathy. 
Diabetologia 1984; 27; 247-252.
101. Kohner EM, Hamilton AM, Saunders SJ, Sutcliffe BA, Bulpitt CJ. The 
retinal blood flow in diabetes. Diabetologia 1975; 11: 27-33.
102. Chahal P, Falon TJ, Jennings SJ, Chowienczyk PJ, Kohner EM. Vitreous 
fluorophotometry in patients with no or minimal diabetic retinopathy. 
Diabetes Care 1986)  9: 134-139.
103. Patel V, Rassam S, Newsom S, Wiek J, Kohner E. Retinal blood flow in 
diabetic nephropathy. Br Med J  1992) 305: 678-683.
104. Grunwald JE, Riva CE, Sinclair SH, Brucker AV. Altered retinal vascular 
response to 100% O2 breathing in diabetes mellitus. Ophthalmol 1984; 91: 
1447-1452.
105. Tuck RR, Schmelzer JD, Low PA. Endoneurial blood flow and oxygen 
tension in the sciatic nerve of rats with experimental diabetic neuropathy. 
Brain 198A) 107: 935-950.
169
106. Low PA, Tuck RR, Dyck PJ, Schmelzer JD, Yao JK. Prevention of some 
electrophysiologic and biochemical abnormalities with oxygen 
supplementation in experimental diabetic neuropathy. Proc N atl A cad  Sol 
USA 1984; 81: 6894-6898.
107. Tesfaye S, Harris N, Jakubowski J, Mody C, Ward JD. Impaired blood 
flow and A-V shunting in human diabetic sural nerve. Diabetic M ed  1990; 7 
(Suppl 2): 29A (Abstract).
108. Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD. Sural 
nerve oxygen tension in diabetes. Br M ed J  1986; 293: 1053-1054.
109. Dyck PJ, Karnes JL, O'Brien P, Okazaki H, Lais A, Engelstad J. The 
spatial distribution of fiber loss in diabetic polyneuropathy suggests 
ischaemia. Ann Neurol 1986)  19: 440-449.
110. Korthals JK, Gieron MA, Dyck PJ. Intima of epineurial arterioles is increased 
in diabetic polyneuropathy. Neurology 1988) 38: 1582-1586.
111. Dyck PJ, Hansen S, Karnes J et al. Capillary number and percentage closed 
in human diabetic sural nerve. Proc Natl Acad Sci (USA) 1985; 52: 2513- 
2517.
112. Britland ST, Young RJ, Sharma AK, Clarke BF. Relationship of endoneurial 
capillary abnormalities to type and severity of diabetic polyneuropathy. 
Diabetes 1990) 39: 909-913.
113. Tooke JE. Capillary pressure in non-insulin-dependent diabetes. In ter Ang io l 
1983; 2: 167-171.
114. Flynn MD, Boolell M, Tooke JE, Watkins PJ. The effect of insulin infusion 
on capillary blood flow in the diabetic neuropathic foot. Diabetic M ed  1992; 
9: 630-634.
115. Shore AC, Jaap AJ, Tooke JE. Capillary pressure in patients with NIDDM. 
Diabetes 199A) 43: 1198-1202.
170
117. Katz MA, McCuskey P, Beggs JL, Johnson PC, Gaines JA. Relationship 
between microvascular function and capillary structure in diabetic and non­
diabetic human skin. Diabetes 1989; 38: 1245-1250.
118. Valensi P, Attali JR, Behar A, Sebaoun J. Isotopic test of capillary
permeability to albumin in diabetic patients: effects of hypertension,
microangiopathy, and duration of diabetes. Metabolism  1987; 36: 834-
839.
119. Valensi P, Attali JR, Behar A, Attalah M. Increased capillary permeability to 
albumin and diabetic neuropathy. Diabetes Res d in  Prac 1991; 11: 41-46.
120. O'Hare JA, Ferriss JB, Twomey B, O'Sullivan DJ. Poor metabolic control, 
hypertension and microangiopathy independently increase the transcapillary 
escape rate of albumin in diabetes. Diabetologia 1983; 25: 260-263.
121. Tur E, Yosipovitch G, Bar-On Y. Skin reactive hyperaemia in diabetic
patients. A study by laser Doppler flowmetry. Diabetes Care 1991; 14:
958-962.
122. Sandeman DD, Pym C, Green EM, Seamark C, Shore AC, Tooke JE. 
Microvascular vasodilation in feet of newly diagnosed non-insulin dependent 
diabetic patients. Br M ed J  1991;  302: 1122-1123.
123. Katz MA, McNeill G. Defective vasodilation response to exercise in
cutaneous precapillary vessels in diabetic humans. Diabetes 1987; 36:
1386-1396.
124. Menon RK, Grace AA, Burgoyne W, Fonseca VA, James IM, Dandona P. 
Muscle blood flow in diabetes mellitus. Evidence of abnormality after 
exercise. Diabetes Care 1992;  15: 693-695.
125. Laakso M, Edelman SV, Brechtel G, Baron AD. Impaired insulin-mediated
skeletal muscle blood flow in patients with NIDDM. Diabetes 1992; 41:
1076 - 1083 .
171
126. McVeigh GE, Brennan GM, Johnston GD et al. Impaired endothelium- 
dependent and independent vasodilation in patients with Type 2 (non-insulin- 
dependent) diabetes mellitus. Diabetologia 1992] 35: 771-776.
127. Ishida K, Ishibashi F, Takashina S. Comparison of renal haemodynamics in 
early non-insulin-dependent and insulin-dependent diabetes mellitus. J  Diab 
Comp 1991] 5: 143-145.
128. Vora JP, Dolben J, Dean JD et al. Renal haemodynamics in newly 
presenting non-insulin dependent diabetes mellitus. Kidney In t 1992; 41: 
829-835.
129. Grunwald JE, Riva CE, Martin DB, Quint AR, Epstein PA. Effect of an 
insulin-induced decrease in blood glucose on the human diabetic retinal 
circulation. Ophthalmol 1981] 94: 1614-1620,
130. Tesfaye S, Harris N, Jakubowski J, Mody C, Ward JD. Impaired nerve 
blood flow and arterio venous shunting in human diabetic sural nerve. 
Diabetic M ed 1990] 7 (Suppl 2): 29A. (Abstract).
131. Yoshida A, Kojima M, Ogasawara H, Ishiko S. Oscillatory potentials and 
permeability of the blood-retinal barrier in non-insulin-dependent diabetes 
mellitus without retinopathy. Ophthalmol 1991] 98: 1266-1271.
132. Myers BD, Nelson RG, Williams GW et al. Glomerular function in Pima 
Indians with non-insulin-dependent diabetes of recent onset. J  d in  Invest 
1991; 88: 524-530.
133. Schmitz A, Christensen T, Taagehoej Jensen F. Glomerular filtration rate 
and kidney volume in normoalbuminuric non-insulin-dependent diabetics. 
Lack of glomerular hyperfiltration and renal hypertrophy in uncomplicated 
NIDDM. Scand J  Clin Lab invest 1989] 49: 103-108.
134. Nelson RG, Loon N, Bennett PH, Berg RL, Mitch WE, Myers BD. 
Glomerular filtration and barrier function in non-insulin-dependent diabetes 
mellitus. Diabetes 1990] 39: 287A. (Abstract).
172
135. Ishibashi F, ishida K, Takashina S. The aetiology of microalbuminuria in
early non-insulin-dependent diabetes mellitus. J  Diab Comp 1991; 5: 107-
109.
136. Yamazaki M, Tani N, Igarashi K et al. Changes in the glomerular pore size
selectivity in patients with Type 2 diabetes mellitus. J  Diab Comp 1991; 5: 
138-139.
137. Ikenaga H, Suzuki H, Ishii N, Itoh H, Saruta T. Enzymuria in non-insulin-
dependent diabetic patients: signs of tubular cell dysfunction, d in  Sci 1993; 
84: 469-475.
138. Chiba Y, Tani N, Yamazaki M, Nakamura H, Ito S, Shibata A. Glomerular 
charge selectivity in non-insulin-dependent diabetes mellitus. J  Diab Comp 
1991; 5: 135-137.
139. Lorenzi M, Cagliero E, Toledo S. Glucose toxicicty for human endothelial 
cells in culture. Delayed replication, disturbed cell cycle, and accelerated 
death. Diabetes 1986', 34: 621-627.
140. Lee T-S, Saltsman A, Ohashi H, King GL. Activation of protein kinase C by
elevation of glucose concentration: proposal for a mechanism in the
development of diabetic vascular complications. Proc Natl A cad Sci USA 
1989; 86: 5141-5145.
141. Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides and 
sodium-potassium ATPase in the pathogenesis of diabetic complications. N  
Eng i J  Med 1981) 316: 599-606.
142. Brownlee M, Vlassara H, Cerami A. Non-enzymatic glycosylation and the 
pathogenesis of diabetic complications. Ann in t M ed 198A) 101: 527-537.
143. Pfeifle B, Ditschuneit H. Effect of insulin on growth of cultured human 
arterial smooth muscle cells. Diabetologia 1981) 20: 155-158.
144. King GL, Goodman AD, Buzney S, Moses A, Kahn CR et al. Receptors and 
growth-promoting effects of insulin and insulinlike growth factors on cells
173
from bovine retinal capillaries and aorta. J  d in  Invest 1985; 75; 1028-
1036.
145. Taggart H, Stout RW. Control of DNA synthesis in cultured vascular 
endothelial and smooth muscle cells. Atherosclerosis 1980; 37: 549-557.
146. Ledbetter SR, Wagner CW, Martin GR, Rohrbach DH, Hassel JR. 
Response of diabetic basement-membrane producing cells to glucose and 
Insulin. Diabetes 1987; 36: 1029-1034.
147. Ginsberg HN. Lipoprotein physiology in nondiabetic and diabetic states : 
relationship to atherogenesis. Diabetes Care 1991; 14: 839-855.
148. Bucala R, Tracey KJ, Cerami A. Advanced glycation products quench nitric 
oxide and mediate defective endothelium-dependent vasodilation in 
experimental diabetes. J  d in  Invest 1991; 87: 432-438.
149. Christlieb AR, Janka H-V, Kraus B et ai. Vascular reactivity to angiotensin II 
and norepinephrine in diabetic subjects. Diabetes 1976; 25: 268-274.
150. Viberti GC, Benigni A, Bognetti E, Remuzzi G, Wiseman MJ. Glomerular 
hyperfiltration and urinary prostaglandins in Type 1 diabetes mellitus. 
Diabetic M ed 1989; 6: 219-222.
151. Baynes JW. Role of oxidative stress in development of complications in 
diabetes. Diabetes 1991; 40: 405-412.
152. Williamson JR, Chang K, Frangos M et al. Hyperglycaemic pseudohypoxia 
and diabetic complications. D/abefes 1993; 42: 801-813.
153. Collier A, Rumley A, Rumley AG et al. Free radical activity and haemostatic 
factors in NIDDM patients with and without microalbuminuria. Diabetes 
1992; 41: 909-913.
154. Ford I, Singh TP, Kitchen S, Makris M, Ward JD, Preston FE. Activation 
of coagulation in diabetes mellitus in relation to the presence of vascular 
complications. Diabetic Med 1991 ; 8: 322-329.
174
155. Walmsley D, Hampton KK, Grant PJ. Contrasting fibrinolytic responses in 
Type 1 {insulin-dependent} and Type 2 (non-insulin-dependent) diabetes. 
Diabetic M ed 1991) 8: 954-959.
156. Ernst E, Matrai A. Alterations in red and white blood cell rheology in Type 2 
diabetes. Diabetes 1986) 35; 1412-1415.
157. Frier BM, Hilsted J. Does hypoglycaemia aggravate the complications of 
diabetes? Z.s/7cef 1985; 11: 1175-1176.
158. Viberti GC, Keen H, Wiseman M. Raised arterial pressure in parents of 
proteinuric insulin-dependent diabetic patients. Br M ed J  1987; 295: 515- 
517.
159. Mangili R, Bending JJ, Scott GS, Li LK, Gupta A, Viberti GC. Increased 
sodium-lithium countertransport activity in red cells of patients with insulin- 
dependent diabetes and nephropathy. N E ng /J  M ed  1988; 318: 146-149.
160. Ubbink DT, Jacobs MJ, Tangelder GJ, Slaaf DW, Reneman RS. Posturally 
induced microvascular constriction in patients with different stages of leg 
ischaemia: effect of local skin heating. CUn Sci 1991) 81: 43-49.
161. Bongard 0 , Fagrell B. Discrepancies between total and nutritional skin 
microcirculation in patients with peripheral arterial occlusive disease. Vasa 
1990; 19: 105-111.
162. Junger M, Frey-Schnewlin G, Bollinger A. Microvascular flow distribution 
and transcapillary diffusion at the forefoot in patients with peripheral 
ischaemia. In t J  M icrocirc CUn Exp 1989) 8: 3-24.
163. McEwan AJ, Ledingham IM. Blood flow characteristics and tissue nutrition 
in apparently ischaemic feet. Br M ed J  1911) ill: 220-224.
164. Seifert H, Jager K, Bollinger A. Analysis of flow motion by the laser Doppler 
technique in patients with peripheral arterial occlusive disease. In t J  
M icrocirc d in  Exp 1988) 7: 223-236.
175
165. Ubbink DT, Jacobs MJ, Slaaf DW, Tangelder GJ, Reneman RS. 
Microvascular reactivity differences between the two legs of patients with 
unilateral lower limb ischaemia. Eur J  Vase Surg 1992; 6: 269-275.
166. Ubbink DT, Jacobs MJ, Slaaf DW, Tangelder GJ, Reneman RS. Capillary 
recruitment and pain relief on leg dependency in patients with severe lower 
limb ischaemia. Circulation 1992-, 85: 223-229.
167. Jacobs MJ, Beches RG, Jorning PJ, Slaaf DW, Reneman RS. 
Microvascular haemodynamics before and after vascular surgery in severe 
limb ischaemia. Eur J  Vase Surg 1990) 4: 525-529.
168. Williams SA, Boolell M, MacGregor GA, Smaje LH, Wassermann S, Tooke 
JE. Capillary hypertension and abnormal pressure dynamics in patients with 
essential hypertension, d in  Sci 1990) 79: 5-8.
169. Williams SA, Tooke JE. Noninvasive estimation of increased structurally- 
based resistance to blood flow in the skin of subjects with essential 
hypertension. In t J  M icrocirc d in  Exp 1992) 11: 109-116.
170. Orlandi C, Rossi M, Finardi G. Evaluation of the dilator capacity of skin 
blood vessels of hypertensive patients by laser Doppler flowmetry. Microvasc 
/?es 1988; 35: 21-26.
171. Carberry PA, Shepherd AMM, Johnson JM. Resting and maximal forearm 
skin blood flows are reduced in hypertension. Hypertension 1992; 20: 349- 
355.
172. Parving H-H, Gyntelberg F. Transcapillary escape rate of albumin and plasma 
volume in essential hypertension. Circ Res 1973; 32: 643-651.
173. Whitney RJ. The measurement of volume changes in human limbs. J  Physioi 
1953; 121: 1-27.
174. Gamble J, Garside IB. A four-channel recording system using an IBM PC/XT 
compatible computer for low frequency data sampling during mercury-in- 
rubber strain gauge plethysmography in humans. J  Physioi 1989; 413: 7p 
(abstract).
176
175. Gamble J, Gartside IB, Christ F. A Reassessment of mercury in silastic 
strain gauge plethysmography for microvascular permeability assessment in 
man. J  Physio! 1998) 464: 407-422.
176. Poulson HL, Nielsen SL. Water filtration in the forearm in short- and long­
term diabetes mellitus. Diabetologia 1916) 12: 437-440.
177. Henriksen O. Local nervous mechanism in regulation of blood flow in human 
subcutaneous tissue. Acta Physioi Scand 1911) 97: 385-391.
178. Fauchald P, Norseth J, Jervell J. Transcapillary colloid osmotic gradient, 
plasma volume and interstitial fluid volume in long-term Type 1 (insulin- 
dependent) diabetes. Diabetologia 19Q6\ 28: 269-273.
179. Gartside IB, Gamble J. Apparatus for the production of step changes in cuff 
pressure for venous occlusion plethysmography in man. J  Physioi 1991; 
438: 10p. (Abstract).
180. Nilsson GE, Oberg PA, Tenland T. A new instrument for continuous 
measurement of tissue blood flow by light beating spectroscopy. iEEE Trans 
Biomed Eng 1980) 27: 12-19.
181. Kiel JW, Riedel GR, Di Resta GR, Shepherd AP. Gastric mucosal blood flow
measured by laser Doppler velocimetry. Am  J  Physioi 1985; 249: G539-
G545.
182. Stern MD, Lappe DL, Bowen PD et al. Continuous measurement of tissue 
blood flow by laser Doppler spectroscopy. Am  J  Physioi 1911) 232: H441- 
H448.
183. Saumet JL, Dittmar A, Leftheriotis G. Non-invasive measurement of skin 
blood flow: comparison between plethysmography, laser-Doppler flowmeter 
and heat thermal clearance method, in t J  M icrocirc CUn Exp 1986; 5: 73- 
83.
184. Tooke JE, Ôstergren J, Fagrell B. Synchronous assessment of human skin 
microcirculation by laser Doppler flowmetry and dynamic capillaroscopy. in t 
J  M icrocirc CUn Exp 1 983; 2: 277-284.
I l l
185. Nilsson GE, Tenland T, Oberg PÂ. Evaluation of a laser Doppler flowmeter
for measurement of tissue blood flow. IEEE Trans Biomed Eng 1980; 27:
697-604.
186. Fagrell B. Laser Doppler flowmetry for evaluating skin microcirculation and its 
relation to nutritional capillary flow. In t J  Microcirc C/in Exp 1984; 3: 434.
187. Saumet JL, Kellogg DL Jr, Taylor WF, Johnson JM. Cutaneous laser-
Doppler flowmetry: influence of underlying muscle blood flow. J  A pp i
Physioi 1988] 65: 478-481.
188. Johnson JM, O'Leary DS, Taylor WF, Kosiba W. Effect of local heating
and cooling on forearm reactive hyperaemia. CUn Physioi 1986; 6: 337-
346.
189. Westerman RA, Widdop RE, Hannaford J et al. Laser Doppler velocimetry in 
the measurement of neurovascular function. A ust Phys Eng Sci M ed  1988; 
11: 53-66.
190. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells In the
relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:
373-376.
191. Westerman RA, Widdop RE, Low A, Hannaford J, Kozak W, Zimmet P. 
Non-invasive tests of neurovascular function: reduced axon reflex responses 
in diabetes mellitus of man and streptozotocin-induced diabetes of the rat. 
Diabetes Res CUn Prac 1988; 5: 49-54.
192. Walmsley D, Wiles PG. Assessment of the neurogenic flare response as a 
measure of nociceptor C fibre function. J  Med Eng Technoi 1990; 14: 194-
196.
193. Parkhouse N, Le Quesne PM. Quantitative objective assessment of 
peripheral nociceptive C fibre function. J  Neurol Neurosurg Psych 1988; 51: 
28-34.
178
194. Hornyak ME, Naver HK, Rydenhag B, Wallin BG. Sympathetic activity
influences the vascular axon reflex in the skin. Acta Physio! Scand 1990;
139; 77-84.
195. Flynn MD, Williams SA, Tooke JE. Clinical television microscopy. J  Med  
Eng T e c h n o iim O ]  13: 278-284.
196. Anderson RR, Parrish JA. The optics of the human skin. J  Investigative  
Dermatol 1981] 77: 13-19.
197. Fowler CJ, Carroll MB, Burns D, Howe N, Robinson K. A portable system 
for measuring cutaneous thresholds for warming and cooling. J  Neurol 
Neurosurg Psychiatry 1987; 50: 1211-1215.
198. Wiles PJ, Pearce SM, Rice PJS, Mitchell JMO. Vibration perception
threshold: influence of age, height, sex and smoking, and calculation of
accurate centile values. Diabetic M ed 1991) 8: 157-161.
199. Michel CC. The investigation of capillary permeability in single vessels. Acta  
Physio! Scand 1919) 463 (Suppl): 67-74.
200. Shami SK, Chittenden SJ, Sarin S. Microvascular vasodilation in non-insulin 
dependent diabetes. Br M ed J  1991) 302: 1465.
201. Scarpello JHB, Martin TRP, Ward J. Ultrasound measurement of pulse-wave
velocity in the peripheral arteries of diabetic subjects, d in  Sci 1980; 58:
53-57.
202. Ferrier TM. Radiologically demonstrable arterial calcification in diabetes
mellitus. Austra l Ann M ed 196A) 13: 222-228.
203. Tovey FI, Karanjia N, Plant GR, Rees M. Oscillotonometry : a simple non- 
invasive method of differentiating proximal arterial obstruction from distal 
microangiopathy in the vascular assessment of diabetics. Practical Diabetes 
1990; 7: 203-205.
204. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME. Enzyme 
immunoassay for intact human insulin in serum or plasma, d in  Chem 1992; 
39: 578-582.
179
205. The Diabetes Control and Complications Trial Research Group. The effect of 
Intensive treatment of diabetes on the development and progression of long­
term complications in insulin-dependent diabetes mellitus. N  Engl J  M ed  
1993; 329: 977-986.
206. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 
(UKPDS) VIII. Study design, progress and performance. Diabetologia 1991) 
34: 877-890.
207. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic 
neuropathy. Br M ed J  1982) 285: 916-918.
208. Camerini-Davalos RA, Velasco C, Glasser M, Bloodworth JMB Jr. Drug- 
induced reversal of early diabetic microangiopathy. N  Engi J  M ed  1983; 
309: 1551-1556.
209. Raskin P, Pietri AO, Unger R, Shannon WA Jr. The effect of diabetic
control on the width of skeletal muscle capillary basement membrane in 
patients with type 1 diabetes mellitus. N Eng! J  M ed  1983; 309: 1546-
1550.
210. Ulrych M. Pathogenesis of essential hypertension : Role of the postcapillary 
segment of the circulation. Angiology 1979) 30: 104-116.
211. Pecoraro RE, Ahroni JH, Boyko EJ, Stensel VL. Chronology and 
determinants of tissue repair in diabetic lower extremity ulcers. Diabetes 
1991; 40: 1305-1313.
212. WHO Study Group. Report on diabetes mellitus. World Health Organisation, 
Technical Report Series 727, 1990, Geneva.
213. Forrest RD, Jackson CA, Yudkin JS. The abbreviated glucose tolerance test 
in screening for diabetes: the Islington diabetes survey. Diabetic M ed  1988; 
5: 557-561.
214. Finch CF, Zimmet PZ, Alberti KGMM. Determining diabetes prevalence : a 
rational basis for the use of fasting plasma glucose concentrations? Diabetic 
M ed 1990) 7: 603-610.
180
215. Melmed S. Acromegaly. N  Eng! J  Med 1990', 322: 966-75.
216. Wass JAM, Cudworth AG, Bottazzo G, Woodrow JC, Besser GM. An
assessment of glucose tolerance in acromegaly and its response to medical
treatment. Clin Endocrinol 1980) 80: 53-59.
217. Wright AD, Hill DM, Lowy C, Russel Fraser T. Mortality in acromegaly. Q
J  Med 1910) 39\ 1-13.
218. Teale JD, Marks V. Inappropriately elevated plasma insulin-like growth 
factor II in relation to insulin-like growth factor I in the diagnosis of non-islet 
cell tumour hypoglycaemia. Clin Endocrinol 1990; 33: 87-98.
219. Clemmons DR, Van Wyk JJ, Ridgway EC, Klinman B, Kjellberg RN, 
Underwood LE. Evaluation of acromegaly by radioimmunoassay of 
somatomedin-C. N Engl J  M ed 1919) 301: 1138-1142.
220. Hosker JP, Matthews DR, Rudenski AS et al. Continuous infusion of
glucose with model assessment : measurement of insulin resistance and S-cell 
function in man. Diabetologia 1986) 28: 401-411.
221. Nakano S, Uchida K, Kigoshi T et al. Circadian rhythm of blood pressure in 
normotensive NIDDM subjects. Its relationship to microvascular 
complications. Diabetes Care 1991) 14: 707-711.
222. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study
(UKPDS) XI; Biochemical risk factors in Type 2 diabetic patients at diagnosis 
compared with age- matched normal subjects. Diabetic M ed  1994; 11:
534-544.
223. White WB. Assessment of ambulatory blood pressure recorders : accuracy
and clinical performance, d in  Invest Med 1991) 14: 202-211.
224. Bendtsen TF, Nyengaard JR. The number of glomeruli in Type 1 (insulin- 
dependent) and Type 2 (non-insulin-dependent) diabetic patients. 
Diabetologia 1992) 35: 844-850.
181
225. Lîthell H, Lindgarde F, Heiising K et al. Body weight, skeletal muscle 
morphology and enzyme activities in relation to fasting serum insulin 
concentration and glucose tolerance in 48-year old men. Diabetes 1981; 30: 
19-25.
226. Lillioja S, Young AA, Culter CL et al. Skeletal muscle capillary density and 
fibre type are possible determinants of in vivo insulin resistance in man. J  
d in  invest 1981) 80; 415-424.
227. Malik RA, Metcalfe J, Sharma AK, Day JL, Rayman G. Skin epidermal 
thickness and vascular density in Type 1 diabetes. Diabetic M ed  1992; 9: 
263-267.
228. Warden K, Naver HK, Nilsson GE, Wallin BG. The cutaneous vascular axon 
reflex in humans characterised by laser Doppler perfusion imaging. J  Physioi 
1993; 460: 185-199.
229. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin 
resistance in insulin-dependent diabetic patients with microalbuminuria. 
Z.s/7cer 1993; it: 883-887.
230. Sandeman DD, Shore AC, Tooke JE. Captopril reduces nailfold capillary 
pressure in Type 1 diabetic patients with established nephropathy. Diabetic 
M ed 1991) 8 (Suppl 1): 37A.
231. Knowler WC, Bennett PH, Ballintine EJ. Increased incidence of retinopathy 
in diabetics with elevated blood pressure. A six-year follow-up study in Pima 
Indians. N Engl J  M ed 1980) 302: 645-650.
182
